Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.  )

Filed by the RegistrantFiled by a Partyparty other than the Registrant


CHECK THE APPROPRIATE BOX:
Preliminary Proxy Statement
Confidential, Forfor Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Under Rule 14a-12under §240.14a-12

aflac_logo.jpg
Aflac Incorporated

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Thanother than the Registrant)


PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX)ALL BOXES THAT APPLY):
No fee required.required
Fee paid previously with preliminary materials
Fee computed on table belowin exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
Fee paid previously with preliminary materials:
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
1) Amount previously paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:

Table of Contents

Notice of

2021

Annual Meeting

of Shareholders and Proxy Statement

Monday, May 3, 2021 at 10 a.m. ET




01_424611-3_fc.jpg


Table of Contents

Our Long-Term Growth Strategy

About Aflac Incorporated

Table of Contents

Notice of 2021

Annual Meeting of Shareholders

You are cordially invited to attend the Annual Meeting of Shareholders (“Annual Meeting”) of Aflac Incorporated (the “Company”), through its subsidiaries, provides financial protection to our millions of policyholders and customers worldwide. The Company’s principal business is supplemental health and life insurance products with the goal to provide customers the best value in supplemental insurance products in the United States (U.S.) and Japan. For nearly seven decades, insurance policies of the Company’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. In the U.S., Aflac is the number one provider of supplemental health insurance products. Aflac Life Insurance Japan is the leading provider of cancer and medical insurance policies in force in Japan.

Our Goal
 To provide customers with the best value in supplemental 
 insurance products in the United States and Japan. 
Our Long-Term Growth Strategy
Our strategy for growth in the U.S. and Japan has remained straightforward and consistent for many years. The Company develops relevant supplemental health insurance products offering financial protection from the rising out-of-pocket expenses associated with medical events that are not covered by the insureds’ primary coverage. We also offer a complement of other voluntary and employer-paid health and life insurance products to fit the needs of its customers. Additionally, the Company aims to obtain more customers by selling where customers prefer to purchase protection, whether through an agent or broker, a distribution partner, or directly to the consumer.
pgxx-pic_eggs.jpg
In this Proxy Statement, the terms “Company,” “we,” or “our” refer to Aflac Incorporated. The Company’s insurance business consists of two reporting segments: Aflac Japan and Aflac U.S. The primary insurance subsidiary in the Aflac Japan segment is Aflac Life Insurance Japan Ltd. (ALIJ). This year’s Annual Meeting willAflac U.S. includes the insurance subsidiaries American Family Life Assurance Company of Columbus (Aflac); Continental American Insurance Company, branded as Aflac Group Insurance; American Family Life Assurance Company of New York (Aflac New York); and Tier One Insurance Company; as well as Aflac Benefits Solutions (ABS), which provides a platform for Aflac Dental and Vision in the U.S. The term “Aflac Global Investments” refers to the Company’s asset management subsidiary, Aflac Asset Management LLC, and its management subsidiary in Japan, Aflac Asset Management Japan Ltd.
References to websites included in this Proxy Statement are provided solely for convenience purposes. Content on the websites, including content on our Company website, is not, and shall not be a completely “virtual meeting”deemed to be, part of shareholders:

this Proxy Statement or incorporated herein or into any of our other filings with the Securities and Exchange Commission.


2024 PROXY STATEMENTDate1
NOTICE OF 2024 ANNUAL MEETING OF SHAREHOLDERS
You are cordially invited to attend the Annual Meeting of Shareholders (“Annual Meeting”) of Aflac Incorporated. This year’s Annual Meeting will be held virtually.
You will be able to attend the Annual Meeting, vote, and Timesubmit your questions during the webcast. The Annual Meeting will be held for the following purposes, all of which are described in the accompanying Proxy Statement:
Virtual (online only)(1)Record DateLogistics
page1_dateandtime.jpg
DATE AND TIME
May 3, 2021
6, 2024
10:00 a.m. ETEastern Time
page1_ivirtual.jpg
VIRTUAL (ONLINE ONLY)
www.virtualshareholdermeeting.com/AFL2021 Using AFL2024 using your 16-digit control number included on your proxy card or notice
February 23, 2021
proposal_1.jpg

You will be able to attend the Annual Meeting, vote, and submit your questions during the webcast. The Annual Meeting will be held for the following purposes, all of which are described in the accompanying Proxy Statement:

DescriptionBoard’s Recommendation
for.jpg
Proposal 1
Page 1
To elect as Directors of the Company the eleventen nominees named in the accompanying Proxy Statement to serve until the next Annual Meeting and until their successors are duly elected and qualifiedFOR eachEach of the eleventen director nominees
Proposal 2
Page 29
page01_icon-noticearrow.jpg
See page13
page01_recorddate.jpg
RECORD DATE
February 27, 2024
proposal_2.jpg
for.jpg
To consider a non-binding advisory proposal on the Company’s executive compensation (“say-on-pay”)
page01_icon-noticearrow.jpg
See page38
FOR
How to Vote
It is important that you vote your shares. We offer several easy and cost-effective voting methods for your convenience.
Proposal 3
Page 62
proposal_3.jpg
for.jpg
To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 20212024
page01_icon-noticearrow.jpg
FOR

In addition, any other business properly presented may be acted upon at the meeting and at any adjournments or postponements of the meeting.

How to Vote

It is important that you vote your shares. We offer several easy and cost-effective voting methods for your convenience.

InternetTelephoneMail
See page 77
In addition, any other business properly presented may be acted upon at the meeting and at any adjournments or postponements of the meeting.
The accompanying proxy is solicited by the Company’s Board of Directors on behalf of the Company. The Proxy Statement and the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, are enclosed.(1) The record date for determining which shareholders are entitled to vote at the Annual Meeting is February 27, 2024. Only shareholders of record at the close of business on that date, or their duly appointed proxies, will be entitled to vote at the Annual Meeting and any adjournment thereof. For more information on how to attend the virtual Annual Meeting, please see Appendix B of the Proxy Statement.
Your vote is important! Even if you expect to attend the virtual Annual Meeting, please vote in advance. If you attend the Annual Meeting online, you may revoke your proxy by submitting a vote during the Annual Meeting.
We are making the Proxy Statement and the form of proxy first available on or about March 21, 2024.
By order of the Board of Directors,
page01_signmloudermilk.jpg

page01_internet.jpg
INTERNET
Visit www.proxyvote.com.www.proxyvote.com. You will need the 16-digit control number that appears on your proxy card or notice.
page01_elephone.jpg
TELEPHONE
If your shares are held in the name of a broker, bank, or other nominee, follow the telephone voting instructions, if any, provided on your proxy card. If your shares are registered in your name, call 1-800-690-6903 and follow the telephone voting instructions. You will need the 16-digit control number that appears on your proxy card.
page01_mail.jpg
MAIL
If you received a full package by mail, complete and sign the proxy card and return it in the enclosed postage pre-paid envelope.

The accompanying proxy is solicited by the Company’s Board of Directors on behalf of the Company. The Proxy Statement and the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, are enclosed.(2) The record date for determining which shareholders are entitled to vote at the Annual Meeting is February 23, 2021. Only shareholders of record at the close of business on that date will be entitled to vote at the Annual Meeting and any adjournment thereof.

Your vote is important! Even if you expect to attend the virtual Annual Meeting, please vote in advance. If you attend the Annual Meeting online, you may revoke your proxy by submitting a vote during the Annual Meeting.

By order of the Board of Directors,

J. Matthew Loudermilk

Secretary

March 18, 2021

Columbus, Georgia

(1)We continue to monitor developments regarding the coronavirus (COVID-19). In the interest of the health and well-being of our shareholders, the Annual Meeting will be held solely by means of remote communication.
(2)
J. Matthew Loudermilk
Corporate Secretary
March 21, 2024
Columbus, Georgia

(1)Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be held on May 3, 2021:6, 2024: This Proxy Statement and the Annual Report are available at proxyvote.com.
icon-qrcode.jpg
TABLET OR SMARTPHONE
Scan the QR code that appears on your proxy card or notice using your mobile device.


2AFLAC INCORPORATED
LETTER FROM THE CHAIRMAN,
CHIEF EXECUTIVE OFFICER AND PRESIDENT
March 21, 2024
Dear Fellow Shareholders:
As I reflect on 2023, I am very proud that our management, employees and sales distribution teams have continued to be resilient stewards of our business. Our goal is to provide customers with the best value in supplemental insurance products in the United States and Japan.
As we embark on 2024, we will celebrate our 50th year of doing business in Japan and 50th year as a publicly traded company on the NYSE. We also are reminded that one thing has not changed since our founding in 1955: families and individuals still seek to protect themselves from financial hardship that not even the best health insurance covers. Today’s complex health care environment has produced incredible medical advancements – with incredible costs – and it’s more important than ever to have a partner. With our inventive approach to offering relevant products, we believe we are that partner.
Growth
For 2023, Aflac Incorporated reported $4.7 billion in net earnings, or $7.78 earnings per diluted share. As a result, net earnings per diluted share rose 12.3%. Adjusted earnings per diluted share* were $6.23, the best year in history despite a weakening yen and the impact of a reinsurance retrocession late in the fourth quarter. When adjusting for the $0.19 per diluted share impact of the yen, adjusted earnings per diluted share excluding the impact of foreign currency* were $6.43, which was a 13.4% increase year over year.
I am pleased with our sales growth in both Japan and the U.S. In early 2023, Aflac Japan completed the rollout of our new cancer product, and we rolled out our new medical product in mid-September that appeals to younger policyholders and provides an opportunity to older policyholders to update their coverage. In the U.S., we enhanced our cancer policy, delivering even greater value to our policyholders. At the same time, we continue to concentrate on scaling up our network dental and vision and our group life and disability businesses in the U.S. in an additional effort to grow our core supplemental health business.
We have also improved persistency in the United States while maintaining strong persistency in Japan well above 90%. We will continue to pursue profitable growth in both the U.S. and Japan with an eye toward improving and maintaining strong persistency.
Strategic Capital Deployment
We place significant importance on continuing to achieve strong capital ratios in the U.S. and Japan on behalf of our policyholders and shareholders. In addition, we have taken proactive steps in recent years to defend cash flow and deployable capital against a weakening yen. We pursue value creation through a balance of actions including growth investments, stable dividend growth and disciplined, tactical stock repurchase.
2023 marked the 41st consecutive year of dividend increases. We treasure our track record of dividend growth and remain committed to extending it, supported by the strength of our capital and cash flows. Last quarter, the Board put us on a path to continue this record when it increased the first quarter 2024 dividend 19% to $0.50. Additionally, we have remained tactical in our approach to repurchasing shares throughout 2023, which led to the historically high $700 million per quarter. As a result, we deployed $2.8 billion in capital to repurchase nearly 39 million of our shares in 2023. Combined with dividends, this means we delivered over $3.8 billion back to shareholders in 2023, while also investing in the growth of our business. At the same time, we have maintained our position among companies with the highest return on capital and lowest cost of capital in the industry.
I like to think that it is efforts like the above that lead to recognition such as appearing on Fortune’s List of World’s Most Admired Companies for the 23rd time, ranking No. 1 in the Insurance: Life and Health industry as a long-term investment for the second consecutive year. Overall, I think we can say that 2023 was another strong year.
We believe in the underlying strengths of our business and our potential for continued growth in Japan and the U.S. – two of the largest life insurance markets in the world. We are well-positioned as we work toward achieving long-term growth while also ensuring we deliver on our promise to policyholders.
2021
*     Adjusted earnings per diluted share and adjusted earnings per diluted share excluding foreign currency impact are not calculated in accordance with generally accepted accounting principles in the United States (GAAP). See Appendix A to this Proxy Statementiii for the definition of these non-GAAP measures and reconciliation to the most comparable GAAP financial measure.


LETTER FROM THE CHAIRMAN, CHIEF EXECUTIVE OFFICER AND PRESIDENT2024 PROXY STATEMENT3

Table of Contents

Letter from the Chairman and Chief Executive Officer

March 18, 2021

Dear Fellow Shareholder:

When I wrote this letter last year, it would have been very difficult to foresee the gravity of what was soon to unfold for our society and for our company due to COVID-19. 2020 was certainly a year that tested the world, including all of us at Aflac Incorporated. While pandemic conditions are ongoing, I am proud to say that 2020 confirmed what I knew all along: the Company is strong, adaptable and resilient.

I want to thank you, our shareholders, as well as our employees and our sales distribution for supporting the people-first initiatives we spearheaded in both the U.S. and Japan in response to the COVID-19 pandemic. In Japan and the U.S., these actions included introducing work-from-home staffing models for our employees to ensure business continuity; expanding COVID-19 coverage and enhancing claims payment protocols to help get funds in the hands of policyholders when they needed us most; expanding premium payment grace periods; interest-free loans; virtual technology initiatives for our sales force; and charitable contributions to help frontline workers.

Consistent with our culture and identity as a socially responsible company, and given our remote working conditions, we stepped up our engagement with our employees through virtual town hall meetings and weekly touch-base letters in which we affirmed our commitment to being there for our policyholders, supporting our employees and sales teams personally and professionally, and creating an ongoing dialogue about social justice among other topics. We advanced our Environmental, Social, and Governance (ESG) disclosures with a dedicated report outlining our ESG policies and adoption of a formal reporting framework for going forward. We were pleased to appear on Fortune’s List of World’s Most Admired Companies for the 20th time, ranking in the Life and Health Category at No. 5 for “Long-Term Investment Value” and No. 3 for both “Use of Corporate Assets” and “Global Competitiveness.”

Even amid the challenges of the current backdrop, we remain focused on helping to provide protection to our policyholders, growing our business, being a good corporate citizen, and driving shareholder value. In doing so, we’ve gained the trust of more than 50 million people worldwide. Following are some additional highlights that stand out from 2020:

GROWTH

While sales were impacted considerably in both Japan and the U.S. due to constrained face-to-face opportunities associated with social distancing protocol and the COVID-19 pandemic, we did anything but sit still. We maintained forward motion, accelerating investment in our platforms and technology while continuing strong earnings performance. In 2020, Aflac Incorporated generated $4.8 billion in net earnings, or $6.67 per diluted share, up 44.6% and 50.6% from last year, respectively, and an increase in adjusted earnings per diluted share on a currency-neutral basis of 10.8% to $4.92, driven by a reduction in the tax rate and higher share accretion. Our results are especially meaningful given pandemic conditions, the low-interest-rate environment in Japan, and absorbing our extensive investments in the business to drive future earned premium growth, which will remain a critical strategic focus for 2021.  

STRATEGIC CAPITAL DEPLOYMENT

We place significant importance on continuing to achieve strong capital ratios in the U.S. and Japan on behalf of our policyholders and shareholders. When it comes to capital deployment, we pursue value creation through a balance of actions including growth investments, stable dividend growth, and disciplined, tactical stock repurchase. Accordingly, our Board of Directors increased the cash dividend 3.7% in 2020, marking the 38th consecutive year of dividend increases. We are very proud of and seek to extend this track record, which is supported by the strength of our capital and cash flows and evidenced by the announcement of a 17.9% increase in the quarterly cash dividend effective with the first quarter of 2021. Fortunately, we entered this pandemic in a very strong capital and liquidity position, which allowed us to confidently repurchase $1.5 billion, or 37.9 million of our shares, in 2020, consistent with our tactical

iv
05_424611-3_pic_letter_amos_d.jpg
Aflac Incorporated
We are well-positioned as we work toward achieving long-term growth while also ensuring we deliver on our promise to policyholders.
Doing the Right Thing: The Aflac Way
Doing the right thing is engrained in The Aflac Way, which has been the cornerstone of how we do business in the U.S. and Japan. Operating this way, we are privileged to help provide financial protection to our policyholders during their time of need. We believe in cultivating and welcoming diversity in our operations, workforce, management team, and Board. We have found that this approach makes good business sense by enabling us to serve our customers better. Plus, we believe people want to do business with a company doing the right thing. As the pioneer of supplemental cancer insurance in both the U.S. and Japan, it has perhaps been most visible in our dedication to children facing cancer and other serious diseases. 2023 marked the 28th year of our partnership with the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, which has become nationally renowned as one of the leading childhood cancer, hematology, and blood and marrow transplant programs in the United States. Contributions from our all-commission sales force, our employees, our executives and Board have exceeded the $173 million mark. 2023 also represented the 23rd year of our partnership with the Aflac Parents House in Japan. Over the years, more than 150,000 pediatric patients and their family members have
called one of the three Aflac Parents House locations a home-away-from home while receiving treatment for cancer or other serious diseases. We also just completed the fifth full year in the U.S. and the fourth full year in Japan of offering My Special Aflac Duck, our smart comforting companion that helps children feel less alone by using state-of-the-art interactive technology during their cancer treatment.
As you will note, Dr. Barbara Rimer will be retiring and not standing for re-election at the 2024 annual meeting. I would like to take this opportunity to express my gratitude to Dr. Rimer for her many years of insightful contributions and dedicated service to the Company since 1995. Her service was invaluable, especially during the pandemic, and we are so grateful.
With these topics as a backdrop, we are privileged to be stewards of the trust and resources you, our owners, place in Aflac Incorporated every day, and we thank you for your support.
It is my pleasure to invite you to virtually attend the 2024 Annual Meeting of Shareholders on Monday, May 6, 2024, where you can learn more about Aflac Incorporated’s recent business performance and strategy for the future. I encourage you to review the proxy materials and Annual Report on Form 10-K as well as Aflac Incorporated’s most recent Business
and Sustainability Report. Then, please vote your shares, even if you plan to attend the virtual Annual Meeting. We want to be sure your shares and your viewpoints are represented.
Sincerely,
page03_sigdamos.jpg
Daniel P. Amos
CHAIRMAN, CHIEF
EXECUTIVE OFFICER AND PRESIDENT

Table of Contents

Letter from the Chairman



4AFLAC INCORPORATED
LETTER FROM THE LEAD
NON-MANAGEMENT DIRECTOR
March 21, 2024
Dear Fellow Shareholders:
It is an honor to serve you as Lead Non-Management Director, alongside such an eminent team of Directors. These fellow Board members bring their skills, expertise and experience from such a broad range of fields, industries and companies. In 2023, we maintained our focus on overseeing the risk and strategy of the Company. In this letter, I want to highlight some of the key topics of oversight in 2023.
Risk Oversight
Our Board provided oversight of the pertinent risks both for the industry and to the Company, while carefully monitoring traditional risks associated with investments and our products and maintaining strong capital ratios. The Board has overseen significant advancements in information security and enhanced information security policy. The goal is to ensure that the Company’s information assets, data, and the data of our customers, are protected.
Board Succession, Refreshment and Onboarding
Our Board retains its balance of tenured members as well as a refreshment with newer members. Independent Board members average about six years of service that provide a balance of expertise for you, the shareholders. Our Board is diverse not only with women and/or people of color comprising approximately 60% of its membership, but also in terms of experience and expertise in a wide range of disciplines, including public health, cybersecurity, investment and finance, insurance operations, the Japanese market, regulatory and risk
management, and marketing and public relations. By combining a diversified membership with such broad expertise and multi-disciplinary skills, we have established an adaptable, insightful and cohesive board that is equipped to pivot quickly to navigate ever-evolving markets.
I also want to thank Dr. Barbara Rimer for her many years of service on the Board. In anticipation of this event, the Board was fortunate to have maintained public health expertise on the Board with the addition of Dr. Miwako Hosoda in 2023. Dr. Hosoda brings nearly 30 years of experience in the field of public health in Japan, our largest market.
Corporate Finance and Investments
In 2023, our investment portfolio continued to benefit from our disciplined strategic asset allocation process. This approach serves as the core to managing long-term asset performance expectations to meet our objectives for capital, risk and liquidity. We also placed equity investments in specialized asset classes as well as Sustainability investments. The Aflac Global Investments team has built a high-quality portfolio that we believe will serve our stakeholders well no matter the economic environment.
Strategic Corporate Development
As we pursue new ways to meet the needs of consumers, businesses and shareholders, we will continue to invest in our network dental and vision and group life, disability, and absence management platforms.
These new business lines modestly impact the top line in 2023. We will continue to leverage these new platforms to enable our core products for future long-term growth.
Commitment To Sustainability
Aflac Incorporated has been carbon neutral in Scope 1 and Scope 2 emissions since 2020 and focused on being and achieving net zero emissions by 2050. We will continue to evaluate and evolve our approach to achieving our objectives.
We have posted our Sustainability Policies and Statements at investors.aflac.com under “Sustainability” for several years, and we updated them in 2023 with Occupational Health and Safety in the Workplace and Responsible Investment Stewardship and Engagement policies. Such transparency and efforts to improve our sustainability have received external recognition, too. In 2023, Aflac Incorporated was included on the Dow Jones Sustainability North America Index for the 10th time and on Bloomberg’s Gender-Equality Index for the fourth consecutive year. Most recently, Ethisphere recognized Aflac Incorporated as one of the World’s Most Ethical Companies for the 18th consecutive year, remaining the only insurance company in the world to receive this honor every year since this award was first introduced in 2007.


LETTER FROM THE LEAD NON-MANAGEMENT DIRECTOR2024 PROXY STATEMENT5
05_424611-3_pic_letter_bowers_p.jpg
“As we shape the Aflac of the future, we do so knowing the Company’s success and financial performance are rooted in our commitment to our purpose.”
In addition, we have also worked to be a reflection of the communities that we serve by being an inclusive workplace and cherishing the value that diversity can bring. To reinforce our commitment to sustainability, officers have had a short-term incentive compensation modifier based on core sustainability targets since 2021. While the modifier led to no adjustment to officers’ short-term incentive compensation in 2023, we are still proud of our achievements related to responsible investing, diverse leadership and use of sustainable electricity.
Shareholder Engagement
We are proud to have been the first publicly traded company in the United States to voluntarily allow shareholders a say-on-pay vote. This is a prime example of how we are responsive as a Board and as a Company to our shareholders. We communicate with our shareholders on a regular basis to understand the issues and concerns that are important. We incorporate this feedback into our
decision-making process. We believe that open communications can have a positive influence on our performance, and we look forward to continuing open discussion with our shareholders going forward.
As Lead Non-Management Director, I will continue to engage with our investors, seek insight into their perspectives, and explore the viewpoints and positions of those who invest in our business.
The Board looks forward to continuing its ongoing dialogue with investors and applying that feedback to help inform business matters as they emerge. We thank you for your support and the privilege of representing you in Aflac Incorporated.
With these vital topics in mind, I encourage you to review the accompanying Proxy Statement and associated materials and vote before our virtual Annual Meeting on May 6, 2024. It is my pleasure, and my privilege, to serve on Aflac Incorporated’s Board, and I look forward, as a fellow shareholder, to witness how the Company works every day to uphold its promises.
Sincerely,
page03_sigbowers.jpg
W. Paul Bowers
LEAD NON-MANAGEMENT
DIRECTOR


6AFLAC INCORPORATED
TABLE OF CONTENTS


2024 PROXY STATEMENT7
2023 BUSINESS HIGHLIGHTS
In 2023, the Company delivered strong operating results.
image_businessHighlightDuck.jpg
NET EARNINGS
EARNINGS PER DILUTED
SHARE (EPS)
RETURN ON EQUITY (ROE)
$4.7B
5.5%p
$7.78
12.3%p
22.1%
ADJUSTED EARNINGS EX-FX*ADJUSTED EPS EX-FX*
ADJUSTED RETURN ON
EQUITY (AROE) EX-FX*
$3.8B
6.4%p
$6.43
13.4%p
14.2%
NEW ANNUALIZED PREMIUM
SALES(1) - AFLAC JAPAN
(IN YEN)
NEW ANNUALIZED PREMIUM
SALES(1) - AFLAC U.S.
10.9%p
5.0%p
CASH DIVIDENDREPURCHASED SHARES
3-YEAR TOTAL
SHAREHOLDER
RETURN (“TSR”)
5.0%p
$2.8B+99.6%
*Adjusted earnings and adjusted earnings per diluted share, excluding foreign currency impact, and AROE, excluding foreign currency impact, are not calculated in accordance with generally accepted accounting principles in the United States (GAAP). See Appendix A to this Proxy Statement for definitions of these non-GAAP measures and reconciliations to the most comparable GAAP financial measures.
(1)As discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2023 Annual Report on Form 10-K.
Prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts. For more complete information regarding the Company’s 2023 performance, please review the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.


8AFLAC INCORPORATED2023 BUSINESS HIGHLIGHTS
Corporate Social Responsibility and Chief Executive Officer

approach. We believe our capital position, by any measure, remains robust given our risk profile, and we continue to have among the highest return on capital and lowest cost of capital in the industry. We place significant importance on continuing to achieve a strong risk-based capital (RBC) and solvency margin ratio (SMR) on behalf of our policyholders and shareholders alike in the U.S. and Japan. Through a combination of dividends and share repurchase, we returned about $2.3 billion to our shareholders in 2020.

CORPORATE CULTURE OF DOING THE RIGHT THING – THE AFLAC WAY

While this was a year filled with unparalleled challenges, our belief in fostering and welcoming all forms of diversity and viewpoints in our operations remains unchanged throughout our workforce, management team, and in the composition of our Board. Not only is this the right approach to take, but it enhances our ability to respond to all of our constituents and live up to the commitments we make to our customers, to our fellow employees and to all the people who rely on us.

Sustainability Highlights

At Aflac Incorporated, we have worked to bebelieve that all things being equal, most people prefer doing business with a company that is also a good corporate citizencitizen. We refer to this as “The Aflac Way,” which is the outward manifestation of our belief that ethics, corporate citizenship, and success go hand in hand. Our efforts include helping families facing childhood cancer and blood disorders such as sickle cell, conducting business with ethics and compassion, providing development and wellness opportunities for decades. It’sour workforce, being ever-mindful of our environmental impact, and serving the right thing to do. We have capturedcommunity through efforts such as helping families facing childhood cancer and blood disorders. This philosophy is woven into our daily operations, our culture, and our actions in the community.
page08_workdiversity.jpg
Workforce Diversity
As of December 31, 2023, women accounted for 54% of Aflac Japan employees and 33% of Aflac Japan leadership roles. Women also held 27% of Aflac Japan management roles, as part of Aflac Life Insurance Japan Ltd’s longer-term plan to increase this percentage to 30% by 2025.
As of December 31, 2023, 49% of Aflac U.S. and the Company employees located in the U.S. were people of color and 66% were women. Women also occupied 51% of leadership roles located in the U.S. and 37% of senior management roles located in the U.S. In 2023, 57% of new hires located in the U.S. were people of color and 68% were women.
page08_community.jpg
Community Investment and Philanthropy
My Special Aflac Duck®is a “smart” robotic companion designed to help childrenwith cancer and sickle cell disease. We aim to put a My Special Aflac Duck in the hands of every child, age 3 and above, diagnosed with cancer and sickle cell disease in the U.S., Japan and Northern Ireland and has given My Special Aflac Ducks to more than 27,000 children through 2023.
We and our employees and agents are responsible for:
More than 150,000 pediatric patientsand their family members who have called Aflac Parents House a home-away-from-home while receiving treatment for serious illnesses, like cancer.
$173 million in support of Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, helping make it one of the top pediatric cancer programs in the United States by U.S. News and World Report.
page08_environment.jpg
Environment
Reduced combined Scope 1 and 2 market-based greenhouse gas emissions by more than 90% from 2007 to 2022
Expect 2023 to be the 4th consecutive year for being carbon neutral for Scope 1 and 2 emissions
Goal of net zero emissions by 2050
We are proud of our Corporate Social Responsibility Report for more than 10 years,commitments and will do so in our integratedthe accolades we have received, a handful of which are listed below, and we invite you to read Aflac Incorporated’s most recent Business and Sustainability Report going forward. I don’t think it’s a coincidence that we have achieved success while focusing on doingat investors.aflac.com under the right things for our policyholders, shareholders, employees, sales distribution, business partners, and communities. I’m proud of what we have accomplished in terms of both our social purpose and financial results, which have ultimately translated into strong, long-term shareholder return.

Doing the right thing is embodied in The Aflac Way, which is woven into the actions of those who represent the Company everywhere. One of the seven commitments of the Aflac Way I referred to in my letter last year was “Treat Everyone with Respect and Care,” and I am proud to say that this commitment was honored time and time again in 2020. This commitment extends to our outreach into the communities in which we do business and operate. This takes shape in various ways within the Aflac family, but most prominently in our dedication to children facing cancer and their families. In addition to marking the 65th year since Aflac Incorporated’s founding and the Aflac Duck’s 20th birthday, 2020 marked the 25th anniversary of our partnership with the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta. It also marked the second year in the U.S. and the first full year in Japan of My Special Aflac Duck, our smart comforting companion that helps children feel less alone by using interactive technology during their cancer treatment.

In closing, I would like to express my gratitude to you, our shareholders, for putting your faith, confidence, trust, and resources in Aflac Incorporated. As we look ahead, delivering on our promise to be there for all of our constituents—you, our shareholders; our employees and sales force; and our policyholders and customers—will remain our priority because that is not only what sets us apart, it’s just who we are.

With these updates as a backdrop, it is my pleasure to invite you to virtually attend the 2021 Annual Meeting of Shareholders on Monday, May 3, 2021, where you can learn more about Aflac Incorporated’s recent business performance and strategy for the future. I encourage you to review the enclosed proxy materials and Annual Report on Form 10-K as well as Aflac Incorporated’s 2020 Business and Sustainability Report, which can be found at esg.aflac.com,“Sustainability” tab to learn more about our company and our latest accomplishments. Then, please vote your shares, even if you plan to attend the virtual Annual Meeting. We want to be sure your shares and your viewpoints are represented.

Sincerely,

Daniel P. Amos

CHAIRMAN AND CHIEF EXECUTIVE OFFICER

2021 Proxy Statementv
initiatives.
page08_pri2.jpg
page08_djsi2.jpg
06_424611-3_log_wmac.jpg
Principles for Responsible Investment (PRI) Signatory
In 2021, Aflac Incorporated became a PRI Signatory, which works to understand the investment implications of ESG factors and to support its international network of investor signatories in incorporating these factors into investment and ownership decisions.
Dow Jones Sustainability North America Index (10th year),
In 2023, the Company was included in the North American index and received high marks for Corporate Governance, Information Security/Cybersecurity & System Availability, and Tax Strategy.
Fortune’s World’s Most Admired Companies (23rd year),
ranking No. 1 in the Insurance: Life and Health category as a long-term investment for the second consecutive year.
pgxx_logo-civic 50points.jpg
06_424611-3_log_wme.jpg
pg8-gfx_bloomberg.jpg
Points of Light’s Civic 50 List (6th consecutive year),
which showcases how leading companies are moving social impact, civic engagement and community to the core of their business.
Ethisphere’s World’s Most Ethical Companies (18th consecutive year),
making it the only insurance company in the world to hold this distinction every year since the inception of the honor in 2007.
Bloomberg’s Gender-Equality Index (4th consecutive year),
which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation, and transparency.


2024 PROXY STATEMENT9

Table of Contents

Letter from the Lead Non-Management Director

March 18, 2021

To My Fellow Shareholders:

I am privileged to serve as Lead Non-Management Director, working with an esteemed team of Board members who demonstrate expertise and acumen in a broad range of disciplines. In the face of an unimaginable, challenging year, the resolve of this Board was stronger than ever as we leveraged our expertise to oversee Aflac Incorporated’s effective and comprehensive response to the global COVID-19 pandemic. Throughout it all, we worked together as one team, while maintaining corporate governance practices and focusing on our business continuity and strategy. I want to share some of the key areas on which my fellow directors and I have focused this past year.

GLOBAL COVID-19 PANDEMIC RESPONSE: ILLUSTRATES THE IMPORTANCE OF A WELL-ROUNDED BOARD

Just as we promote diversity within our Company operations, we cultivate diversity and well-rounded expertise within our Board to ensure we have a 360-degree view of our operations. Looking at 2020, the importance and benefit from this approach cannot be overstated. For example, the Aflac Incorporated Board drew upon the experience of all its members, and in particular Dr. Barbara Rimer, dean of the University of North Carolina Gillings School of Global Public Health, whose public health expertise was invaluable in helping guide us through the pandemic. Together, the team worked in lockstep to ensure proper oversight and that management was fully engaged in taking care of employees, policyholders, shareholders, and the community as we navigated the pandemic. Notable action-items include the broad expertise in the medical arena that prompted us to pivot early to remote staffing models; the expertise in IT and cybersecurity that helped accelerate virtual technology and protect sensitive information; and the risk oversight that helped ensure controls were in place. While the number of formally planned meetings remained unchanged, the scope of information and communications increased substantially as the Board moved swiftly to take action during this unprecedented time.

STRATEGIC CORPORATE DEVELOPMENT

Early in 2020, it became clear that despite the challenges we were facing, it was vital to advance the momentum of our investment in the long-term growth of our Company. This momentum included integrating and building upon our 2019 acquisition of Argus (now Aflac Dental & Vision) for our planned national launch in 2021 as well as the 2020 closing of our acquisition of Zurich North America’s group benefits business. These two acquisitions help secure a more prominent spot when enrolling policyholders, which better positions Aflac U.S. for future success. Also in 2020, weclosed on a distribution alliance and ownership stake with Trupanion in the quickly growing market of pet insurance.

COMMITMENT TO SUSTAINABILITY

We began establishing, defining, and living Aflac Incorporated’s corporate purpose many years ago, even before this became a topic of interest among our investors. It was first thought of as the way we operate and later as the Aflac Way — guiding principles that exemplifies the compassion, ethics and spirit of the Company. The Aflac Way is an integral part of our corporate social responsibility and sustainability in creating long-term value for shareholders. We have seen moreinterest in Environmental, Social, and Governance (ESG) topics from investors and other stakeholders over the last several years. Consistent with our culture as a socially responsible company, we have advanced our ESG disclosures with a dedicated report outlining our ESG policies and capturing ourefforts through key disclosure frameworks, namely the Sustainability Accounting Standards Board (SASB) and the Task Force on Climate-related Financial Disclosures (TCFD). To be a steward of the planet, we are committing this year to expanding our carbon emissions goal to be net zero, including our Scope 3 emissions, by 2050. This global net-zero climate commitment will demand a comprehensive and transparent approach, and thus we will provide appropriate reporting and hold ourselves accountable along the way. We have enhanced our disclosure in other meaningful ways this past year by posting online our approach to ESG Investing, Tax, Carbon Neutrality, Human Rights, Human Capital Management, Diversity and Inclusion, Supply Chain Approach and Philosophy, Cybersecurity, and Aflac Global Investments ESG Investing. Visit Aflac Incorporated’s ESG site, esg.aflac.com, for these and additional disclosures that are aligned with our spirit of transparency and clarity on where we stand as a Company.

viAflac Incorporated
VOTING ROADMAP

Table of Contents

Letter from the Lead Non-Management Director

We are proud our efforts to increase our transparency and improve our sustainability have received external recognition. The Company was recognized by Ethisphere as one of the World’s Most Ethical Companies for the 15th consecutive year, remaining the only insurance company in the world to receive this honor every year since this award was first introduced in 2007. For the second time, Aflac Incorporated was recognized on Bloomberg’s Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation, and transparency.

RISK OVERSIGHT

It is important that our Board maintains its focus on identifying risks that are relevant to both the industry and to the Company. Along with carefully monitoring traditional risks associated with investments and our product risk profile, as well as maintaining strong capital ratios and managing operational risk, the Board has overseen significant advancements in information security. The Board has enhanced our information security policy with the goal of ensuring that the Company’s information assets and data, and the data of its customers, are appropriately protected.

As lead director, I will continue engaging our investors, gaining insight into their perspectives, and considering the viewpoints and positions of those who invest in our business.

The Board looks forward to continuing its ongoing dialogue with investors and acting upon that feedback, and we thank you for your support and the privilege of representing you and your shares in Aflac Incorporated. With these vital topics in mind, I encourage you to review the accompanying Proxy Statement and associated materials and to vote your shares before our virtual Annual Meeting on May 3, 2021. It is my pleasure, and my privilege, to serve on Aflac Incorporated’s Board, and I look forward, as a fellow shareholder, to the many ways the Company will continue upholding its promises.

Sincerely,

W. Paul Bowers

LEAD NON-MANAGEMENT DIRECTOR

2021 Proxy Statement
pg9_proposal1.jpg
vii
 The Board of Directors
 recommends a vote

Table of Contents

Proxy Summary

This summary highlights information contained elsewhere in this Proxy Statement, but it does not contain all of the information you should consider. For more information, please refer to the following:

AGENDA AND VOTING MATTERS

To elect as Directors FOR each of the Company the eleventen
 nominees named in this Proxy Statement
FOReach nominee
 proxy statement. 
PAGE 1
To consider a non-binding advisory proposal on the Company’s executive compensation (“say-on-pay”)FOR
PAGE 29
To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firmFOR
PAGE 62

Please read the entire Proxy Statement before voting. This Proxy Statement and the accompanying proxy are being delivered to shareholders on or about March 18, 2021.

For more complete information regarding the Company’s 2020 performance, please review the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. In this Proxy Statement, the terms “Company,” “we,” or “our” refer to Aflac Incorporated. The term “Aflac” refers to the Company’s subsidiary, American Family Life Assurance Company of Columbus. The term “Aflac U.S.” refers collectively to the Company’s United States insurance subsidiaries, Aflac; American Family Life Assurance Company of New York (Aflac New York), a wholly owned subsidiary of Aflac; Continental American Insurance Company (CAIC), branded as Aflac Group Insurance; and Tier One Insurance Company (TOIC); as well as Argus Dental & Vision, Inc. (Argus), a benefits management organization and national network dental and vision company. The term “Aflac Japan” refers to Aflac Life Insurance Japan Ltd. The term “Aflac Global Investments” refers to the Company’s asset management subsidiary, Aflac Asset Management LLC and its management subsidiary in Japan, Aflac Asset Management Japan Ltd.

viiiAflac Incorporated

Table of Contents

Proxy Summary

Proposal 1
Election of Directors
Each Director stands for election annually. The following provides summary information about the nominees.nominees, all of whom are named in this Proxy Statement. Our Board believes it is appropriate to maintain a diverse balance of longer tenured members, who bring stability and valuable Company-specific knowledge with a historical perspective, and newer members, who bring fresh viewpoints and new ideas.
page01_notice-arrow.jpg
See page 13
pg9_proposal2.jpg
The Board of Directors
 recommends a vote
FOR each of the eleven nominees.
PAGE 1

Director Nominees Summary

    DirectorCommittee Memberships
 NameINDAgeSinceARCCDCGCSREFI
DANIEL P. AMOS
Chairman and Chief Executive Officer, Aflac Incorporated
 691983     
W. PAUL BOWERS
Lead Director
Chairman and Chief Executive Officer of Georgia Power Co.
642013   
TOSHIHIKO FUKUZAWA
President and CEO, Chuo Real Estate Co., Ltd.
642016      
THOMAS J. KENNY
Former Partner and Co-Head of Global Fixed Income, Goldman Sachs Asset Management
572015    
GEORGETTE D. KISER
Operating Executive, The Carlyle Group
532019     
KAROLE F. LLOYD
Certified Public Accountant and retired Ernst & Young LLP audit partner
622017    
NOBUCHIKA MORI
Representative Director, Japan Financial and Economic Research Co. Ltd.
642020       
JOSEPH L. MOSKOWITZ
Retired Executive Vice President, Primerica, Inc.
672015   
BARBARA K. RIMER, DrPH
Dean and Alumni Distinguished Professor, Gillings School of Global Public Health, University of North Carolina, Chapel Hill
721995     
KATHERINE T. ROHRER
Vice Provost Emeritus, Princeton University
672017     
MELVIN T. STITH
Dean Emeritus of the Martin J. Whitman School of Management at Syracuse University
742012    
our executive
 compensation program. 
ARAudit & RiskCGCorporate GovernanceEExecutiveIndependent
CCompensationCSRCorporate Social
Responsibility &
Sustainability
FIFinance & InvestmentChair
CDCorporate DevelopmentMember

2021 Proxy Statementix

Table of Contents

Proxy Summary

BOARD TENURE

2021 Independent Director nominees (10)

7 of 10 Independent Director
nominees are
minority and or women

DIVERSITY OF SKILLS, EXPERIENCE AND ATTRIBUTES

2021 all Director nominees (11)


Corporate Governance Highlights

Annual director elections
Majority vote standard for director elections
Independent Lead Director
Active and responsive shareholder engagement process
Annual Board evaluations, including individual director interviews
Shareholder ability to call special meetings
Shareholder right of proxy access
Robust CEO succession planning process
Director mandatory retirement age

Historical Board Support

2020 AVERAGEDIRECTORSUPPORTLAST FIVE-YEAR AVERAGEDIRECTORSUPPORT

percentage of the votes cast in favor of election of the nominees


Corporate Social Responsibility and Sustainability Highlights

We carefully consider the impact our actions will have on our communities and our planet – not only today, but in the years to come.
We are invested in an inclusive and equitable work environment.

We are proud of the accolades we have received, a handful of which are listed below, and we invite you to read Aflac Incorporated’s 2020 Business and Sustainability Report, at esg.aflac.com, to learn more about our initiatives.

Fortune’s Most Admired Companies (20th time)
Ethisphere’s World’s Most Ethical Companies (15th consecutive year)
Bloomberg’s Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation, and transparency (2nd consecutive year)
Through its Women’s Empowerment Program, Aflac Japan surpassed its goal of reaching 30% of women in leadership positions (assistant manager or higher) one year ahead of schedule in 2019. Now, Aflac Japan has raised the bar and is on pace to a new target of filling 30% of manager or higher positions by women by the end of 2025.

xAflac Incorporated

Table of Contents

Proxy Summary

Proposal 2
Executive Compensation
(“Say-on-Pay”)
We are committed to achieving a high level of total return for our shareholders.shareholders and believe our executive compensation program is designed to strongly link executive pay to Company performance. From the end of August 1990, when Daniel P. Amos was appointed the CEO,Chief Executive Officer (CEO), through December 31, 2020,2023, the Company’s total return to shareholders, including reinvested cash dividends, has exceeded 7,689%15,446%, compared with 2,326%3,075% for the Dow Jones Industrial Average, 2,088%2,812% for the S&P 500 Index, and 895%1,471% for the S&P 500 Life & Health Insurance Index over the same period.
page01_notice-arrow.jpg
See page 38
pg9_proposal3.jpg
The Board of Directors recommends
 and the Audit and Risk
 Committee recommend a
 vote FOR our executive compensation.the ratification of
 the selection of KPMG LLP.
Ratification of Auditors
In February 2024, the Audit and Risk Committee voted to appoint KPMG LLP, an independent registered public accounting firm, to perform the annual audit of the Company’s consolidated financial statements for fiscal year 2024, subject to ratification by its shareholders.
page01_notice-arrow.jpg
PAGE 29
See page 77

Please read the entire Proxy Statement before voting.

This Proxy Statement and the accompanying proxy were first sent or made available to shareholders on or about March 21, 2024.


10AFLAC INCORPORATEDVOTING ROADMAP
Director Nominees Summary
05_424611-3_photo_amosD2.jpg
05_424611-3_pic_director_bowers_p.jpg
Lead Non-Management Director
page10_collins.jpg
pg11-pic_miwakoh.jpg
DANIEL P. AMOS, 72
Chairman, Chief Executive
Officer and President,
Aflac Incorporated
Director Since 1983
Committees: E, FI
W. PAUL BOWERS, 67
Retired Chairman and Chief Executive Officer,
Georgia Power Co.
Director Since 2013
Committees: AR*, CD, CSR, E
ARTHUR R. COLLINS, 64
Founder and Chairman
of theGROUP
Director Since 2022
Committees: CG, CSR
MIWAKO HOSODA, 54
Professor, Seisa University
Director Since 2023
page10_kenny.jpg
page10_kiser.jpg
page10_lloydkarolef.jpg
page10_mori.jpg
THOMAS J. KENNY, 60
Former Partner and Co-Head of
Global Fixed Income, Goldman
Sachs Asset Management
Director Since 2015 
Committees: CD, CSR, FI
GEORGETTE D. KISER, 56
Operating Executive,
The Carlyle Group
Director Since 2019 
Committees: AR*, C
KAROLE F. LLOYD, 65
Certified Public Accountant and
retired Ernst & Young LLP audit
partner
Director Since 2017
Committees: AR*, CD, E, FI
NOBUCHIKA MORI, 67
Representative Director, Japan
Financial and Economic Research
Co. Ltd.
Director Since 2020
Committees: CG, FI
05_424611-3_pic_director_moskowitz_j.jpg
05_424611-3_pic_director_rohrer_k.jpg
JOSEPH L.
MOSKOWITZ, 70

Retired Executive Vice President,
Primerica, Inc.
Director Since 2015
Committees:AR*, C, CD, E
KATHERINE T.
ROHRER, 70

Vice Provost Emeritus,
Princeton University
Director Since 2017
Committees: C, CG, E
Committee Key
ARAudit & RiskCCompensationCDCorporate DevelopmentCGCorporate Governance
CSRCorporate Social
Responsibility
& Sustainability
EExecutiveFIFinance & InvestmentlChair
page10_ind.jpg
Independent*Financial Expert


VOTING ROADMAP2024 PROXY STATEMENT11
Board Tenure
2024 Independent Director nominees (9)
boardTenure.jpg
20-3 Years
6 of 9
 Independent
 Director Nominees
 are people of color
 and/or women
44-7 Years
38+ Years
Diversity of Skills, Experience and Attributes
2024 all Director nominees (10)
90%
Independent
4398046511595
30%
Current or Former CEO
4398046511623
30%
Marketing and Public Relations
4398046511660
50%
Japanese Market Expertise
4398046511692

90%
Investment and Financial Expertise
4398046511734
80%
Operations Experience
4398046511763
100%
Regulatory and Risk Management Experience
4398046511811
60%
Industry Experience
4398046511838

20%
Public Health Experience
4398046511870
40%
Digital/Cybersecurity
4398046511898
40%
Woman Director
4398046511919
40%
Directors of Color
4398046511944
Corporate Governance Highlights
page21_check.jpg  Annual director elections
page21_check.jpg  Majority vote standard for director elections 
page21_check.jpg  Independent Lead Non-Management Director
page21_check.jpg  Active and responsive shareholder engagement process
page21_check.jpg  Annual Board evaluations, including individual director interviews
page21_check.jpg  Shareholder ability to call special meetings
page21_check.jpg  Shareholder right of proxy access 
page21_check.jpg  Robust CEO succession planning process
page21_check.jpg  Director mandatory retirement age


12AFLAC INCORPORATEDVOTING ROADMAP
Executive Compensation Highlights

Our executive compensation philosophy is to provide pay that is aligned with the Company’s results. We believe this is the most effective method for creating shareholder value and it has played a significant role in making the Company an industry leader. Our compensation program is designed to align pay and performance, and generally targets market median positioning, and delivers the majority of direct compensation through performance-based elements. This ensures proper alignment with our shareholders and ties compensation for named executive officers (NEOs) to the Company’s performance.

The Company’s executive compensation program reflects our corporate governance best practices principles:

Independent
Oversight
The Board’s independent Compensation Committee oversees the program.
The Compensation Committee retains an independent compensation consultant that reports only to that Committee.
The independent compensation consultant briefs the full Board annually on CEO pay and performance alignment.
Shareholder Alignment
All employees are prohibited from hedging Company stock.
Officers and Directors may not pledge the Company’s stock or, unless approved by the Compensation Committee, enter into 10b5-1 plans.
We do not provide change-in-control excise tax gross-ups.
All employment agreements contain double trigger change-in-control requirements.
Long-Standing Commitment
We have had a clawback policy since 2007.
We were the first public company in the U.S. to voluntarily provide shareholders with a say-on-pay vote – three years before such votes became mandatory.
Executive officers and Directors may not enter into 10b5-1 plans unless approved by the Compensation Committee or pledge the Company’s stock.
All employees are prohibited from hedging Company stock.
Executive officers and Directors have been subject to stock ownership guidelines for almost two decades.
We have had a clawback policy since 2007.
We do not provide for change-in-control excise tax gross-ups.
All employment agreements contain double trigger change-in-control requirements.

The effect of COVID-19 created un-planned volatility in our results for the Aflac U.S. and Aflac Japan segments.

2020 Business Highlights

In 2020, the Company delivered strong operating results.

NET EARNINGS

$4.8B  (44.6%)▲

EPS                     ADJUSTED EPS*

50.6%10.8%

RETURN ON EQUITY

15.3%

ADJUSTED RETURN ON EQUITY (“AROE”)*

15.0%

REPURCHASED SHARES

$1.5B

CASH DIVIDEND

3.7%

3 YEAR TSR

+8.6%


U.S. and Japan sales(1) were decreased by 30.8% and 36.2%, respectively.
Total revenues decreased 0.7% to $22.1 billion. Total adjusted revenues increased 0.3% to $22.3 billion reflective of continued growth of the in-force business at both Aflac U.S. and Aflac Japan. Total adjusted revenues, excluding current period foreign currency impact* decreased 1.0% to $22.0 billion.
Earnings per share (EPS) and Aflac U.S. earnings results were generally impacted positively with lower benefit ratios in the U.S. and overall lower expense run-rates. Aflac Japan’s strong performance was attributed almost entirely to net investment income as the positive impact on the benefit ratio from lower routine visits was offset by higher persistency.
We acquired Zurich Benefits which was a key step in the Company’s buy-to-build strategy to deliver best-in-class true group products to employers and unique solutions to distribution partners. Along with entering a growth market, we believe this portfolio expansion will increase producer productivity and assist with recruiting and retaining agents and expand broker markets.

*Adjusted earnings per diluted share excluding foreign currency impact, total adjusted revenues, excluding current period foreign currency impact, and AROE excluding foreign currency impact, are not calculated in accordance with generally accepted accounting principles in the United States (GAAP). See the Appendix to this Proxy Statement for definitions of these non-GAAP measures and reconciliation to the most comparable GAAP financial measure.
(1)As defined in Item 1. Business in the Company’s 2020 Annual Report on Form 10-K.

2021 Proxy Statementxi

Table of Contents

Proxy Summary

2020

2023 Executive Compensation

The total target direct compensation mix for 20202023 for (1) our CEO and (2) our CEO together withthe average of our other NEOs is illustrated in the following charts and reflects the performance-based nature of our compensation program:

CEO TARGET COMPENSATION MIXCEO +OTHER NEOs AVERAGE TARGET COMPENSATION MIX
03_424611-3_pie_ceotargetcompensationmix.jpg
10%
Base Salary
03_424611-3_pie_neotargetcompensationmix.jpg
19%
Base Salary
24%
Management Incentive Plan
33%
Management Incentive Plan
66%
Long-Term Incentive
48%
Long-Term Incentive

Recent Say-on-PaySay-On-Pay Votes

2020
SAY-ON-PAY
SUPPORT
We are pleased that our named executive compensation program received the voting support of over 97% of our shareholders last year. We believe this continued support reflects favorably on changes we have made to our executive compensation program over the past few years to more tightly link compensation metrics to our business strategy while incorporating feedback received from our shareholders. We work hard to ensure we implement best practices in executive compensation while staying focused on performance-based program elements that align with shareholder interests. We will continue to review our compensation program each year to determine if additional changes are warranted.
2023 SAY-ON-PAY
SUPPORT
97.3%
03_424611-3_pie_support.jpg
FIVE-YEAR
AVERAGE
SAY-ON-PAY
SUPPORT
96.6%
03_424611-3_pie_fiveyearaverage.jpg
page01_notice-arrow.jpg

We are pleased that, for the past two consecutive years, our executive compensation received the voting support of 98% of our shareholders. We believe this continued support reflects favorably on changes we have made to our executive compensation program over the past few years to more tightly link compensation metrics to our business strategy while incorporating feedback received from our shareholders. We work hard to ensure we implement best practices in executive compensation while staying focused on performance-based program elements that align with shareholder interests. As noted in the Program Changes for 2021 section of the Compensation Discussion and Analysis, the Compensation Committee has made changes to the Management Incentive Plan formula to include an ESG modifier for 2021. We will continue to review our compensation program each year to determine if additional changes are warranted.


Learn more in the Compensation Discussion & Analysisunder the heading “Outcome of 2020 Say-on-Pay Vote”

Proposal 3
Ratification of Auditors
In February 2021, the Audit and Risk Committee voted to appoint KPMG LLP, an independent registered public accounting firm, to perform the annual audit of the Company’s consolidated financial statements for fiscal year 2021, subject to ratification by its shareholders.
The Board of Directors and the Audit and Risk Committee recommend a vote FOR the ratification of   the selection of KPMG LLP.PAGE 62

xiiAflac Incorporated


2024 PROXY STATEMENT13

Table of Contents

Attending the Virtual Annual Meeting

We continue to monitor developments regarding the coronavirus (COVID-19). In the interest of the health and well-being of our shareholders, the Board has made the decision that the Annual Meeting be held solely by means of remote communication.

How to Join the Virtual Annual Meeting

Shareholders as of the close of business on February 23, 2021 (Record Date) are invited to attend the virtual Annual Meeting at www.virtualshareholdermeeting.com/AFL2021 by entering the 16-digit control number included on their proxy card or notice that they previously received. If you hold your shares in street name and did not receive a 16-digit unique control number with your proxy materials, please contact your bank, broker, or other holder of record as soon as possible to obtain a valid legal proxy and for instructions on how to obtain a control number to be admitted to and to vote at the Annual Meeting. Online access to the webcast will open 15 minutes prior to the designated start time. Shareholders may submit questions in writing through the virtual meeting platform. Those who do not have a control number may attend as guests, but will not be able to vote shares or submit questions during the webcast. While voting during the virtual meeting will be permitted, Aflac Incorporated encourages shareholders to vote in advance of the meeting.

Vote BEFORE the meeting:

Vote by one of the following methods by 11:59 p.m. Eastern Time on May 2, 2021 for shares held directly and by 11:59 p.m. Eastern Time on April 28, 2021 for shares held in a Plan:

Go to www.proxyvote.com, or

Call 1-800-690-6903, or

Mark, sign and date your proxy card and return it in the postage-paid envelope we previously provided.

Vote DURING the meeting:

Go to www.virtualshareholdermeeting.com/ AFL2021.

Shareholders may attend and vote during the virtual Annual Meeting by following the instructions on the website above.

CORPORATE GOVERNANCE MATTERS

The meeting webcast will begin promptly at 10 a.m., Eastern Standard Time, on Monday, May 3, 2021. We encourage you to access the meeting prior to the start time, as check-in will begin at 9:45 a.m. If you experience technical difficulties during the check-in process or during the meeting, please call the technical support number that will be posted on the virtual Annual Meeting log-in page for assistance.


2021 Proxy Statementxiii

Table of Contents

Table of Contents

Notice of 2021 Annual Meeting of Shareholders
iiiHow to Vote
pg9_proposal1.jpg
image_duck proposal 1.jpg
Letter from the Chairman and Chief Executive Officer
Letter from the Lead Non-Management Director
Proxy Summary
ixDirector Nominees Summary
xCorporate Governance Highlights
xHistorical Board Support
xCorporate Social Responsibility and Sustainability Highlights
xiExecutive Compensation Highlights
xi2020 Business Highlights
xii2020 Executive Compensation
xiiRecent Say-on-Pay Votes
Attending the Virtual Annual Meeting
xiiiHow to Join the Virtual Meeting
Corporate Governance Matters
1PROPOSAL 1:
1Board’s Active Role in Responding to COVID-19
2Board Composition
2Information about the Board of Directors
3Director Nominees
8Board Succession Planning and Refreshment Process
9Director Nominating Process
10Board Self-Evaluation
11Director Independence
11Independent Director Tenure Mix
12Our Board and Committees
12Board Leadership Structure
13Lead Non-Management Director
13Committee Structure
21Meeting Attendance
21Board Responsibilities
21Enterprise-Wide Risk Oversight
22Code of Business Conduct and Ethics
22Chief Executive Officer and Executive Management Succession Planning
23Commitment to Social Responsibility and Sustainability
23Shareholder Outreach
23Our Approach
24Governance Documents
24Director Compensation
24Cash Compensation
25Equity Compensation
25Vesting
25Retirement Plans
262020 Director Compensation
27CD&A At-A-Glance
Executive Compensation
29 PROPOSAL 2:
Executive Compensation (“Say-on-Pay”)
29Compensation Discussion and Analysis
30Executive Summary
35Compensation Design and Philosophy
37Performance-Based Compensation: How Performance Goals Are Set
38Importance of Measuring Management’s Performance Excluding the Impact of Currency
38MIP Target-Setting Considerations
39Equity Granting Policies
402020 Executive Compensation
48Additional Executive Compensation Plan Practice and Procedures
49Compensation Committee Report
50Executive Compensation Tables
502020 Summary Compensation Table
512020 All Other Compensation
512020 Perquisites
522020 Grants of Plan-Based Awards
532020 Outstanding Equity Awards at Fiscal Year-End
542020 Option Exercises and Stock Vested
54Pension Benefits
56Nonqualified Deferred Compensation
57Potential Payments Upon Termination or Change in Control
60CEO Pay Ratio
61Equity Compensation Plan Information
Audit Matters
62 PROPOSAL 3:
Ratification of Auditors
62Audit Fees and Other Fees
62Pre-Approval Policies and Procedures
63Audit and Risk Committee Report
64Related Person Transactions
Stock Ownership
67Beneficial Ownership of the Company’s Securities
67Security Ownership of Directors
68Security Ownership of Management
68Delinquent Section 16(a) Reports
Solicitation and Revocation of Proxy
Other Matters
Appendix – Definition of Non-U.S. GAAP Measures and Reconciliations to Corresponding U.S. GAAP Measures


xivAflac Incorporated

Table of Contents

Corporate Governance Matters

Proposal 1

Election of Directors

Each Director stands for election annually. The Directors up for election at the Annual Meeting are named in this Proxy Statement. The following provides summary information about the nominees. Our Board believes it is appropriate to maintain a diverse balance of longer tenured members, who bring stability and valuable Company-specific knowledge with a historical perspective, and newer members, who bring fresh viewpoints and new ideas.

The Board of Directors recommends a vote FOR each of the eleven nominees.

The Company proposes that the following eleven individuals be elected to the Board. These individuals have been nominated by the Board’s Corporate Governance Committee. If elected, they are willing to serve for a one-year term expiring at our 2022 Annual Meeting of Shareholders. Each Director will hold office until his or her successor has been elected and qualified or until the Director’s earlier death, resignation or removal. The peopleten nominees named in the accompanying proxy (or their substitutes) will vote to elect these nominees unless specifically instructed to the contrary. However, if any nominee becomes unable or unwilling to serve or is otherwise unavailable for election, the people named in the proxy (or their substitutes) will have discretionary authority to vote or to refrain from voting on any substitute nominee. The Board has no reason to believe that any of the nominees will be unable or unwilling to serve.

All of the nominees are currently members of our Board.

We expect all of our Directors to have a demonstrated ability to make a meaningful contribution to the Board’s oversight of the business and affairs of the Company. As shown below and on the following pages, our nominees have a range of skills and experience in areas that are critical to our industry and our operations.

Board’s Active Role in Responding to COVID-19

this Proxy Statement.

Barbara K.

Rimer, DrPH

As we navigated pandemic conditions, the Board drew upon the experience of all of its members to ensure that proper oversight was in place and that management was fully engaged in taking care of employees, policyholders, distribution, shareholders, and the community. Just some action-item examples include the broad expertise in the medical arena that prompted us to pivot early to remote staffing models; the expertise in IT and cybersecurity that helped accelerate virtual technology and protect sensitive information; and the risk oversight that helped ensure that controls were in place. The Company had the unique benefit of significant COVID-19-relevant expertise on the Board, specifically Dr. Barbara Rimer, who is Dean and Alumni Distinguished Professor of the Gillings School of Global Public Health at The University of North Carolina at Chapel Hill. Early on at the outbreak of the coronavirus, Dr. Rimer advised the Company about the emerging threat of the virus, which prompted us to immediately implement travel restrictions, shift to working remotely, and instate several social distancing measures both in Japan and the U.S. We took immediate action to ramp up work-from-home staffing models with more than 75% of onsite employees in Japan and more than 90% of onsite employees in the U.S. working from home by the end of April 2020, which ensured business continuity with little disruption in operations. In addition, the Company adjusted its approach to employee benefits to accommodate the need for extended paid leave and to account for school closings.

While the number of formally planned meetings remained unchanged, the scope of information exchanged between the Board and management expanded and communications with management increased exponentially during this unprecedented time, including receiving weekly COVID-19 reports from management’s global crisis management team.

2021 Proxy Statement1
The Company proposes that the following ten individuals be elected to the Board. These individuals have been nominated by the Board’s Corporate Governance Committee. If elected, they are willing to and will serve for a one-year term expiring at our 2025 Annual Meeting of Shareholders. Each Director will hold office until his or her successor has been elected and qualified or until the Director’s earlier death, resignation, or removal. The people named in the accompanying proxy (or their substitutes) will vote to elect these nominees unless specifically instructed to the contrary. However, if any nominee becomes unable or unwilling to serve or is otherwise unavailable for election, the people named in the proxy (or their substitutes) will have discretionary authority to vote or to refrain from voting on any substitute nominee. The Board has no reason to believe that any of the nominees will be unable or unwilling to serve if elected.
All nominees are currently members of our Board.
We expect all of our Directors to have a demonstrated ability to make a meaningful contribution to the Board’s oversight of the business and affairs of the Company. As shown below and on the following pages, our nominees have a range of skills and experience in areas that are critical to our industry and our operations.


14AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

Table of Contents

Corporate Governance Matters

Board Composition

Information about the Board of Directors

Skills and Experience
Independent
Marketing and Public Relations
Current or former CEO
Operations Experience
Japanese Market Experience
Investment and Financial Expertise
Regulatory and Risk Mgmt. Experience
Industry Experience
Public Health Experience
Digital/Cybersecurity Experience
Race/Ethnicity:
White
Black or African American
Asian
Gender:
Male
Female

2Aflac Incorporated
Director Nominees

Table of Contents

Corporate Governance Matters

Director Nominees

Daniel P. Amos

CHAIRMAN, CHIEF
EXECUTIVE OFFICER AND PRESIDENT OF AFLAC INCORPORATED
05_424611-3_photo_amosD.jpg
W. Paul Bowers
RETIRED CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF AFLAC INCORPORATED

Mr. Amos has been GEORGIA POWER CO.

LEAD NON-MANAGEMENT DIRECTOR
05_424611-3_pic_board_bowers_p.jpg
AGE
72
DIRECTOR
SINCE
1983
COMMITTEES
E    FI
AGE
67
DIRECTOR
SINCE
2013
COMMITTEES
AR*    CD    CSR    E
Chief Executive Officer of the CompanyAflac Incorporated and Aflac since 1990
Chairman of Aflac Incorporated and Aflac since 2001 was
President of Aflac from July 2017 to May 2018 and was
President of Aflac Incorporated since January 2024 and from February 2018 through December 2019. He has spent 402019
Spent 50 years in various positions at Aflac.

SKILLS AND RECOGNITION

Institutional Investor magazine has named Mr. Amos one of America’s Best CEOs in the life insurance category five times. Harvard Business Review has named Mr. Amos among the World’s Best Performing CEOs in each of the past four years. CR Magazine recently honored himAflac

Notable Experience Aligned with a Lifetime Achievement Award for his dedication to corporate responsibility.

Our Strategy and Key Board Contributions

Mr. Amos’ more than 40 years of experience at Aflac Incorporated provides invaluable expertise and insights to both the leadership team and the Board on how to effectively execute strategic priorities in unpredictable macroeconomic and competitive landscapes. His experience and approach deliver insightful expertise and guidance to the Board of Directors on topics relating to corporate governance, people management, and risk management.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Mr. Amos has appeared five times on Institutional Investor magazine’s lists of America’s Best CEOs for the insurance category, has been recognized as one of the 100 Best-Performing CEOs in the World by the Harvard Business Review five times, and has received a Lifetime Achievement Award for his dedication to corporate responsibility by CRMagazine.
Public Company Boards
Synovus Financial Corp. (2001-2011)

Southern Company (2000-2006)

AGE

69

DIRECTOR SINCE

1983

COMMITTEES

Executive (Chair)
Finance and Investment

W. Paul Bowers

CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF GEORGIA POWER CO.

Mr. Bowers has been

Retired as chairman and chief executive officer of Georgia Power, the largest subsidiary of Southern Company, a gas and electricity utility holding company, on July 1, 2021, a position that he held since 2011. He also served as president2011
President of Georgia Power from 2011 until November 2020. Before that, Mr. Bowers served as chief2020
Chief financial officer of Southern Company from 2008 to 2010. Previously, he served2010
Served in various senior executive positions across Southern Company in Southern Company Generation, Southern Power, and the company’s former U.K. subsidiary, where he was president and chief executive officer of South Western Electricity LLC/Western Power Distribution. Mr. Bowers has announced his anticipated retirement from Georgia Power in April this year.

SKILLS AND RECOGNITION

Distribution

Notable Experience Aligned with Our Strategy and Key Board Contributions
Mr. Bowers brings to the Board a valuable and unique perspective from his considerable financial knowledge, national and international business experience operating in a highly regulated industry, and expertise in corporate development and managing the evolving risks associated with cybersecurity.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

cybersecurity.

Public Company Boards
Brand Industrial Holding, Inc. (since 2019)
Audit Committee Chair (since 2019)
Exelon Corporation (since 2021)
Audit Committee and Corporate Governance Committee (since 2022)
Other Board or Leadership Positions, Professional Memberships or Awards
Chair, Atlanta Committee for Progress (2016)

Nuclear Electric Insurance Ltd. (since 2009); Chairman(2017-2019)

Board of Regents of the University System of Georgia (2014-2018)

Federal Reserve Bank of Atlanta’s Energy Policy Council (2008-2018)

LEGEND:
* Financial Expert Board of Brand Industrial Holding, Inc, (since 2019)AR Audit and Audit Committee Chair (since 2019)

INDEPENDENT

LEAD NON-MANAGEMENT DIRECTOR

AGE

64

DIRECTOR SINCE

2013

COMMITTEES

Risk • Compensation • CD Corporate Development (Chair)

Audit and Risk*

• CG Corporate Governance

CSR Corporate Social Responsibility and Sustainability

• Executive

*    Financial Expert

• 
FI Finance and Investment •
page10_ind (2).jpg
Independent •
page19_chair.jpg
Chair •
page19_member.jpg
Member

2021 Proxy Statement3


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT15
Arthur R. Collins
FOUNDER AND CHAIRMAN
OF theGROUP
pg15_collins.jpg
Miwako Hosoda
PROFESSOR, SEISA UNIVERSITY
pg16-pic_miwakoh.jpg

Table of Contents

Corporate Governance Matters

Toshihiko Fukuzawa

PRESIDENT AND

AGE
64
DIRECTOR
SINCE
2022
COMMITTEES
CG  CSR
AGE
54
DIRECTOR
SINCE
2023


Founder and Chairman of theGROUP, a government relations and strategic communications consulting firm, since 2011
Chairman and CEO OF CHUO REAL ESTATE CO., LTD

Mr. Fukuzawa has been the president and chief executive officer of Chuo Real Estate Co., Ltd., a real estate development and leasing company in Japan, since July 2018. Previously, he was the president and chief executive officer of Yushu Tatemono Co., Ltd., also a real estate development and leasing company in Japan, from June 2015 to June 2018. He served as deputy president at Mizuho Trust & Banking Co., Ltd. from April 2013 to March 2015, managing executive officer and head of the IT System Group at Mizuho Bank Ltd. from June 2011 to March 2013, and deputy president at Mizuho Information & Research Institute from June 2009 to June 2011. From 2002 to 2009, he held executive officer and general manager positions at Mizuho Bank, Ltd., part of Mizuho Financial Group,Public Private Partnership, Inc. Mr. Fukuzawa held various positions of increasing responsibility at Dai-Ichi Kangyo Bank, Ltd., which he joinedestablished, from 1989 to 2011

Experienced and trusted strategic advisor to corporate leaders and domestic and foreign governments with concentrations in 1979.

SKILLS AND RECOGNITION

Over a 36-year careerreal estate, healthcare, and global public policy

Additional areas of expertise include financial services, trade, energy, information technology, consumer products, agriculture, transportation, manufacturing, and national security
Notable Experience Aligned with Our Strategy and Key Board Contributions
Mr. Collins has more than 30 years of experience as a professional bankertrusted advisor and strategist providing counsel to corporate leaders, heads of state and their governments, and non-profit executives and their boards. He brings his expertise in governmental affairs and regulatory matters and provides our Board with the relevant skills and perspective to effectively navigate the challenges of the regulatory and geopolitical environments and continue to execute our strategic priorities.
Public Company Boards
KB Home (since 2020)
Nominating and Corporate Governance Committee
Management Development and Compensation Committee
RLJ Lodging Trust (since 2016)
Compensation, Nominating and Corporate Governance Committees
Other Board or Leadership Positions, Professional Memberships or Awards
Member, Council on Foreign Relations (since 2023)
Member, Ford’s Theatre Board of Trustees (since 2023)
Member, Smithsonian’s National Museum of Asian Art Board of Trustees (since 2022)
Vice Chair, Brookings Institution Board of Trustees (2014-2023)
Member, Economic Club of Washington, D.C. (since 2012)
Chairman, Morehouse School of Medicine Board of Trustees (since 2009)
Member, Meridian International Center Board of Trustees (2009-2017)
Chairman, Florida A&M University Board of Trustees (2001-2003)
Professor, Seisa University, Faculty of Life Network Science from 2012 to present
Vice President from 2013 to 2021
Research fellow, Harvard T.H. Chan School of Public Health
Abe Fellow in the Department of Society, Human Development and Health from 2010 to 2012
Takemi Fellow in the Department of Global Health and Population, The Takemi Program in International Health from 2008 to 2010
Associate, Columbia University, Mailman School of Public Health, Department of Sociomedical Sciences from 2005 to 2008
Research Fellow, Japan Mr. Fukuzawa gainedSociety for the Promotion of Science from 2002 to 2005
Notable Experience Aligned with Our Strategy and Key Board Contributions
Dr. Hosoda brings over 30 years of extensive businessexperience and IT knowledgeexpertise in the field of sociology of health. Her research on the social aspects of healthcare, collaborative efforts among welfare, education, and experience withmedical sectors for complex health problem-solving, and patient community engagement. These areas include a wide range of Japanese financial services institutions, including insurance companies. Hetopics such as international comparisons of health governance, peer support among individuals with illnesses or disabilities, and practical implementation of community care. In addition to her primary interests, Dr. Hosoda is also an expert in public health, bioethics, social welfare, and environmental science. Her interdisciplinary expertise provides theour Board with valuable insighta profound technical understanding of our customer’s needs and expertise relevantpriorities in the Japanese public health landscape.
Other Board or Leadership Positions, Professional Memberships or Awards
Board of Directors, The University of Tokyo, New York Office, Inc. (Since 2023)
Board of Directors, Brain Injury Caring Communities Society (2017 to the Company’s2020), President (since 2023)
Representative Director, Inclusive Action For All (since 2020)
Vice president, Asia Pacific Sociological Association (since 2021); President (2017 to 2020)
Board of Trustees, The Japanese business.

INDEPENDENT

AGE

64

DIRECTOR SINCE

2016

COMMITTEES

Finance and
Investment

Foundation for Cancer Research (2015 to 2021)
LEGEND:
* Financial Expert • AR Audit and Risk • Compensation • CD Corporate Development • CG Corporate Governance
CSR Corporate Social Responsibility and Sustainability • Executive • FI Finance and Investment •
page10_ind (2).jpg
Independent •
page19_chair.jpg
Chair •
page19_member.jpg
Member


16

AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
Thomas J. Kenny

FORMER PARTNER AND CO-HEAD OF GLOBAL FIXED INCOME, GOLDMAN SACHS ASSET MANAGEMENT

Mr. Kenny has served as a trustee of TIAA-CREF, a financial services organization, since 2011. He currently serves as the

pg16_kenny.jpg
Georgette D. Kiser
OPERATING EXECUTIVE, THE CARLYLE GROUP
pg16_kiser.jpg
AGE
60
DIRECTOR
SINCE
2015
COMMITTEES
CD    CSR    FI
AGE
56
DIRECTOR
SINCE
2019
COMMITTEES
AR*    C
Co Chair of the TIAA-CREFNuveen Funds Board of Trustees, previously served as Chair of the Investment Committee, and also currently sits on the TIAA-CREF Funds Audit and Compliance, Investment and Nominating and Governance Committees. Prior to his role at TIAA-CREF, Mr. Kenny held(a TIAA Company) since January 2024
Held a variety of leadership positions at Goldman Sachs for twelve years, most recently serving as partner and advisory director. He also serveddirector
Served as co-head of the Global Cash and Fixed Income Portfolio team at Goldman Sachs Asset Management, where he was responsible for overseeing the management of more than $600 billion in assets across multiple strategies with teams in London, Tokyo, and New York. Before joining Goldman Sachs, Mr. Kenny spentYork
Spent thirteen years at Franklin Templeton. He is a Templeton
CFA charter holder.

SKILLS AND RECOGNITION

holder

Notable Experience Aligned with Our Strategy and Key Board Contributions
Mr. Kenny’sKenny has extensive experience in asset and investment management and, financial marketsspecifically, portfolio solutions for insurance companies. His significant accounting and finance knowledge, as well as experience from serving in leadership roles on several company boards, provides the Board with valuable insight and expertise.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

expertise that supports our capital allocation decision-making and the evaluation of potential strategic transactions that drive long-term shareholder value.

Other Board or Leadership Positions, Professional Memberships or Awards
Nuveen Funds (a TIAA Company), Co-Chair (since January 2024):
Executive Committee, Chair (since January 2024)
Investment Committee (since January 2024)
Compliance Committee (since January 2024)
Nomination and Governance Committee (since January 2024)
Open End Fund Committee (since January 2024)
ParentSquare (since 2021)
CREF Board of Trustees, Chairman (since 2017)

2017 through 2023)

TIAA-CREF Fund Complex:

Executive Committee, Chair(since 2017)

 (2017 through 2023)

Investment Committee (since 2011)

2011 through 2023)

Audit and Compliance Committee (since 2018)

2018 through 2023)

Nominating and Governance Committee (since 2017)

2017 through 2023)

Ad Hoc CREF Special Projects Committee (since 2020)

2020 through 2023)

INDEPENDENT

AGE

57

DIRECTOR SINCE

2015

COMMITTEES

Finance and Investment (Chair)
Corporate Development
Corporate Social Responsibility and Sustainability

4Aflac Incorporated

Table of Contents

Corporate Governance Matters

Georgette D. Kiser

OPERATING EXECUTIVE, THE CARLYLE GROUP

Ms. Kiser is an Operating Executive at The Carlyle Group, a global alternative asset management firm, since May 2019, where she advises Carlyle professionals through the investment process, from sourcing deals, conducting diligence, managing companies and exiting transactions. She also helpstransactions

Helps set IT strategy for Carlyle Portfolio companies and drives IT / IT/digital diligence and advisory efforts. Ms. Kiser was a
Former managing director and chief information officer, at The Carlyle Group, where she was responsible for leading the firm’s global technology and solutions organization from February 2015 until May 2019. In this role, Ms. Kiser developed2019
Developed and drove information technology strategies across the global enterprise, which includes the firm’s application development, data, digital, infrastructure, cybersecurity, and program management and outsourcing activities. Prior to joining The Carlyle Group, Ms. Kiser held positions of increasing responsibilityactivities
Serves as an independent advisor who helps lead due diligence and technical strategies across various middle market private equity and venture capital firms
Led teams that provided creative solutions for investment front office, trading, and back-office operations at T. Rowe Price Associates, Inc., also a global alternative asset management firm, from 1996 to 2015, including the role of vice president, Enterprise Solutions
Worked for General Electric within their aerospace unit
Notable Experience Aligned with Our Strategy and Capabilities within the services and technology organization.

SKILLS AND RECOGNITION

Key Board Contributions

Throughout Ms. Kiser’s three-plus decade career, she has established extensive experience and success developing and leading talented teams to deliver decision support systems and technical solutions, including cybersecurity, for financial services firms. She has consistently been recognized for bringing credibility to solutions and technical organizations in addition to building strong business partnerships, leveraging human and technical resources, implementing investment and customer management systems, and producing advanced data management solutions.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Public Company Boards

Jacobs Engineering (since 2019)

Adtalem Global Education (since 2018)

NCR Voyix Corporation (formerly NCR Corporation) (since 2020)

YearUp.org (National Capital Region)

Other Board of Trustees (since 2016)

The Boys’ Latin School of Maryland Board of Trustees (since 2009)

or Leadership Positions, Professional Memberships or Awards

Previously served on the Boards of Trustees for the University of Baltimore Foundation, T. Rowe Price Foundation, the University of Baltimore Merrick School of BusinessBrown Advisory Board The Maryland Business Roundtable STEMnet board, and the Greater Baltimore Committee Leadership

mutual fund (since 2022)

INDEPENDENT

AGE

53

DIRECTOR SINCE

2019

COMMITTEES

Audit and Risk*

Compensation

LEGEND:
* Financial Expert

• 
AR Audit and Risk • Compensation • CD Corporate Development • CG Corporate Governance
CSR Corporate Social Responsibility and Sustainability • Executive • FI Finance and Investment •
page10_ind (2).jpg
Independent •
page19_chair.jpg
Chair •
page19_member.jpg
Member


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT17

Karole F. Lloyd

CERTIFIED PUBLIC ACCOUNTANT
AND RETIRED ERNST & YOUNG LLP AUDIT PARTNER

Ms. Lloyd is a certified

pg17_karole.jpg
Nobuchika Mori
REPRESENTATIVE DIRECTOR, JAPAN FINANCIAL AND ECONOMIC RESEARCH CO. LTD.
pg17_mori.jpg
AGE
65
DIRECTOR
SINCE
2017
COMMITTEES
AR*    CDE    FI
AGE
67
DIRECTOR
SINCE
2020
COMMITTEES
CG    FI
Certified public accountant and retired as vice chair and regional managing partner for Ernst & Young, LLP (“EY”), a global accounting firm, in December 2016. She brings2016
Brings more than 37 years of work experience and leadership, most recently as part of the US Executive Board, Americas Operating Executive and the Global Practice Group for EY, and has extensive experience in the audits of large financial services, insurance, and health care companies. Ms. Lloyd servedcompanies
Served many of EY’s highest profile clients through mergers, IPOs, acquisitions, divestitures, and across numerous industries including banking, insurance, consumer products, transportation, real estate, manufacturing, and retail. She has servedretail
Served as an audit partner for publicly held companies in both the United States and Canada. Ms. Lloyd’s otherCanada
Other experience includes leadership and consulting with respect to financial reporting, board governance and legal matters, regulatory compliance, internal audit, and risk management.

SKILLS AND RECOGNITION

management

Notable Experience Aligned with Our Strategy and Key Board Contributions
Ms. Lloyd’s extensive accounting and advisory experience across the financial serviceservices industry, combined with her leadership skills and strategic thinking, provide valuable perspective forsupports our AuditBoard’s oversight of risk and Risk Committee.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

helps inform our capital allocation decision-making and the evaluation of potential strategic transactions that drive long-term shareholder value.

Public Company Boards
Churchill Downs Incorporated  and Audit Committee (since 2018)

Audit Committee
Other Board or Leadership Positions, Professional Memberships or Awards
CERT Certificate in Cybersecurity Oversight
The University of Alabama President’s Advisory Council (since 2003)

The University of Alabama Board of Visitors for the Commerce and Business School (since 2001)

Atlanta Symphony Orchestra Board of Directors (since 2010)

Metro Atlanta Chamber of Commerce, Board of Trustees and Executive Committee(2009-2016)

INDEPENDENT

AGE

62

DIRECTOR SINCE

2017

COMMITTEES

Audit and Risk* (Chair)

Executive

Finance and Investment

*      Financial Expert

2021 Proxy Statement5

Table of Contents

Corporate Governance Matters

Nobuchika Mori

REPRESENTATIVE DIRECTOR, JAPAN FINANCIAL AND ECONOMIC RESEARCH CO. LTD.

Mr. Nobuchika Mori is representativeRepresentative director of the Japan Financial and Economic Research Co. Ltd., a research and consulting firm. In this role, he has been responsiblefirm

Responsible for providing research and consulting services to companies in Japan and abroad since July 2018. He is currently also an2018
Eminent guest professor at the Center for Advanced Research in Finance, Graduate School of Economics, University of Tokyo (since July 2022)
Senior research scholar and adjunct professor and senior research scholar at Columbia UniversityUniversity’s School of International and Public Affairs (since October 2018). From July 2015 until his retirement in July 2018, Mr. Mori served as commissioner(2018 to 2021)
Commissioner of the Financial Services Agency of Japan (the “JFSA”), Japan’s integrated financial regulator. In this role, he ledregulator, from July 2015 until his retirement in July 2018
Led supervision of financial institutions including banks, securities firms and insurance companies and directed
Directed legislative and regulatory planning to ensure financial stability and enhance economic growth in Japan. Before becoming the head of JFSA, he spent moreJapan
More than 30 years in senior positions at JFSA and Japan’s Ministry of Finance (the “MOF”), including before becoming the head of JFSA, including:
JFSA Vice Commissioner for Policy Coordination
JFSA Director General for Inspection and
JFSA Director General for Supervision (July 2014 to July 2015). He also served
Served in a range of diplomatic posts reflecting his expertise in international financial markets and regulatory standards, including as the including:
Chief Representative in New York for the MOF
Minister of the Embassy of Japan in the United States of America and as
Deputy Treasurer at the Inter-American Development Bank.

SKILLS AND RECOGNITION

Bank

Notable Experience Aligned with Our Strategy and Key Board Contributions
Over a three-plus decade career immersed in Japan’s finance industry as a financial regulator, policymaker, and standard setter in Japan and internationally, Mr. Mori gained extensive specialized economic, policy, and financial regulatory expertise, knowledge and experience. He brings to the Board indispensable, significant insight with respect to the Company’s Japanese business operations from his considerable financial and economic knowledge, international business experience, and regulatory acumen spanning highly regulated industries in Japan and internationally.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Other Board or Leadership Positions, Professional Memberships or Awards
Center on Japanese Economy and Business (CJEB) Professional Fellow (since 2018)

INDEPENDENT

AGE

64

DIRECTOR SINCE

2020

LEGEND:
* Financial Expert • AR Audit and Risk • Compensation • CD Corporate Development • CG Corporate Governance
CSR Corporate Social Responsibility and Sustainability • Executive • FI Finance and Investment •
page10_ind (2).jpg
Independent •
page19_chair.jpg
Chair •
page19_member.jpg
Member


18

AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
Joseph L. Moskowitz

RETIRED EXECUTIVE VICE PRESIDENT, PRIMERICA, INC.

Mr. Moskowitz retired from

05_424611-3_pic_board_moskowitz_j.jpg
Katherine T. Rohrer
VICE PROVOST EMERITUS, PRINCETON UNIVERSITY
05_424611-3_pic_board_rohrer_k.jpg
AGE
70
DIRECTOR
SINCE
2015
COMMITTEES
AR*    C    CD    E
AGE
70
DIRECTOR
SINCE
2017
COMMITTEES
C    CG    E
Executive vice president of Primerica, Inc., an insurance and investments company, where he served as executive vice president from 2009 until 2014, leading the Product Economics and Financial Analysis Group. He joinedGroup
Joined Primerica in 1988 and served in various capacities, including managing the group responsible for financial budgeting, capital management support, earnings analysis, and analyst and stockholder communications support. He served as chiefsupport
Chief actuary from 1999 to 2004. Before joining Primerica, Mr. Moskowitz was vice2004
Vice president of Sun Life Insurance Company from 1985 to 1988 and was a senior
Senior manager at KPMG from 1979 to 1985.

SKILLS AND RECOGNITION

1985

Notable Experience Aligned with Our Strategy and Key Board Contributions
With forty years of actuarial experience and leadership roles in the financial servicesinsurance industry, Mr. Moskowitz provides our Board with vital insight into the analysis and evaluation of actuarial and financial models, which form the basis of various aspects of corporate planning, financial reporting, and risk assessment, to the Board.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

assessment.

Other Board or Leadership Positions, Professional Memberships or Awards
Fellow, Society of Actuaries

(since 1979)

Member, American Academy of Actuaries

(since 1979)

INDEPENDENT

AGE

67

DIRECTOR SINCE

2015

COMMITTEES

Audit and Risk*

Compensation (Chair)

Corporate Development

Executive

*      Financial Expert

6Aflac Incorporated

Table of Contents

Corporate Governance Matters

Barbara K. Rimer, DrPH

DEAN AND ALUMNI DISTINGUISHED PROFESSOR, GILLINGS SCHOOL OF GLOBAL PUBLIC HEALTH, UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL

Dr. Rimer has been dean of the University of North Carolina Gillings School of Global Public Health since 2005, and alumni distinguished professor since 2003. Previously, she was director of the Division of Cancer Control and Population Sciences at the National Cancer Institute. She is a former director of Cancer Control Research and professor of community and family medicine at the Duke University School of Medicine. She was elected to the Institute of Medicine in 2008.

SKILLS AND RECOGNITION

At the Gillings School of Public Health, Dr. Rimer works to improve public health, promote individual well-being, and eliminate health inequities across North Carolina and around the world. In 2012, Dr. Rimer was appointed Chairman of the President’s Cancer Panel and was reappointed twice since then. Her insight and leadership with respect to the public health sector are extremely relevant to the Company’s business and operations.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Chair, President’s Cancer Panel (2012-2019)

Elected to Institute of Medicine (2008)

Awarded the American Cancer Society Medal of Honor (2013)

University of North Carolina at Chapel Hill General Alumni Association’s Faculty Service Award (2020)

INDEPENDENT

AGE

72

DIRECTOR SINCE

1995

COMMITTEES

Corporate Social Responsibility and Sustainability (Chair)

Corporate Governance

Katherine T. Rohrer

VICE PROVOST EMERITUS, PRINCETON UNIVERSITY

Dr. Rohrer is viceVice provost emeritus at Princeton University having served as vice

Vice provost for Academic Programs from 2001 until 2015. Prior to assuming this role, starting in 1988, Dr. Rohrer held2015
Held several senior leadership positions at Princeton University, including associate dean of the faculty and assistant dean of the college. Following her retirement, she servedcollege, starting in 1988
Served as interim associate dean of the graduate school in 2016-17. At2016 to 2017
Assistant professor at Columbia University she was an assistant professor from 1982 to 1988. Dr. Rohrer is also a trustee1988
Trustee of Emory University, where she serves on the executive committee as well as the academic affairs committee, which she chaired from 2013 to 2020.

SKILLS AND RECOGNITION

2020

Notable Experience Aligned with Our Strategy and Key Board Contributions
With more than 30 years as a university leader, Dr. Rohrer bringsprovides our Board with a wealth of experience highlighted by a commitment to academic rigor and financial management. Her operational expertise includes: executing on institutional budgetary decisions; leading academic governance and priority-setting; spearheading the recruitment of deans and other senior academic administrators; developing university-level messaging and communications; and managing endowments. Dr. Rohrer’s management career has included a focus on social responsibility, inclusion, and diversity.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Other Board or Leadership Positions, Professional Memberships or Awards
Emory University Board of Trustees (since 2008)

(2008-2022)

Academic Affairs Committee (Chair 2013-2020)

Executive Committee (since 2012)

(2012-2022)

Finance Committee (2014-2020)

Previously served on the boards of Morristown-Beard School, Morristown, NJ; Trinity Church, Princeton, NJ; Crisis Ministry of Trenton and Princeton (now “Arm in Arm”); and Dryden Ensemble.

Ensemble

INDEPENDENT

AGE

67

DIRECTOR SINCE

2017

COMMITTEES

LEGEND:
* Financial Expert • AR Audit and Risk • Compensation

• CD Corporate Development • CG Corporate Governance

2021 Proxy Statement7

Table of Contents

Corporate Governance Matters

Melvin T. Stith

DEAN EMERITUS OF THE MARTIN J. WHITMAN SCHOOL OF MANAGEMENT AT SYRACUSE UNIVERSITY

Dr. Stith is dean emeritus of the Martin J. Whitman School of Management at Syracuse University, having served as dean from 2005 until 2013. Recently, Dr. Stith served as interim president of Norfolk State University from January 2018 to June 2019. Prior to assuming this role, Dr. Stith was the dean emeritus and the Jim Moran Professor of Business Administration at Florida State University for thirteen years. He has been a professor of marketing and business since 1977 following his service as a captain in the U.S. Army Military Intelligence Command.

SKILLS AND RECOGNITION

Dr. Stith’s financial acumen and his leadership skills in consensus-building, risk management, and executive management add an important dimension to the composition of our Board.

OTHER BOARD OR LEADERSHIP POSITIONS, PROFESSIONAL MEMBERSHIPS OR AWARDS

Synovus Financial Corp. (1998-2019)

Flowers Foods, Inc. (since 2004)

Jim Moran Foundation (since 2000)

Previously served on the boards of Correctional Services Corporation, JM Family Enterprises Youth Automotive Training Center, the Keebler Company, United Telephone of Florida, and Rexall Sundown.

INDEPENDENT

AGE

74

DIRECTOR SINCE

2012

COMMITTEES

Corporate Governance (Chair)
CSR Corporate Social Responsibility and Sustainability
• 
Executive

• FI Finance and Investment •
page10_ind (2).jpg
Independent •
page19_chair.jpg
Chair •
page19_member.jpg
Member


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT19

Director Not Eligible for Re-election
Pursuant to the Company’s Guidelines on Significant Corporate Governance Issues, Dr. Barbara K. Rimer, who turned 75 prior to our Annual Meeting, is not eligible to be nominated for re-election. As a result, the Company has not nominated Dr. Rimer for election to the Board at the 2024 Annual Meeting and reduced the number of authorized Directors from eleven to ten. Dr. Rimer has served on our Board since 1995. We thank Dr. Rimer for her service to the Board.
Director Independence
The Board annually assesses the independence of each Director and Director nominee. Daniel P. Amos is an employee of the Company. The Board has determined that all of the other Directors during the last completed fiscal year and Director nominees are “independent” under New York Stock Exchange (“NYSE”) listing standards. None of the independent nominees has a material relationship with the Company, either directly or as a partner, shareholder, or officer of an organization that has a relationship with the Company. The Board made its determination based on information furnished by all Directors regarding their relationships with the Company and research conducted by management.
2024 Independent Director Nominee Tenure Mix
 a diverse balance of longer 
 tenured members and 
 newer members 
04_424611-3_gfx_Independent Director Nominee.jpg
Board Succession Planning and Refreshment Process

Our Board believes it is appropriate to maintain a diverse balance of longer tenured members, who bring stability and valuable Company-specific knowledge with a historical perspective, and newer members, who bring fresh viewpoints and new ideas. Our regular self-evaluation process ensures we maintain a cohesive, diverse, and well-constituted board of high integrity that exemplifies the right balance of perspectives, experience, independence, skill sets, and subject matter experts required for prudent oversight. Over the last five years, we have added fivefour new directorsdirector nominees as we make it a priority to identifyprioritize candidates with the skills needed to ensure effective oversight.

8Aflac Incorporated
Board Changes since 2019
4 of 4
 new nominees have been
 women and/or people
 of color
Skills of Directors Joining the Board since 2019
Image_0.jpg
INVESTMENT AND FINANCIAL
Image_1.jpg
REGULATORY AND RISK MANAGEMENT
Image_2.jpg
PUBLIC HEALTH
Image_3.jpg
OPERATIONS
Image_4.jpg
JAPANESE MARKET
Image_5.jpg
INDUSTRY
Image_6.jpg
DIGITAL/CYBERSECURITY


20AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

Table

Board of Contents

Corporate Governance Matters

Directors Nominees Skills, Experience, and Diversity

page20_namesamosd.jpg
page20_bowersp.jpg
page20_collinsa.jpg
pg21-name_miwakoh.jpg
page20_kennyt.jpg
page20_georgettek.jpg
page20_lloydk.jpg
page20_morin.jpg
page20_moskowitzj.jpg
page20_rohrerk.jpg
Skills and Experience
MARKETING AND PUBLIC RELATIONS: Understanding of the Company’s strong brand and its role in developing and marketing our insurance products offering financial protection.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
CURRENT OR FORMER CEO: Chief executive officer (CEO) experience brings an understanding of how to oversee and lead complex organizations.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
OPERATIONS EXPERIENCE: Provides valuable senior executive experience and organizational management perspective relevant to management and operations.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_icon_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
JAPANESE MARKET EXPERIENCE: Involvement working for an international company or working or living in Japan provides insight into our business and strategy in the market.
page20_icon_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
INVESTMENT AND FINANCIAL EXPERTISE: Understanding of investment markets and financial statements that assists in evaluating and overseeing our investment strategy, asset management, capital structure, and financial reporting.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
REGULATORY AND RISK MGMT. EXPERIENCE: Involvement and understanding of the operating environment for a highly regulated industry and impact of government action as well as identifying and controlling business and financial risks.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
INDUSTRY EXPERIENCE: Experience providing in-depth knowledge of the insurance and/or financial services industry.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
PUBLIC HEALTH EXPERIENCE: Expertise that provides insight with respect to the public health sector, medical care, and medical ethics, which is relevant to our strategy, business, and operations.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
DIGITAL/CYBERSECURITY EXPERIENCE: Understanding of new technology or the management of information security and cybersecurity risks, risk mitigation, regulation and policy.
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
INDEPENDENT
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
Race/Ethnicity
WHITE
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
BLACK OR AFRICAN AMERICAN
page20_outlinecircle.jpg
page20_outlinecircle.jpg
ASIAN
page20_outlinecircle.jpg
page20_outlinecircle.jpg
Gender
MALE
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
FEMALE
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg
page20_outlinecircle.jpg


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT21
Director Nominating Process

Our Corporate Governance Committee is responsible for establishing criteria, screening candidates and evaluating the qualifications of persons who may be considered for service as a Director.

1SUCCESSION PLANNING
Our Corporate GovernanceThe Committee considers the current and long-term needs of our business and seeks potential candidates in light of evolving needs, current Board structure, tenure, skills, experience, and diversity.

2IDENTIFICATIONOF CANDIDATES

The Committee may identify potential candidates from three sources:

•   

page21_check.jpgsuggestions from current Directors and executive officers;

•   

page21_check.jpgfirms that specialize in identifying director candidates; and/or

•   

page21_check.jpgas discussed below, candidates recommended by shareholders.

THRESHOLDQUALIFICATIONS
3THRESHOLD QUALIFICATIONS

The Committee believes that, at a minimum, nominees for Director must have:

•   

page21_check.jpga demonstrated ability to make a meaningful contribution to the Board’s oversight of the business and affairs of the Company; and

•   

page21_check.jpgan impeccable record and reputation for honest and ethical conduct in both professional and personal activities.

4ADDITIONAL QUALIFICATIONS
The Committee strives to build a diverse Board that is strong in its collective knowledge. In particular,Among other skill sets, the Committee looks for nominees with experience in the following areas:
page21_check.jpgaccounting and finance
business operationscorporate governance
page21_check.jpgmanagement and leadership
business judgmentglobal markets
page21_check.jpgvision and strategy
page21_check.jpg  business operations
page21_check.jpg  business judgment 
page21_check.jpgindustry knowledge
page21_check.jpg  corporate governance
page21_check.jpg  global markets 
page21_icon_check.jpgcommunication
In addition, the Committee considers such factors as values and disciplines, ethical standards, diversity (including gender, ethnicity, race, color, and national origin), and background, within the context of the characteristics and needs of the Board as a whole in nominating Directors. Nominees must be betweenDirectors may sit on no more than four public company boards (including our own) or no more than one additional public company board if the agesDirector is an officer of 21 and 74.the Company. All of our Director nominees currently comply with our policy on outside board service. The Committee reviews requests from Directors to serve on the board of other public companies.

5MEETING WITH CANDIDATES

Once the Committee identifies one or more potential nominees, its members:

•   

page21_check.jpgreview publicly available information and contact candidates who warrant further consideration;

•   

page21_check.jpgrequest further information for those potential nominees willing to be considered for a Board seat;

•   

page21_check.jpgconduct one or more interviews with each prospectivepotential nominee; and

•   

page21_check.jpgmay contact references provided by candidates and speak with members of the business community or other people who have firsthand knowledge of a candidate’s record.

This process enables the Corporate Governance Committee to compare the accomplishments and qualifications of all potential nominees.

6DECISION ANDNOMINATION
The Committee nominates the candidates best qualified to serve the interests of the Company and all shareholders for nomination and approval by the Board.

ELECTION
7ELECTION
Shareholders consider the nominees and elect Directors at the Annual Meeting of Shareholders to serve one-year terms. The Board may also appoint Directors during the year when determined to be in the best interests of the Company and its shareholders.

2021 Proxy Statement9


22AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

Table of Contents

Corporate Governance Matters

Consideration of Director Candidate from Shareholders

The Corporate Governance Committee will consider Director candidates recommended by shareholders. As with any prospective nominee, the Corporate Governance Committee will evaluate shareholder-nominated candidates in light of the needs of the Board and the qualifications of the particular individuals. In addition, the Corporate Governance Committee may consider the number of shares held by the recommending shareholder and the length of time such shares have been held.

To recommend a candidate for the Board, a shareholder must submit the recommendation in writing, including: (i) the name of the shareholder and evidence of the person’s ownership of common stock of the Company (“Common Stock”), including the number of shares owned and the length of time of ownership; and (ii) the name of the candidate, the candidate’s resume or qualifications to be a Director, and the candidate’s consent to be named as a Director if nominated by the Board.

The shareholder recommendation and information described above generally must be received by the Corporate Secretary not less than 90 nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of shareholders. However, if the annual meeting is called for a date that is not within 25 days before or after such anniversary date, notice by the shareholder, to be timely, must be received no later than the close of business on the tenth day following the day on which notice of the date of the annual meeting was mailed or public disclosure of that date was made, whichever occurs first.

Shareholder recommendations and accompanying information should be sent to the Corporate Secretary at Aflac Incorporated as described at the end of this Proxy Statement under the heading “Other Proposals or Director Nominations to be Brought Before our 2022 Annual Meeting.”

Our proxy access bylaw permits a shareholder (or group of up to twenty shareholders) owning shares of our outstanding Common Stock representing at least 3% of the votes entitled to be cast on the election of Directors to nominate and include in our proxy materials Director candidates constituting up to 20% of the Board. The nominating shareholder or group of shareholders must have owned their shares continuously for at least three years, and the nominating shareholder(s) and nominee(s) must satisfy other requirements specified in our Bylaws.

Board Self-Evaluation

The effectiveness of our Board is of the utmost importance. The Board recognizes that we live in a dynamic world that requires regular self-evaluation to ensure that we have the best skill set and experience to serve the Company and that the Board is fulfilling its responsibilities.

ANNUALASSESSMENTOVERSIGHT
Consideration of Director Candidates from Shareholders
The Corporate Governance Committee will consider Director candidates recommended by shareholders. As with any potential nominee, the Corporate Governance Committee will evaluate shareholder-nominated candidates in light of the needs of the Board and the qualifications of the particular individuals. In addition, the Corporate Governance Committee may consider the number of shares held by the recommending shareholder and the length of time such shares have been held.
To recommend a candidate for the Board, a shareholder must submit the recommendation in writing, including: (i) the name of the shareholder and evidence of the person’s ownership of common stock of the Company (“Common Stock”), including the number of shares owned and the length of time of ownership; (ii) the name of the candidate, the candidate’s principal occupation or employment or qualifications to be a Director; (iii) the candidate’s consent to be named as a Director if nominated by the Board, and (iv) other requirements specified in our Bylaws.
The shareholder recommendation and information described above generally must be received by the Corporate Secretary not less than 90 nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of shareholders. However, if the annual meeting is called for a date that is not within 25 days before or after such anniversary date, notice by the shareholder, to be timely, must be received no later than the close of business on the 10th day following the day on which notice of the date of the annual meeting was mailed or public disclosure of that date was made, whichever occurs first. In the case of a special meeting of shareholders called for the purpose of electing directors, the recommendation and accompanying information must be received by the Corporate Secretary not later than the close of business on the 10th day following the day on which notice of the special meeting was mailed or public disclosure of the date of the special meeting was made, whichever first occurs.
Shareholder recommendations and accompanying information should be sent to the Corporate Secretary at Aflac Incorporated as described at the end of this Proxy Statement under the heading “Other Proposals or Director Nominations to be Brought Before our 2025 Annual Meeting.”
Our proxy access bylaw permits a shareholder (or group of up to twenty shareholders) owning shares of our outstanding Common Stock representing at least 3% of the votes entitled to be cast on the election of Directors to nominate and include in our proxy materials Director candidates constituting up to 20% of the Board. The nominating shareholder or group of shareholders must have owned their shares continuously for at least three years, and the nominating shareholder(s) and nominee(s) must satisfy other requirements specified in our Bylaws.
Board Self-Evaluation
The effectiveness of our Board is of the utmost importance. The Board recognizes that we live in a dynamic world that requires regular self-evaluation to ensure that we have the best skill set and experience to serve the Company and that the Board is fulfilling its responsibilities.
1    ANNUAL ASSESSMENT OVERSIGHT
The Corporate Governance Committee is charged with overseeing an annual process of self-evaluationself-evaluation for the Board as a whole and for its individual members.
2COMMITTEESELF-EVALUATIONS
The charters of each Board committee also require annual evaluations of the performance of the committee, which are typically overseen by each committee’s chair.
3ONE-ON-ONEDISCUSSIONS
The annual process, which includes completion of written questionnaires for the Board and for each committee on which the Director serves, involves an interview of each Director.
4EXECUTIVESESSIONS
The Chairman discusses the results of the surveys and interviews with the full Board in executive sessions. In addition, the Lead Non-Management Director leads executive sessions with the Board, without the Chairman, to discuss the self-evaluation results.
5FEEDBACKINCORPORATED
Based on the self-evaluation results, any follow-ups including changes in practices or procedures are considered and implemented, as appropriate.

10Aflac Incorporated

Table of Contents

Corporate Governance Matters

AGENDA TOPICS DISCUSSED

Board structure and composition

Effectiveness of oversight and other responsibilities

Access to management, information, management, and other resources

Meetings and materials

Quality of director participation

Fulfillment of charter responsibilities

Refreshment and succession

In addition to the formal self-evaluation process, the Non-employee Directors regularly meet in executive session, during which the Board’s performance and oversight responsibilities are frequently discussed.

Director Independence

The Board annually assesses the independence of each Director and Director nominee. Daniel P. Amos is an employee of the Company. The Board has determined that all of the other Director and Director nominees are “independent” under New York Stock Exchange (“NYSE”) listing standards. None of the independent nominees has a material relationship with the Company, either directly or as a partner, shareholder, or officer of an organization that has a relationship with the Company. The Board made its determination based on information furnished by all Directors regarding their relationships with the Company and research conducted by management.

Independent Director Tenure Mix

2021 Proxy Statement11


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT23

Table of Contents

Corporate Governance Matters

Our Board and Committees

Board Leadership Structure

The Board does not have a policy on whether or not the role of the Chairman and Chief Executive Officer should be separate. If the Chairman and Chief Executive Officer roles are filled by the same person, or if the Chairman is not independent, the Board believes that an independent Director should be appointed to serve as the Lead Non-Management Director. The Lead Non-Management Director is elected annually by the Board (effective at the first Board of Director’sDirectors meeting following the Annual Meeting of Shareholders) based upon a recommendation by the Corporate Governance Committee. Although subject to an annual election, the Lead Non-Management Director is generally expected to serve for more than one year, but no more than four years.

year.
The Board believes its existing corporate governance practices achieve independent oversight and management accountability. These governance practices are reflected in the Company’s Guidelines on Significant Corporate Governance Issues and the Committee charters. In particular:
a substantial majority of our Board members are independent;
the Audit and Risk, Compensation, and Corporate Governance Committees all comprise independent Directors;
the Company has a Lead Non-Management Director with significant responsibilities, as described below; and
the Non-employee Directors meet at each regularly scheduled Board meeting in executive session without management present.

05_424611-3_photo_amosD_nobg.jpg
Daniel P. Amos
Chairman and
CHAIRMAN, CEO

AND PRESIDENT

Mr. Amos has served as Chairman of the Board since 2001 and as CEO since 1990. The Board believes the most effective Board leadership structure for the Company is for the CEO to continue to serve as Chairman, working with a Lead Non-Management Director. This structure has served the Company well for many years. The CEO is ultimately responsible for the day-to-day operation of the Company and for executing the Company’s strategy, and the Company’s performance is an integral part of Board deliberations. Accordingly, the Board believes that Mr. Amos is the Director most qualified to act as Chairman. The Board believes that Mr. Amos’ in-depth, long-term knowledge of the Company’s operations and his vision for the Company’s development provides decisive and effective leadership for the Board. However, the Board retains the authority to modify this structure to best advance the interests of all shareholders if circumstances warrant such a change.

05_426223-1_photo_ourboardandcommittees_bowersP.jpg
W. Paul Bowers
Lead Non-Management Director

LEAD NON-MANAGEMENT DIRECTOR
The Corporate Governance Committee has nominated Mr. Bowers to serve as Lead Non-Management Director, a position he has held since May 2019. Mr. Bowers’ experience at Southern Company, particularly his strong leadership and operational background, make him well-suited to serve as our Lead Non-Management Director. He has also served as Chair of the Corporate Development Committee and is a member of the Audit and Risk, Corporate Social Responsibility and Sustainability, and Executive Committees.

The Board believes its existing corporate governance practices achieve independent oversight and management accountability. These governance practices are reflected in the Company’s Guidelines on Significant Corporate Governance Issues and the Committee charters. In particular:

a substantial majority of our Board members are independent;
the Audit and Risk, Compensation, and Corporate Governance Committees all comprise independent Directors;
Lead Non-Management Director
The responsibilities of the Company has a Lead Non-Management Director, with significant responsibilities, as described below; and
the Non-employee Directors meet at each regularly scheduled Board meetingoutlined in executive session without management present.

12Aflac Incorporated
our Guidelines on Significant Corporate Governance Issues, include:

Table of Contents

Corporate Governance Matters

Lead Non-Management Director

The responsibilities of the Lead Non-Management Director include:

consulting with the Chairman and Corporate Secretary to establish the agenda for each Board meeting;
setting the agenda for, and leading, all executive sessions of the Non-employee Directors;
when appropriate, discussing with the Chairman matters addressed at such executive sessions;
presiding over meetings of the Board at which the Chairman is not present;
presiding over discussions of the Board when the topic presents a potential conflict of interest for the Chairman;
facilitating discussions among the Non-employee Directors between Board meetings;
serving as a liaison between the Non-employee Directors and the Chairman;
when appropriate, serving as a liaison between management and the Board;
representing the Board in shareholder outreach; and
facilitating the annual Board self-evaluation in coordination with the Chairman.
The Lead Non-Management Director has the authority to call meetings of the independent Directors.


24AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

The Lead Non-Management Director has the authority to call meetings of the independent Directors.

Committee Structure

The Board has seven standing committees: Audit and Risk; Compensation; Corporate Development; Corporate Governance; Corporate Social Responsibility and SustainabilitySustainability; Executive; and Finance and Investment. Each committee (other than the Executive Committee) operates under a written charter adopted by the Board. Charters for the Audit and Risk Committee, the Compensation Committee, and the Corporate Governance Committee all can be found on the Company’s website, aflac.com, under “Investors,” then “Governance,” and then “Governance Documents.”

All members of the Audit and Risk, Compensation and Corporate Governance Committees qualify as “outside” Directors as defined by Section 162(m) of the Internal Revenue Code, “Non-employee Directors” within the meaning of Rule 16b-3 under the Securities Exchange Act of 1934, and independent Directors under NYSE listing standards, as appropriate.

Board Committee Refreshment

The Corporate Governance Committee considers the periodic rotation of committee members and committee chairs to introduce fresh perspectives and to broaden and diversify the views and experience represented on Board committees. TheBeginning May 6, 2024, the Corporate Governance Committee has nominated Mr. Nobuchika MoriDr. Miwako Hosoda to serve on the Corporate GovernanceSocial Responsibility and Sustainability Committee beginning May 3, 2021.

2021 Proxy Statement13
and Mr. Arthur R. Collins to serve as Chairman of the Corporate Social Responsibility and Sustainability Committee.

Table of Contents

Corporate Governance Matters

The Audit and Risk Committee

MEMBERS*

Karole F. Lloyd
(Chair)

W. Paul Bowers

Georgette D. Kiser

Joseph L. Moskowitz

NUMBER OF MEETINGS IN 2020

12

*
The Audit and Risk Committee

NUMBER OF
MEETINGS IN 2023
9

All members of the committee
are Financial Experts
pg24_karole.jpg
05_424611-3_photo_bowersP.jpg
pg24-pic_kisergeorgette.jpg
05_426223-1_photo_committee_moskowitzJ.jpg
Karole F. Lloyd
(Chair)
W. Paul
Bowers
Georgette D.
Kiser
Joseph L.
Moskowitz

RESPONSIBILITIES

Responsibilities
ensuring that management maintains the reliability and integrity of the financial reporting process and systems of internal controls of the Company and its subsidiaries regarding finance, accounting, and legal matters;

issuing annually the Audit and Risk Committee Report set forth below;

selecting, overseeing, evaluating, determining funding for, and, where appropriate, replacing or terminating the independent registered public accounting firm;

monitoring the independence and performance of the independent registered public accounting firm;

pre-approving audit and non-audit services provided by the independent registered public accounting firm;

pre-approving or ratifying all related person transactions that are required to be disclosed in this Proxy Statement;

overseeing the performance of the Company’s internal auditing department;

assisting with Board oversight of the Company’s compliance with legal and regulatory requirements;

requirements as well as the Company's code of business ethics and policy on conflict of interest;

overseeing the Company’s policies, process, and structure related to enterprise risk engagement and management, including information security; and

providing an open avenue of communication among the independent registered public accounting firm, management, the internal auditing department, and the Board.

Relationship with Independent Registered Public Accounting Firm.The independent registered public accounting firm has direct access to the Audit and Risk Committee and may discuss any matters that arise in connection with its audits, the maintenance of internal controls, and any other matters relating to the Company’s financial affairs. The Audit and Risk Committee may authorize the independent registered public accounting firm to investigate any such matters, and may present its recommendations and conclusions to the Board. At least annually, the Audit and Risk Committee reviews the services performed and the fees charged by the independent registered public accounting firm. For additional information, see “Proposal 3: Ratification of Auditors” and the “Audit and Risk Committee Report” sections beginning on page 62.

78.

All Audit and Risk Committee members have been determined by the Board to be “audit committee financial experts,” as such term is defined in Item 401(h)407(d)(5) of SECSecurities and Exchange Commission (SEC) Regulation S-K.


14Aflac Incorporated


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT25
The Compensation Committee

NUMBER OF
MEETINGS IN 2023
6
05_424611-3_pic_boardrefreshment_moskowitz_j.jpg
pg25_kiser.jpg
05_424611-3_photo_rohrerK.jpg
Joseph L.
Moskowitz
(Chair)
Georgette D.
Kiser
Katherine T.
Rohrer

Table of Contents

Corporate Governance Matters

The Compensation Committee

MEMBERS

Joseph L. Moskowitz
(Chair)

Georgette D. Kiser

 

Katherine T. Rohrer

NUMBER OF MEETINGS IN 2020

4

RESPONSIBILITIES

Responsibilities
reviewing and approving compensation levels, equity-linked incentive compensation, and annual incentive awards under the Company’s Management Incentive Plan;

reviewing, at least annually, the goals and objectives of the Company’s executive compensation plans;

evaluating annually the performance of the CEO with respect to such goals and objectives and determining the appropriate compensation level;

evaluating annually the performance of the Company’s other executive officers in light of such goals and objectives and setting their compensation levels based on this evaluation and the recommendation of the CEO;

viewingreviewing the Company’s incentive compensation programs to determine whether they encourage excessive risk taking, and evaluating compensation policies and practices that could mitigate any such risk; and

reviewing the Company’s generalother compensation and benefit plans to ensure they promote our goals and objectives.

The Compensation Committee may delegate power and authority to any subcommittees as the Compensation Committee seems appropriate to any subcommittees.

deems appropriate.

Compensation Committee Interlocks and Insider Participation.No member of the Compensation Committee is a current or former employee or officer of the Company or any of its subsidiaries. During 2020,2023, no Director was an executive officer of another entity on whose compensation committee any executive officer of the Company served. In addition, no member of the Compensation Committee had any relationship requiring disclosure under the section titled “Related Person Transactions” in this Proxy Statement.


2021 Proxy Statement15
The Corporate Development Committee

NUMBER OF
MEETINGS IN 2023
5
05_424611-3_pic_boardrefreshment_bowers_p.jpg
pg25_kenny.jpg
pg27_karole.jpg
05_426223-1_photo_committee_moskowitzJ.jpg
W. Paul Bowers
(Chair)
Thomas J.
Kenny
Karole F.
Lloyd
Joseph L.
Moskowitz

Table of Contents

Corporate Governance Matters

The Corporate Development Committee

MEMBERS

W. Paul Bowers
(Chair)

Thomas J. Kenny

Joseph L. Moskowitz

NUMBER OF MEETINGS IN 2020

5

RESPONSIBILITIES

Responsibilities

reviewing the Company’s corporate and strategic organizational development to identify, evaluate, and execute on appropriate opportunities that could enhance long-term growth and build shareholder value;

assisting the Board in reviewing, evaluating, and approving specific strategic plans for corporate development activities, including mergers, acquisitions, dispositions, joint venture, marketing and distribution arrangements, and strategic equity investments;

assisting the Board in reviewing proposals to enter new geographic markets;

reviewing corporate development proposals prepared by the Company’s officers and managers and other strategic projects as determined by the Board to ensure consistency with the Company’s long-term strategic objectives; and

assisting the Board in monitoring the nature of investments made as part of Aflac Ventures in both the U.S. and Japan, including the Company’s overall corporate venture capital strategy.


16Aflac Incorporated


26AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
The Corporate Governance Committee

NUMBER OF
MEETINGS IN 2023
3
05_424611-3_photo_rohrerK_.jpg
05_424611-3_photo_CollinsA.jpg
pg26_mori.jpg
pg26_barbara.jpg
Katherine T.
Rohrer
(Chair)
Arthur R.
Collins
Nobuchika
Mori
Barbara K.
Rimer, DrPH
(until May 6, 2024)

Table of Contents

Corporate Governance Matters

The Corporate Governance Committee

MEMBERS

Melvin T. Stith
(Chair)

Barbara K. Rimer, DrPH

Katherine T. Rohrer

NUMBER OF MEETINGS IN 2020

3

RESPONSIBILITIES

Responsibilities
selecting individuals qualified to serve as Directors to be nominated to stand for election to the Board;

recommending assignments to the Board’s standing committees;

advising the Board with respect to matters of Board structure, composition, and procedures;

developing and recommending to the Board a set of corporate governance principles applicable to the Company;

monitoring compliance with the Company’s political participation program;

overseeing the evaluation of the Board; and

ensuring that the Company’s management development and succession plans are appropriate.


2021 Proxy Statement17
The Corporate
Social Responsibility and Sustainability Committee
NUMBER OF
MEETINGS IN 2023
3
page26-pic_rimerbarbara.jpg
05_424611-3_photo_bowersP.jpg
05_424611-3_photo_CollinsA.jpg
pg25_kenny.jpg
Barbara K. Rimer,
DrPH
(Chair)
(until May 6, 2024)
W. Paul
Bowers
Arthur R.
Collins
Thomas J.
Kenny

Table of Contents

Corporate Governance Matters

The Corporate Social Responsibility and Sustainability Committee

MEMBERS

Barbara K. Rimer, DrPH
(Chair)

W. Paul Bowers

Thomas J. Kenny

Melvin T. Stith

NUMBER OF MEETINGS IN 2020

3

RESPONSIBILITIES

Responsibilities
CORPORATE SOCIAL RESPONSIBILITY

overseeing the Company’s policies, procedures, and practices with respect to corporate social responsibility and sustainability, recognizing that these goals and initiatives vary widely among industries, organizations and geographies, in the context of what is appropriate and relevant to the Company, our people and the communities we serve;

monitoring and reviewing the impact of the Company’s activities on customers, employees, communities, and other stakeholders in light of the Board’s fundamental duty to preserve and promote long-term value creation for the Company’s shareholders;

•   monitoring and reviewing the Company’s strategies, procedures, and practices related to corporate social responsibility on a global basis, including significant philanthropic and community engagement activities;

•   monitoring and reviewing the development of metrics, information systems, and procedures to track progress toward achievement of the Company’s corporate social responsibility objectives;

monitoring preparation ofreviewing the Company’s annual Corporate Social Responsibility report,corporate social responsibility and reviewing suchsustainability report before it is published; and

monitoring and reviewing the Company’s support of charitable, educational, and business organizations.

SUSTAINABILITY

monitoring and reviewing the Company’s policies, procedures, and practices related to corporate social responsibility and sustainability in light of the Company’s intent to foster the sustainable growthgrowth* of the Company on a global basis;

•   monitoring and reviewing the Company’s strategies, policies, procedures, and practices related to environmental and related health and safety matters;

•   monitoring and reviewing the Company’s policies, procedures, and practices that enable us to proactively respond to evolving public sentimentregulatory and government regulationsinvestor expectations with regard to sustainability, especially in the areas of environmental stewardship, energy use, recycling, and carbon emissions (i.e., our carbon footprint);

reviewing the goals and objectives of the Company’s environmental stewardship policy, and amending or, to the extent an amendment requires Board approval, recommending that the Board amend, these goals and objectives if the Committee deems appropriate; and

reviewing the Company’s communication and marketing strategies related to sustainability.

*    We believe “sustainable growth” means being able to meet the needs of our shareholders and customers while taking into account the needs of future generations, and also ensuring the long-term preservation and enhancement of the Company’s financial, environmental, and social capital.


18Aflac Incorporated


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT27
The Finance
and Investment Committee

NUMBER OF
MEETINGS IN 2023
4
pg27_kenny.jpg
05_424611-3_photo_amosD.jpg
pg27_karole.jpg
pg26_mori.jpg

Table of Contents

Corporate Governance Matters

The Executive Committee

MEMBERS

Daniel P. Amos
(Chair)

W. Paul Bowers

Karole F. Lloyd

Joseph L. Moskowitz

Melvin T. Stith

NUMBER OF MEETINGS IN 2020

4

PURPOSE

During the intervals between meetings of the Board, the Executive Committee may exercise all of the powers of the Board that may be delegated under Georgia law.

COMPOSITION

Under the Company’s Bylaws, the Executive Committee must consist of at least five Directors, including the Chief Executive Officer, the Chairman of the Board, and such additional Directors as the Board may from time to time determine. Currently, the membership of the Executive Committee also includes the chairpersons of the Audit and Risk, Compensation, and Corporate Governance Committees, and includes the Company’s Lead Non-Management Director. The Chief Executive Officer (or another member of the Executive Committee chosen by him) is the Chairman of the Executive Committee.


2021 Proxy Statement
Thomas J. Kenny
(Chair)
19
Daniel P.
Amos
Karole F.
Lloyd
Nobuchika
Mori

Table of Contents

Corporate Governance Matters

The Finance and Investment Committee

MEMBERS

Thomas J. Kenny
(Chair)

Daniel P. Amos

Toshihiko Fukuzawa

Karole F. Lloyd

NUMBER OF MEETINGS IN 2020

5

RESPONSIBILITIES

Responsibilities

FINANCE RESPONSIBILITIES

reviewing and reassessing significant financial policies and matters of Treasury and corporate finance, including the Company’s overall capital structure, dividend policy, share repurchase program and liquidity, and the issuance or retirement of debt and other capital securities;

reviewing and providing guidance to the Board on significant reinsurance transactions and strategies;

•   reviewing and providing guidance on the Company’s credit ratings, ratings strategy, and overall rating agency dialogue;

•   reviewing and providing guidance to the Board on the financing strategy and capital impact of corporate development activities and multiyear strategic capital project expenditures;

reviewing and reassessing the Company’s overall hedging strategy, including foreign exchange and cash flow hedging, and ensuring proper governance over policies and procedures associated with trading in derivative instruments;

in partnership with the Compensation Committee, overseeing the Company’s processes for managing the finances of the employee pension and defined contribution benefit plans, including the related investment policies, actuarial assumptions, and funding policies; and

in partnership with the Audit and Risk Committee, reviewing and providing guidance on the Company’s corporate insurance coverages.

coverages; and 
in partnership with the Corporate Social Responsibility and Sustainability Committee, review and provide guidance on corporate social responsibility and sustainability factors relating to issuance and application of proceeds of sustainability bonds and other social and/or sustainability-oriented debt of the Company.
INVESTMENT

INVESTMENT RESPONSIBILITIES

overseeing the investment process and the policies, strategies, and programs of the Company and its subsidiaries relating to investment risk management;

periodically reviewing and assessing the adequacy of the Global Investment Policy of the Company and its subsidiaries, and approving any changes to that policy;

reviewing the performance of the investment portfolios and transactions made on behalf of the Company and its subsidiaries; and

reviewingin partnership with the performanceCorporate Social Responsibility and Sustainability Committee, review and provide guidance on integration of corporate social responsibility and sustainability factors into the investment process and investment risk management policies, strategies and programs.
The Executive Committee

NUMBER OF
MEETINGS IN 2023
3
05_424611-3_photo_amosD.jpg
05_424611-3_photo_bowersP.jpg
pg27_karole.jpg
photo_exeCommittee_MoskowitzJ.jpg
05_424611-3_photo_rohrerK.jpg
Daniel P. Amos (Chair)
W. Paul
Bowers
Karole F.
Lloyd
Joseph L.
Moskowitz
Katherine T.
Rohrer
Responsibilities
PURPOSE
During the intervals between meetings of the investment portfoliosBoard, the Executive Committee may exercise all of the powers of the Board that may be delegated under Georgia law.
COMPOSITION
Under the Company’s Bylaws, the Executive Committee must consist of at least five Directors, including those Directors who are officers of the Company, and its subsidiaries.

such additional Directors as


20Aflac Incorporated
the Board may from time to time determine. Currently, the membership of the Executive Committee also includes the Chairs of the Audit and Risk, Compensation, and Corporate Governance Committees, and includes the Company’s Lead Non-Management Director. The Chairman of the Board (or another member of the Executive Committee chosen by him) is the Chairman of the Executive Committee.


28AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

Table of Contents

Corporate Governance Matters

Meeting Attendance

The Board met 4four times in 2020,2023, and all Directors attended at least 75% of the meetings of the Board and the committees on which they served for the period for which they served. It is Company policy that each Director should attend the Annual Meeting. All Directors serving at the time attended the 20202023 Annual Meeting, which was held virtually due to the COVID-19 pandemic.

virtually.

Board Responsibilities

Enterprise-Wide

Oversight of Risk Oversight

Our Board oversees our enterprise-wide risk management system, which is designed to achieve organizational and strategic objectives, improve long-term performance, and enhance shareholder value. Risk management requires more than just understanding the risks we face and the steps management takes to manage those risks. The Board also must understand what level of risk is appropriate for the Company. Our Directors are equipped to make all of these determinations because they are integral to the process of setting the Company’s business strategy.

While the Board oversees the risk-management process generally, several Board and management committees have specific roles that correspond with their areas of responsibility.

Role of Management

The Company’s management is responsible for day-to-day risk management. Our enterprise risk-management framework, which is aligned with and overseen by the Board and its committees, includes several executive management committees whose roles incorporate risk management across the enterprise. For example, executive management’s Global Risk Committee oversees the processes for identifying, assessing, measuring, monitoring, controlling, and mitigating the key risks associated with the Company. Other management committees are responsible for implementing policies and risk-management processes relating to strategic, operational, investment, competitive, regulatory and legislative, product, reputational, and compliance risks.

Audit and Risk Committee

Under its charter, the Audit and Risk Committee’s responsibilities include risk management and compliance oversight. Specifically, the Audit and Risk Committee:

Board of Directors
Our Board oversees our enterprise-wide risk management system, which is designed to achieve organizational and strategic objectives, improve long-term performance, and enhance shareholder value. The Board must understand the risks the Company faces and the steps management takes to manage those risks as well as what level of risk is appropriate for the Company. Our Directors are equipped to make all of these determinations because they are integral to the process of setting the Company’s business strategy.
The Board oversees the risk-management process in conjunction with Board and management committees, each with varying aspects of enterprise risk management as part of their responsibilities. Examples of Board committee risk management oversight are noted below.
page27_opt01-arrowdown.jpg
AUDIT AND RISK COMMITTEE
Under its charter, the Audit and Risk Committee’s responsibilities include risk management and compliance oversight.
Specifically, the Audit and Risk Committee:
discusses guidelines and policies governing the process by which senior management and the relevant departments of the Company assess and manage exposure to risk;
risk, as well as the Company’s major financial risk exposures and the steps management has taken to monitor and control such exposures;
reviews the Company’s risk assessment and enterprise risk-management framework, including risk-management guidelines, risk appetite, risk tolerances, key risk policies, and control procedures;
reviews critical regulatory risk-management filings and enterprise risk-management material shared with regulators and rating agencies;
reviews the general structure, staffing models, and engagement of the Company’s risk governance departments and practices;
reviews the Company’s major financial risk exposures and evaluates processes and controls that management has adopted to monitor and manage those risks;
meets in executive session with key senior leaders involved in risk management;
reviews with the internal auditors, the independent auditor, and the Company’s financial management team the adequacy and effectiveness of our internal controls, including information security policies and internal controls regarding information security, and any special steps adopted in light of material control deficiencies; and
reports to the Board, at least annually, with respect to matters related to key enterprise risks and risk management areas of concentration.

2021 Proxy Statement21
FINANCE AND INVESTMENT COMMITTEE

Table of Contents

Corporate Governance Matters

Spotlight on Information Security Risk Oversight

The Board has adopted an information security policy directing management to establish and operate an information security program with the goal of ensuring that the Company’s information assets and data, and the data of its customers, are appropriately protected. The Board has delegated oversight of the Company’s information security program to the Audit and Risk Committee. The Company’s senior officers, including its Global Security and Chief Information Security Officer, are responsible for the operation of the information security program and communicate quarterly with the Audit and Risk Committee on the program, including with respect to the state of the program, compliance with applicable regulations, current and evolving threats, and recommendations for changes in the information security program. The information security program also includes a cybersecurity incident response plan that is designed to provide a management framework across Company functions for a coordinated assessment and response to potential security incidents. This framework establishes a protocol to report certain incidents to the Global Security and Chief Information Security Officer and other senior officers, with the goal of timely assessing such incidents, determining applicable disclosure requirements and communicating with the Audit and Risk Committee. The incident response plan directs the executive officers to report certain incidents immediately and directly to the Lead Non-Management Director.

For more information, see the Aflac Incorporated Cybersecurity Disclosure on the Company’s ESG site at esg.aflac.com.

Finance and Investment Committee

The Finance and Investment Committee oversees the investment process and investment risk management of the Company and its subsidiaries by monitoring investment policies, strategies, and transactions and reviewing the performance of the investment portfolio and overall capital and liquidity position of the Company.

Investment processThe manner in which we invest cash flows of the Company and its subsidiaries by monitoring investment policies, strategies, and manage investments to emphasize safety, liquidity, returns, tax considerations, applicable lawstransactions and regulations, and conformity withreviewing the needsperformance of the Companyinvestment portfolio and its subsidiaries.overall capital and liquidity position of the Company. Specific risk oversight responsibilities include:
Investment risk
risk:Includes liquidity risk, market risk, and credit risk.
Liquidity risk
risk:When an investment is not marketable and cannot be bought or sold quickly enough to prevent or minimize a loss.
Market risk
risk:The risk that market movements will cause fluctuations in the value of our assets, the amount of our liabilities, or the income from our assets.
Credit risk
risk: The risk of loss arising from the failure of a counterparty to perform its contractual obligations.
Enterprise: Capital & Liquidity risk
risk:Review of enterprise capital adequacy, access to capital, and maintenance of liquidity position to protect credit ratings and the Company’s ability to meet short and long-term obligations.

Compensation Committee

COMPENSATION COMMITTEE
The Compensation Committee oversees the Company’s compensation plans and practices and strives to create incentives that encourage a level of risk-taking behavior consistent with the Company’s business strategy. Specific risk oversight responsibilities include:
reviewing the Company’s incentive compensation arrangements to determine whether they encourage unnecessary or excessive risk-taking;
reviewing at least annually the relationship between the Company’s compensation and risk management policies and practices; and
evaluating compensation policies and practices that could mitigate any such risk.
As more fully discussed in the Compensation Discussion and Analysis section of this Proxy Statement, the Compensation Committee establishes incentive compensation performance objectives for management that are directly linked to the Company’s results, aligned with shareholder interests, and realistically attainable so as not to encourage excessive risk taking.


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT29
Role of Management
The Company’s management is responsible for day-to-day risk management. Our enterprise risk-management framework, which is aligned with and overseen by the Board and its committees, includes several executive management committees whose roles incorporate risk management across the enterprise. For example, executive management’s Global Risk Committee oversees the processes for identifying, assessing, measuring, monitoring, and mitigating key risks in addition to ensuring transparency and appropriateness of reporting to executive leadership. Other management committees, and specific management positions such as the Company’s Global Chief Risk Officer, its General Counsel, and its Global Chief Compliance Officer, are responsible for implementing policies and risk-management processes relating to strategic, operational, investment, competitive, regulatory and legislative, product, reputational, and compliance risks.
Spotlight on Information Security Risk Oversight
The Board has adopted an information security policy directing management to establish and operate a global information security program with the goals of identifying, assessing and monitoring existing and emerging cybersecurity threats and ensuring that the Company’s information assets and data, and the data of its customers, are appropriately protected. The Board has delegated oversight of the Company’s information security program to the Audit and Risk Committee. The Company’s senior officers, including  its Global Security and Chief Information Security Officer, are responsible for the operation of the global information security program and communicate quarterly with the Audit and Risk Committee on the program, including with respect to the state of the program, compliance with applicable regulations, current and evolving threats, and recommendations for changes in the global information security program. The information security program also includes a cybersecurity incident response plan that is designed to provide a management framework across Company functions for a coordinated assessment and response to potential security incidents. This framework establishes a protocol to report certain incidents to the Global Security and Chief Information Security Officer and other senior officers, with the goal of timely assessing such incidents, determining applicable disclosure requirements, and communicating with the Audit and Risk Committee. The incident response plan directs the executive officers to report certain incidents immediately and directly to the Lead Non-Management Director or the Chair of the Audit and Risk Committee.
For more information, see the Aflac Incorporated Cybersecurity Disclosure at investors.aflac.com under the “Sustainability” tab, then “Policies and Statements.” See also Item 1C of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
Oversight of Strategy
The Board oversees and monitors strategic planning. Business strategy is a key focus at the Board level and embedded in the work of Board committees. In addition to strategic plans being reviewed by the Board annually, the Board holds periodic retreats in the U.S. and Japan focused on strategic development, and the Corporate Development Committee reviews strategy with respect to non-organic investment considerations. The Board believes that overseeing and monitoring strategy is a continuous process and takes a multilayered approach in exercising its duties.


30AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
Commitment to Corporate Social Responsibility and Sustainability
Oversight of Corporate Social Responsibility and Sustainability
Board of Directors
Our Board plays critical environment, social, and governance oversight and leadership roles through its efforts to identify, promote, and monitor responsible and ethical corporate governance mechanisms, corporate social responsibility and sustainability goals and related compensation programs, and risk management policies that identify and assess climate-related risks.
page27_opt01-arrowdown.jpg
Corporate Social Responsibility and
Sustainability Committee
Oversees the Company’s policies, procedures, and practices with respect to corporate social responsibility (CSR) and sustainability
Monitors the preparation of and reviews the Company’s annual report that provides more detail around CSR and sustainability initiatives
Coordinates with:
The Finance and Investment Committee regarding guidance on CSR and sustainability factors relating to issuance and application of proceeds of sustainability bonds and other social and/or sustainability oriented debt of the Company and oversight of the investment process
The Compensation Committee relating to incorporating CSR and sustainability factors into executive compensation programs
The Corporate Governance Committee to incorporate diversity, equity, and inclusion efforts with regards to the Company’s policies and principles relating to succession planning and management development
Updates received by the Board through the Corporate Social Responsibility and Sustainability Committee
U.N. Sustainable Development Goals
Environmental initiatives
Workplace diversity and inclusion efforts
Philanthropic activities
Audit and Risk Committee
Oversees the Company’s policies, process, and structure related to enterprise risk engagement and management, which includes CSR and sustainability risks and opportunities
Role of Management
Management periodically meets with the Corporate Social Responsibility and Sustainability Committee, as well as other Board Committees, to report on how sustainability-related risks and opportunities inform actions that are coordinated and aligned with the broader goals of the Company and are integrated into organizational strategy, plans of action, management policies, and performance objectives, including how progress is monitored against targets and goals.
2023 Key Corporate Social Responsibility and Sustainability Initiatives
Throughout the year, the Corporate Social Responsibility and Sustainability Committee monitored the progress of the four 2023 MIP Modifier objectives in the following categories: responsible investing (insurance subsidiary portfolios); climate net zero emissions; and diversity, equity, and inclusion. See the “Compensation Discussion and Analysis” section of this Proxy Statement,document for more discussion on these items.


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT31
Human Capital Management
Board of Directors
Our Board is actively engaged in overseeing the Company’s people and culture strategy. Several committees review and report back to the Board on a broad range of human capital management topics and related risks.
page27_opt01-arrowdown.jpg
Compensation Committee
Reviews the Company’s compensation plans to ensure promotion of the Company’s goals and objectives, including sustainability goals and objectives
Corporate Governance Committee
Oversees the Company’s policies and principles relating to succession planning and management development, and ensures that appropriate succession plans are in place
Corporate Social Responsibility and Sustainability Committee
Provides guidance and oversight of the Company’s corporate social responsibility activities, including metrics and procedures to track progress toward achievement of the Company’s goals
Aflac U.S. and Aflac Japan both place an emphasis on the Compensation Committee establishes incentive compensation performance objectivesemployee value proposition and overall employee experience. This includes a broad range of development and growth opportunities as well as a robust menu of engagement and wellness offerings. Diversity, equity, and inclusion (DEI) has continued to be a key theme in the Aflac culture and critical to our human capital management strategy. At Aflac Japan, promotional efforts have successfully focused on the development of women into leadership positions. In the U.S., recruiting efforts target both entry level and mid to senior level hiring and include partnerships with colleges and universities, including historically black colleges and universities, and civic organizations to attract diverse talent. Aflac U.S. also offers a variety of internships, co-operative opportunities and transitional programs to allow emerging talent to develop. Educational opportunities are available for management that are realistically attainable so as notself-development and growth to encourage excessive risk taking.

Code of Business Conducthelp employees further enhance their technical and Ethics

The Company’s Code of Business Conduct and Ethics applies to all Directors, executives, and employees of the Company and its subsidiaries. In addition, there are provisions specifically applicable to the Chief Executive Officer, the Chief Financial Officer, and the Chief Accounting Officer. The Company intends to satisfy any disclosure requirements regarding amendments to, or waivers of, any provision of the Code of Business Conduct and Ethics by posting such information on our website, aflac.com, under “Investors,” then “Governance,” then “Governance Documents.”

professional skills.

To see Aflac Incorporated’s most recent Business and Sustainability Report, other sustainability disclosures including the most recent EEO-1 report and the sustainability policy statements, please visit investors.aflac.com under the “Sustainability” tab.


32AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
Chief Executive Officer and Executive Management Succession Planning

The Board, in coordination with the Corporate Governance Committee, is responsible for succession planning for key executives to ensure continuity in senior management. As part of that effort, the Board and the Corporate Governance Committee ensure that the Company has an appropriate process for addressing Chief Executive Officer succession as a matter of regular planning and in the event of extraordinary circumstances.

22Aflac Incorporated

Table of Contents

Corporate Governance Matters

The Chief Executive Officer plays an active role in the succession-planning process for other executive management positions. In coordination with the Company’s executive management team, including the General Counsel and the Director ofChief Human Resources Officer, the Chief Executive Officer periodically evaluates potential successors, reviews development plans recommended for such individuals, and makes recommendations to the Corporate Governance Committee. Together these parties also identify potential successors for other critical executive management positions. In addition, the Chief Executive Officer reviews executive succession planning and management development at an annual executive session of independent Directors.

Commitment to Social Responsibility and Sustainability

As noted above, the Company has a dedicated, Board-level committee, which oversees the Company’s policies, procedures, and practices with respect to corporate social responsibility (CSR) and sustainability. Specifically, the Board, through this committee, receives updates on the business’ focus on certain U.N. Sustainable Development Goals, environmental initiatives, workplace diversity and inclusion efforts, and philanthropic activities. The Corporate Social Responsibility and Sustainability Committee also monitors the preparation of and reviews the Company’s annual report that provides more detail around CSR and sustainability initiatives. To see Aflac Incorporated’s 2020 Business and Sustainability Report and the policy statements around ESG Investing, Tax, Carbon Neutrality, Human Rights, Human Capital Management, Diversity and Inclusion, and Supply Chain Approach and Philosophy, please visit esg.aflac.com.

Shareholder Outreach

Engagement

The Company has a long history of engaging shareholders to learn about the issues and concerns that are important to them.them and address any concerns that they may have. We believe that open communications can have a positive influence on our performance as we address key concerns aroundseek to continually improve our corporate governance, environmental, and social topics. For example, we are proud to have been the first publicly traded company in the United States to voluntarily allow shareholders a say-on-pay vote. In keeping with this governance philosophy, we communicate with our shareholders on a regular basis and incorporate their feedback into our decision-makingdecision-making process.

Based on engagement, the Board amended the Company’s Bylaws and Guidelines on Significant Corporate Governance Issues to eliminate the Emeritus Director category in 2023.

Our Approach

YEAR-ROUND ENGAGEMENT

Aflac Incorporated’s Investor and Rating Agency Relations team proactively engages year-round with shareholders and fixed income investors, including:

•  current and prospective

•  retail and institutional               

  portfolio management and stewardship teams

These efforts often include executive management and occasionally the Lead Non-Management Director and extend to:

•  proxy advisory firms,

•  ESG rating firms and

•  credit rating agencies

Both outside of and leading up to the annual meeting, the Vice President of Investor Relations and Corporate Secretary conduct meetings (in person when possible and by telepresence) and calls to update investors and regularly relay feedback to the Chairman, Lead Non-Management Director and the Board. During 2020 engagements, we discussed our policy statements on the recently launched esg.aflac.com as well as the following topics:

•  Business Update & COVID-19 Response: Provided an update on our business and focus areas in light of the ongoing COVID-19 pandemic, including actions we have taken to support our employees and customers through this challenging time;

•  Environmental & Social Initiatives: Discussed our sustainability goals and diversity and inclusion initiatives, our focus on human capital management and fostering a supportive corporate culture for employees, and recent enhancements to our sustainability reporting;

2021 Proxy Statement23
Who We EngageHow We EngageTopics of Engagement

Table of Contents

Corporate Governance Matters

SHAREHOLDERS, FIXED INCOME INVESTORS, AND AGENCIES
Aflac Incorporated’s Investor and Rating Agency Relations team proactively engages year-round with shareholders and fixed income investors, including: 
current and prospective, 
retail and institutional, 
portfolio management, and stewardship teams
These efforts often include executive management and occasionally the Lead Non-Management Director and extend to: 
proxy advisory firms, 
ESG rating firms, and 
credit rating agencies
 Year-Round 
Engagement
Both outside of and leading up to the annual meeting, the Vice President of Investor Relations and Corporate Secretary conduct meetings (in person when possible and by videoconference) and calls to update investors and regularly relay feedback to the Chairman, Lead Non-Management Director, and the Board.
During 2023 engagements, we discussed our policy statements as well as the following topics:
Business Update:Provided an update on our strategic focus areas, succession planning, and recent performance in light of the recent challenging macroeconomic and geopolitical environment;
Board Composition:Discussed the alignment of board composition and skills with company strategy;Company strategy and
 performance;
Executive Compensation:Reviewed key features of our compensation program and its continued alignment with companyCompany strategy and performance.performance;
Environmental & Social Initiatives:Discussed our sustainability objectives and achievements for the year, including detail on our diversity, equity, and inclusion goals and initiatives; and
Disclosure Enhancements:Added descriptions of skills and experience in the Director nominee matrix based on engagement feedback. 
page32_shareholders.jpg


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT33

Over

Description of Time-Phased Voting Rights (10-for-1)
Time-phased voting rights entitle any holder of shares of the courseCompany’s Common Stock which have been beneficially owned for a period of these meetings, two topics48 consecutive months prior to the record date of any meeting of shareholders to ten votes on each ballot item (“long-term shares”). Holders of Common Stock shares held for less than 48 consecutive months are entitled to one vote per each such share (“short-term shares”).
These rights were consistently discussed: climate change and diversity and inclusion. The feedback received as part of these conversations were informative and valuable in forming corporate strategy in 2021 as it relates to these issues. For example, as a result of discussionapproved by over 90% of our environmentalshareholders in 1985 and social goals,serve to amplify the Corporate Social Responsibility and Sustainability Committee has recommendedvoice of long-term shareholders by providing them, regardless of affiliation or views on management or the Board, more say by virtue of their longer financial commitment to the Compensation Committee an ESG compensation modifierCompany.
The Company’s time-phased voting rights differ significantly from dual-class share structures as neither the long-term shares nor the short-term shares (1) have a preference over the other with regard to dividends or upon liquidation, (2) carry any preemptive rights enabling a holder to subscribe for 2021. Also, following investor dialogue regarding bestor receive shares, (3) are entitled to vote cumulatively for Directors, or (4) differ in any respect other than the additional voting rights.
In past engagements, our shareholders have expressed a range of perspectives on our voting rights structure in the context of our overall strong governance profile. The majority of shareholders with whom we engaged expressed that while they have a philosophical preference for one-share one-vote structures, they did not have concerns with Aflac Incorporated’s time-phased voting rights given our long history of strong corporate governance practices and expectations around reducingextensive shareholder engagement. Some investors expressed that they prefer one-share one-vote structures in all instances. Further, some of our carbon footprint,investors expressed that they did not have an established view on the Company has made a commitmenttopic or had no preference on these structures and deferred to include Scope 3 emissionsmanagement and the Board’s recommendations. These discussions have helped to its existing 2040 carbon neutrality goal.

inform our Board’s ongoing discussion and approach to our voting rights and governance profile.

Please refer to Description of Voting Rights section on page 84 for more information on our voting rights.
Communications with Directors

Shareholders and other interested parties may contact members of the Board by mail. If you wish to communicate with the Board, any individual Director, or any group or committee of Directors, address your correspondence to the Board or to such individual Director, group, or committee, c/o the Corporate Secretary of Aflac Incorporated, 1932 Wynnton Road, Columbus, Georgia 31999. The Corporate Secretary will forward any message that is not in the nature of advertising, promotions of a product or service, or patently offensive material.

Governance Documents

Charters for the Audit and Risk Committee, the Compensation Committee, and the Corporate Governance Committee, as well as the Company’s Guidelines on Significant Corporate Governance Issues, the Code of Business Conduct and Ethics and other governance-relatedgovernance-related documents, may all can be found on the Company’s website, aflac.com, under “Investors,” then “Governance,” then “Governance Documents.” Shareholders can request printed copies of these documents by submitting a request to the Corporate Secretary at the address shown above.

Code of Business Conduct and Ethics
The Company’s Code of Business Conduct and Ethics applies to all Directors, executives, and employees of the Company and its subsidiaries. In addition, there are provisions specifically applicable to the Chief Executive Officer, the Chief Financial Officer, and the Chief Accounting Officer. The Company intends to satisfy any disclosure requirements regarding amendments to, or waivers of, any provision of the Code of Business Conduct and Ethics by posting such information on our website, aflac.com, under “Investors,” then “Governance,” then “Governance Documents.”


34AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS
Director Compensation

Directors who also serve as employees of the Company or its subsidiaries do not receive compensation as Board members. The Compensation Committee reviews the policy regarding total compensation for Non-employee Directors at least every other year and recommends compensation to the Board consistent with that policy. When making its recommendation, the Compensation Committee considers a variety of factors, including the Non-employee Director pay packages at our peer group companies, the skills and backgrounds required of Non-employee Directors to serve on the Company’s Board, and the balance between the cash and equity components of the package. The Board makes final determinations regarding Non-employee Director compensation.

The Compensation Committee assesses Director compensation and uses its independent compensation consultant to benchmark against peers every other year.

The Compensation Committee assesses Director compensation and uses its independent compensation consultant to benchmark against the peer group at least every other year.

Cash Compensation

Cash

For 2023, cash compensation for the Non-employee Directors was as follows:

All Non-employee Directors (annual cash retainer)$135,000 annually
All Audit and Risk Committee membersAdditional $10,000$15,000 annually
Chairs—Compensation, Corporate Governance, Corporate Social Responsibility and Sustainability, Corporate Development, Finance and InvestmentAdditional $20,000$25,000 annually
Chair—Audit and RiskAdditional $30,000$35,000 annually
Chair—CompensationAdditional $25,000 annually
Lead Non-Management DirectorAdditional $50,000 annually

Non-employee Directors may elect to have all or a portion of their Board annual cash retainer and other cash compensation paid in the form of immediately vested nonqualified stock options, restricted stock that vests after one year of continued service, or a combination thereof as determined by the Board. In 2020,2023, one Non-employee Director elected to receive restricted stock in lieu of aan annual cash annual retainer.

24Aflac Incorporated
retainer and other cash compensation.

Table of Contents

Corporate Governance Matters

Equity Compensation

As shown below, Non-employee Directors also receive equity on a regular basis to ensure that their interests are aligned with those of our shareholders.

Timing of equity grant
Form of equity grant(1)
Value of equity grant(2)
Upon joining the Boardnonqualified stock options, restricted stock, stock appreciation rights, restricted stock, or a combination thereofaggregate value as determined by the Board not in excess of the value of a nonqualified stock option covering 20,000 shares of Common Stock
Annually, at the discretion
of the Board
restricted stock, nonqualified stock options, stock appreciation rights, or a combination thereof
aggregate dollar value of approximately $155,000  $165,000 (3)

(1)If the Board determines that restricted stock grants will be made, it may permit Non-employee Directors to elect to receive nonqualified stock options in lieu thereof. In 2023, the Board made grants of restricted stock, and none of the Non-employee Directors made the election.
(2)The values of any nonqualified stock options or stock appreciation rights are determined based upon the most current Black-Scholes-Merton three-year period valuation price of option shares as determined by the Compensation Committee’s independent compensation consultant. For grants made in the three-year period of 2022 to 2024, our deemed fair value of a stock option is $17.34.
(3)The aggregate dollar value will be increased to $180,000 in 2024 to align the grant with the peer group median as determined by the Compensation Committee’s independent compensation consultant.
(1)
PositionIf the Board grants restricted stock, it may permit Non-employee Directors to elect to receive nonqualified stock options instead. In 2020, three Non-employee Directors made this election. Two Non-employee Directors elected to receive all stock options and one Non-employee Director elected to receive half of the grant value in the form of nonqualified stock options.Ownership GuidelineWhat CountsWhat Does Not Count
(2)Non-employee DirectorsThe values of any stock options or stock appreciation rights are determined based upon the most current Black-Scholes-Merton three-year period valuation price of option
5xannual cash retainer
Ownership includes all shares as determinedbeneficially owned by the Compensation Committee’s independent compensation consultant. For grants made in the three-year period of 2019 to 2021, our deemed fair value of aNon-employee Director, as well as time-based, unvested restricted shares.
Stock options (vested or unvested) do not count toward these stock option is $6.54.ownership guidelines.

Non-employee Directors are required to hold shares worth at least four times the amount of the annual cash retainer.

For additional information, please see “Stock Ownership Guidelines; Hedging“Additional Executive Compensation Plan Practice and Pledging Restrictions”Procedures” on page 48.

58.



CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT35
Vesting

Grants of stock options or, if elected, restricted stock, made to Non-employee Directors upon joining the Board become vested one year from the grant date, generally subject to continued service. Grants of restricted stock or, if elected, stock options, made to Non-employeeNon-employee Directors at the time of an annual meeting become vested at the next annual meeting, generally subject to continued service. Notwithstanding the foregoing, as noted under the “Cash Compensation” section above, stock options granted to Non-employee Directors at their election in lieu of their annual cash retainer and other cash compensation are fully vested upon grant. Upon death or disability or a change in control of the Company, Non-employee Directors will become 100% vested in all outstanding options and stock awards.

Retirement Plans

The Company maintains a retirement plan for Non-employee Directors who have attained age 55 and completed at least five years of service on the Board, but that plan was closed to new participants effective 2002 and2002. Dr. Rimer is the only Non-employee Director who participates in the retirement plan. The dollar value and length of payment of the annual retirement benefits were frozen effective May 3, 2010. For qualifying participants, payments under the plan begin upon termination of service as a Non-employee Director and continue for the shorter of the number of years the participant served as Non-employee Director prior to May 3, 2010, or the life of the participant (or, if applicable, his or her surviving spouse). On an annual basis, such payments are equal to the annual compensation paid to a participant during his or her service as a Non-employee Director during the 12-month period immediately preceding May 3, 2010, excluding committee fees, and subject to a cap of $30,000 for the annual cash retainer fee and $2,000 per meeting. The Non-employee Directors do not participate in any nonqualified deferred compensation plans.

2021 Proxy Statement25

Table of Contents

Corporate Governance Matters

2020

2023 Director Compensation

The following table identifies each item of compensation paid to Non-employee Directors for 2020.

Name(1) Fees
Earned
or Paid in
Cash(2)
($)
 Stock
Awards(3)
($)
 Option
Awards(4)
($)
 Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings(5)
($)
 All Other
Compensation
($)
 Total
($)
W. Paul Bowers 266,667 - 150,027 - - 416,694
Toshihiko Fukuzawa 138,333 155,012 - - - 293,345
Robert B. Johnson* 48,333 - - - - 48,333
Thomas J. Kenny 110,000 - 150,027 - - 260,027
Georgette D. Kiser 145,000 155,012 - - - 300,012
Karole F. Lloyd 178,333 155,012 - - - 333,345
Nobuchika Mori** 90,000 130,809 -   - 220,809
Joseph L. Moskowitz 173,333 77,506 75,017 - - 325,856
Barbara K. Rimer, DrPH 158,333 155,012 - 33,411 - 346,756
Katherine T. Rohrer 139,167 155,012 - - - 294,179
Melvin T. Stith 138,333 155,012 - - - 293,345

*Robert B. Johnson’s term on the Board of Directors ended May 4, 2020.
**Nobuchika Mori was elected to the Board of Directors on May 4, 2020.
(1)Daniel P. Amos is not included in the table because he is an employee and thus did not receive compensation for his services as a Director. The compensation received by Mr. Amos as an employee is shown in the Summary Compensation Table.
(2)W. Paul Bowers elected to receive his annual retainer in restricted stock. The value of these shares on the grant date was $215,000.
(3)This column represents the dollar amount recognized in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“ASC 718”) for financial statement purposes with respect to the 2020 fiscal year for the fair value of restricted stock granted in 2020. The fair values of the awards granted in 2020 were calculated using the closing per-share stock price on the date of grant of $35.75 for the awards granted on May 4, 2020. As of December 31, 2020, the following Non-employee Directors held the following number of restricted stock awards: W. Paul Bowers, 6,145; Toshihiko Fukuzawa, 4,430; Georgette D. Kiser, 4,430; Karole F. Lloyd, 4,430; Nobuchika Mori, 3,738; Joseph L. Moskowitz, 2,215; Barbara K. Rimer, 4,430; Katherine T. Rohrer, 4,430; and Melvin T. Stith, 4,430.
(4)In accordance with the SEC’s reporting requirements, this column represents the dollar amount recognized in accordance with ASC 718 for financial statement purposes with respect to the 2020 stock option grants. The Company’s valuation assumptions are described in Note 12 “Share-Based Compensation” in the Notes to the Consolidated Financial Statements in the Company’s Annual Form 10-K filed with the SEC for the year ended December 31, 2020. Stock options granted to Non-employee Directors vest after one year generally subject to continued service. As of December 31, 2020, each Non-employee Director held stock options covering the following number of shares of Common Stock: William P. Bowers, 23,701; Thomas J. Kenny, 23,701; Joseph L. Moskowitz, 53,580; and Barbara K. Rimer, 97,322.
(5)Represents change in pension value. Barbara K. Rimer participates in the Directors’ retirement plan. The other directors do not participate in the Directors’ retirement plan since they first became Directors after the plan was closed to new participants in 2002.

26Aflac Incorporated
2023.
Name(1)
Fees
Earned
or Paid in
Cash(2)
($)
Stock
Awards(3)
($)
Option
Awards
($)
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings(4)
($)
All Other
Compensation(5)
($)
Total
($)
W. Paul Bowers225,011 165,065 — — — 390,076 
Arthur R. Collins135,000 165,065 — — 17,618 317,683 
Toshihiko Fukuzawa*45,000 — — — — 45,000 
Miwako Hosoda90,000 346,804 — — — 436,804 
Thomas J. Kenny160,000 165,065 — — 13,077 338,142 
Georgette D. Kiser150,000 165,065 — — — 315,065 
Karole F. Lloyd185,000 165,065 — — — 350,065 
Nobuchika Mori135,000 165,065 — — — 300,065 
Joseph L. Moskowitz175,000 165,065 — — 16,628 356,693 
Barbara K. Rimer, DrPH160,000 165,065 — — 16,483 341,548 
Katherine T. Rohrer160,000 165,065 — — — 325,065 
*    Toshihiko Fukuzawa’s term on the Board of Directors ended May 1, 2023.
(1)Daniel P. Amos is not included in the table because he is an employee and thus did not receive compensation for his services as a Director. The compensation received by Mr. Amos as an employee is shown in the Summary Compensation Table.
(2)W. Paul Bowers elected to receive his annual cash retainer and other cash compensation in restricted stock. The fair value of these shares, calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“ASC 718”) using the closing per-share stock price on the date of grant of $70.36, was $225,011.
(3)This column represents the dollar amount recognized in accordance with ASC 718 for financial statement purposes with respect to the 2023 fiscal year for the fair value of restricted stock granted in 2023. The fair values of the awards granted in 2023 were calculated using the closing per-share stock price on the date of grant of $70.36 for the awards granted on May 1, 2023. As of December 31, 2023, the following Non-employee Directors held the following number of restricted stock awards: W. Paul Bowers, 5,640; Arthur R. Collins 2,386; Miwako Hosoda, 5,014; Thomas J. Kenny, 2,386; Georgette D. Kiser, 2,386; Karole F. Lloyd, 2,386; Nobuchika Mori, 2,386; Joseph L. Moskowitz, 2,386; Barbara K. Rimer, 2,386; and Katherine T. Rohrer, 2,386.
(4)Represents change in pension value. Barbara K. Rimer participates in the Directors’ retirement plan. The other directors do not participate in the Directors’ retirement plan since they first became Directors after the plan was closed to new participants in 2002. The aggregate change in the actuarial present value of the accumulated benefit obligation was a decrease of $13,903.
(5)Amounts include charges for spousal travel, meals, and entertainment costs.


36AFLAC INCORPORATEDCORPORATE GOVERNANCE MATTERS

Table of Contents

Corporate Governance Matters

CD&A At-A-Glance

This summary highlights certain information contained in the Compensation Discussion and Analysis below, but it does not contain all of the information you should consider.

2020

2023 Business Overview

CASH 3 YEAR TSR  
DIVIDEND    
+3.7% +8.6%  
     
     
RETURN ON NET EARNINGS ADJUSTED EPS
EQUITY    
15.3% $4.8B +10.8%*
     
     
SHARE AFLAC JAPAN SOLVENCY AFLAC RISK
REPURCHASE MARGIN RATIO BASED CAPITAL
$1.5B 960% 508%
     

*
CASH DIVIDEND
+5.0%
Adjusted earnings per diluted share excluding foreign currency impact is not calculated in accordance with generally accepted accounting principles in the
3-YEAR TSR
+99.6%
NET EARNINGS
$4.7B
REPURCHASED SHARES
$2.8B
RETURN ON EQUITY (ROE)
22.1%
EARNINGS PER DILUTED SHARE (EPS)
$7.78 12.3%p
ADJUSTED RETURN ON EQUITY (AROE) EX-FX*
14.2%
ADJUSTED EPS EX-FX*
$6.43 13.4%p
AFLAC JAPAN SOLVENCY
MARGIN RATIO (SMR)
1,219%
AFLAC U.S. (GAAP). See the Appendix to this Proxy Statement for the definition of this non-GAAP measure and reconciliation to the most comparable GAAP financial measure.COMBINED RISK-BASED CAPITAL (RBC) RATIO(1)
710%

PAY-FOR-PERFORMANCE COMPENSATION PHILOSOPHY

Our executive compensation program is designed

 Pay-For-Performance 
 Compensation Philosophy 
OUR COMPENSATION PHILOSOPHY PILLARS
1We Pay for Performance.
2We Seek to Attract and Retain Talent.
3We Use Compensation “Best Practices.”
*    Adjusted return on equity excluding foreign currency impact and adjusted earnings per diluted share excluding foreign currency impact are not calculated in accordance with generally accepted accounting principles in the U.S. (GAAP). See Appendix A to drive shareholder value via three critical features:

1.A pay-for-performance philosophy and compensation program structure that directly motivates our executives to achieve our annual and long-term strategic and operational goals
2.Compensation elements that help us attract and retain high-caliber talent to lead the Company
3.“Best practice” compensation governance policies, such as stock ownership guidelines, clawback provisions, and no change-in-control excise tax gross-ups
this Proxy Statement for the definition of these non-GAAP measures and reconciliation to the most comparable GAAP financial measures.


(1)    The Company calculates its combined RBC ratio to include all U.S. regulated life insurance entities as if they were a single combined U.S. RBC entity net of intercompany items related to capital resources and risk.
Elements of Our Executive Compensation Program

We consider annual incentive (e.g., our Management Incentive Plan) and long-term incentive compensation to be the most important compensation awarded; these pay elements represent the largest part of total rewards for executives and provide the strongest link to Company results and shareholder value creation.

CEO TARGET COMPENSATION MIXCEO +OTHER NEOs AVERAGE TARGET COMPENSATION MIX
03_424611-3_pie_ceotargetcompensationmix.jpg
10%
Base Salary
24%
Management Incentive Plan
66%
Long-Term Incentive
03_424611-3_pie_neotargetcompensationmix.jpg
19%
Base Salary
33%
Management Incentive Plan
48%
Long-Term Incentive

2021 Proxy Statement27


CORPORATE GOVERNANCE MATTERS2024 PROXY STATEMENT37

Table of Contents

Corporate Governance Matters

20202023 Management Incentive Plan Performance

PerformancePerformanceResult
Corporate Metric:
Adjusted Earnings per Diluted Share on a Consolidated Basis for the Company (Excluding Foreign Currency Effect)$6.56*
pg37_exceededmaxgoal.jpg
Adjusted earnings per diluted share on a consolidated basis for the Company (excluding foreign currency effect)$4.89Exceeded Maximum Goal
U.S. Segment Metrics:
Increase (decrease) in New Annualized Premium5.06%(31.14%)Below Minimum Goal
pg37_targetgoal.jpg
Increase (decrease) in Net Earned Premium1.89%(1.17%)Below Minimum Goal
pg37_targetgoal.jpg
Cost Savings from Transformation Initiatives$55.0 million
pg37_exceededmaxgoal.jpg
Japan Segment Metrics:
New Annualized Premium (in billions of Yen) (excluding Japan Post sales)yen)¥50.260.7Below Minimum Goal
pg37_targetgoal.jpg
Decrease in Net Earned Premium (third sector and first sector protection sales)(as adjusted for MIP)**(6.84)%(0.98%)Above Minimum Goal
pg37_targetgoal.jpg
Cost Savings from Transformation Initiatives (in billions of yen)¥4.9
pg37_exceededmaxgoal.jpg
Global Investments Metrics:
Net Investment Income (U.S. and Japan GAAP segments only)Segments Only)Budget plus 4.76%5.66%Exceeded Maximum Goal
pg37_exceededmaxgoal.jpg
Credit Losses/Impairments$($125200 million)
pg37_targetgoal.jpg
MIP Modifier:Above Target Goal
Four Sustainability Objectives+0%Three Sustainability
Objectives Achieved

2018-2020

*    Adjusted earnings per diluted share on a currency-neutral basis for the full year came in at $6.43 per share as reported; however, applying the definition of the compensation metric increased the achieved result to $6.56 on a currency-neutral basis.
** See Appendix A to this Proxy Statement for the definition of this non-GAAP financial measure, which describes how the measure is calculated from our audited financial statements.
2021-2023 Long-Term Incentive Performance Results

PerformancePerformanceResult
Metrics:
Currency Neutral AROE Result (70% weighted)
(70% Weighted)
15.0%15.1%Above Target Goal
pg37_targetgoal.jpg
SMR (15% weighted)
(15% Weighted)
917%953%Exceeded Maximum Goal
pg37_exceededmaxgoal.jpg
RBC (15% weighted)
(15% Weighted)
675%543%
pg37_exceededmaxgoal.jpg
RTSR Modifier96th percentileAbove Target Goal

28Aflac Incorporated
pg37_exceededmaxgoal.jpg
pg37_exceededmaxgoal.jpg
Exceeded Maximum Goal
pg37_belowtargetgoal.jpg
Below Minimum Goal
pg37_maximumgoal.jpg
Between Target and Maximum Goal
pg37_minimumgoal.jpg
Between Minimum and Target Goal

Table of Contents

Executive Compensation



38

Proposal 2

AFLAC INCORPORATED

EXECUTIVE COMPENSATION
pg1proposal_2.jpg
Named Executive Officer Compensation
(“Say-on-Pay”)

We are committed to achieving a high level of total return for our shareholders. From the end of August 1990, when Daniel P. Amos was appointed the CEO, through December 31, 2020,2023, the Company’s total return to shareholders, including reinvested cash dividends, has exceeded 7,689%15,446%, compared with 2,326%3,075% for the Dow Jones Industrial Average, 2,088%2,812% for the S&P 500 Index, and 895%1,471% for the S&P 500 Life & Health Insurance Index over the same period.

page38_proposal2duck.jpg
The Board of Directors recommends a vote FOR our executive compensation.compensation program.

We believe our compensation policies and procedures are centered on a pay-for-performance culture and are strongly aligned with the long-term interests of our shareholders. Beginning in 2008, we voluntarily provided our shareholders an annual advisory vote (commonly known as “Say-on-Pay”), which is now required by the Dodd-Frank Wall Street Reform and Consumer Protection Act. In accordance with Section 14A of the Securities Exchange Act of 1934, this vote gives you as a shareholder the opportunity to endorse or not endorse the compensation of our named executive officers through the following resolution:

“Resolved, on an advisory basis, the shareholders of Aflac Incorporated approve the compensation of the named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and accompanying tables and narrative in the Notice of 20212024 Annual Meeting of Shareholders and Proxy Statement.”

Because your vote is advisory, it will not be binding upon the Board. However, the Compensation Committee will take into account the outcome of the vote when considering future executive compensation arrangements.

Compensation Discussion and Analysis

This Compensation Discussion and Analysis (“CD&A”) provides a detailed description of our executive compensation philosophy and programs, the decisions made by the Compensation Committee related to those programs, and the factors considered when making those decisions.

SIGNIFICANT INFORMATION IN THIS SECTION

30
Compensation Discussion and Analysis
This Compensation Discussion and Analysis (“CD&A”) provides a detailed description of our executive compensation philosophy and programs, the decisions made by the Compensation Committee related to those programs, and the factors considered when making those decisions.
IN THIS SECTION
312020
34
35
35
40
44
48

2021 Proxy Statement29


EXECUTIVE COMPENSATION2024 PROXY STATEMENT39
Executive Summary
This CD&A focuses on our named executive officers (“NEOs”) for 2023, who were:

Table of Contents

Executive Compensation

This CD&A focuses on our named executive officers (“NEOs”) for 2020, who were:

05_424611-3_photo_amosD.jpg
pg39_broden.jpg

pg39_crawford.jpg
05_424611-3_pic_executive summary.jpg
pg39_tillman.jpg
Daniel P. Amos

Chairman and Chief Executive Officer

 CHAIRMAN AND 
 CHIEF EXECUTIVE 
 OFFICER (CEO)

Max K. Brodén

Executive Vice President, Chief Financial Officer

 EXECUTIVE 
 VICE PRESIDENT, 
 CHIEF FINANCIAL 
 OFFICER (CFO) and Treasurer

Frederick J.
Crawford

President, Chief Operating Officer(1)

 PRESIDENT AND 
 CHIEF OPERATING 
 OFFICER (COO)

Bradley E. Dyslin
 EXECUTIVE 
 VICE PRESIDENT, 
 GLOBAL CHIEF 
 INVESTMENT OFFICER; 
 PRESIDENT, AFLAC 
 GLOBAL INVESTMENTS 

Eric M. Kirsch

Executive Vice President, Global Chief Investment Officer; President, Aflac Global Investments

Audrey Boone Tillman

Executive Vice President, General Counsel

 EXECUTIVE 
 VICE PRESIDENT, 
 GENERAL COUNSEL

(1)     Pursuant to the terms of an employment letter of agreement (the “LOA”) entered into with Mr. Crawford on October 30, 2023, Mr. Crawford will serve as Executive Summary

Vice President of the Company, effective January 1, 2024 through his retirement with the Company on September 30, 2024. For more information regarding the employment letter of agreement, see “Employment Agreements” on page 58.

Pay-For-Performance Compensation Philosophy

Our compensation programs are designed to ensure that a substantial amount of executive pay is directly linked to the Company’s results. We believe this is the mostan appropriate and effective method for creating alignment with shareholder interests and that it has played a significant role in making the Company an industry leader. Importantly, performance-based elements of our compensation programs apply to all levels of Company management—not just the executive officers. In fact, pay-for-performance components permeate compensation at nearly every employee level. As a result, we are able to attract, retain, motivate, and reward talented individuals who have the necessary skills to manage our growing global business on a day-to-day basis and to position the Company for success in the future.

The Board’sCompensation Committee’s independent compensation consultant, Mercer LLC, works with the Compensation Committee to review executive compensation practices, including the competitiveness of pay levels, design issues, market trends, and other technical considerations.

Our executive compensation program is designed to drive shareholder value via three critical features:

123
A pay-for-performance philosophy and compensation program structure that directly motivates our executives to achieve our annual and long-term strategic and operational goals
Compensation elements that help us attract and retain high-caliber talent to lead the Company“Best practice” compensation governance policies, such as stock ownership guidelines, clawback provisions, and no change-in-control excise tax gross-ups


 
40A pay-for-performance philosophy and compensation program structure that directly motivates our executives to achieve our annual and long-term strategic and operational goalsAFLAC INCORPORATED Compensation elements that help us attract and retain high-caliber talent to lead the Company     “Best practice” compensation governance policies, such as stock ownership guidelines, clawback provisions, and no change-in-control excise tax gross-ups

30Aflac Incorporated
EXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

2020 Business Overview

TSR
2023 Business Overview
 Total 
 Shareholder 
 Return (“TSR”) 

CASH DIVIDEND


+3.7%

5.0%

We increased our cash dividend, marking the38th 41stconsecutive year of increasing the dividend.

3 YEAR

3-YEAR TSR


+8.6%

99.6%

Our three-year total shareholder return*TSR* was 8.6%99.6%, versus -11.7%57.8% for the S&P 500 Life and Health Insurance subindex.index. Our annual total shareholder return*TSR* was -13.6%17.4%, versus -9.5%4.6% for the S&P 500 Life and Health Insurance index.

3 YEAR

3-YEAR TSR COMPARED
RELATIVE
TO PEERS

PEER GROUP (“RTSR”)

Percentile Rank 63%

96.0%
Financial
Highlights

RETURN ON EQUITY

15.3%

We generated a strong returnon equity, and our AROE(1) forthe full year was 15.0%.

(ROE)

NET EARNINGS(2)

$4.8B

Net earnings increased 44.6% over 2019.

EARNINGS PER DILUTED
SHARE (EPS)

22.1%$4.7B
$7.78 12.3%p
AROE EX-FX(1)
14.2%
ADJUSTED EARNINGS EX-FX(1)
$3.8B
ADJUSTED EPS EX-FX(1)

+10.8%

Adjusted earnings per diluted share, excluding the impact of foreign currency.

$6.43
13.4%p
Aflac U.S.:

Sales were
down 30.8%up 5.0%.
Aflac Japan:
Sales were
down 36.2%.
Net Earned Premium wasdown1.17%up 1.9%, which was above the target MIP goal.
Aflac Japan:
Sales were up10.9%.
Net Earned Premium (as adjusted for MIP)(2)wasdown 0.98%6.8%, which was slightly below the target MIP goal.
Capital
REPURCHASED SHARES

SHARE REPURCHASE

REGULATORY
CAPITAL RATIOS*
$1.5B

2.8B

We repurchased approximately 37.938.9 million of the Company’s shares as part of a balanced capital allocation program.

REGULATORY CAPITAL RATIOS*

960%

1,219%
Aflac Japan Solvency Margin Ratio

508%

(SMR)

710%
Aflac Risk BasedU.S. Combined Risk-Based Capital

(RBC) Ratio
(3)

*
As of December 31, 2020
2023
(1)
The adjusted return on equity (AROE), excluding the impact of foreign currency, (AROE)and adjusted earnings and adjusted earnings per diluted share (adjusted EPS), excluding the impact of foreign currency, (adjusted EPS) metrics are our principal financial measures used to evaluate management’s performance, and we believe they continue to be a key driver of shareholder value. See the Appendix A to this Proxy Statement for definitions of these non-GAAP measures and reconciliation to the most comparable GAAP financial measures.
(2)See Appendix A to this Proxy Statement for the definition of this non-GAAP financial measure, which describes how the measure is calculated from our audited financial statements.
(3)The Company calculates its combined RBC ratio to include all U.S. regulated life insurance entities as if a single combined U.S. RBC entity net of intercompany items related to capital resources and risk.
(2)The Company recognized a one-time income tax benefit of $1.4 billion due to the release of valuation allowances which were predominantly established on the Company’s deferred foreign tax credit benefits.

 

2021 Proxy Statement31


EXECUTIVE COMPENSATION2024 PROXY STATEMENT41

Table of Contents

Executive Compensation

20202023 Operating Results

In 2020,2023, the Company advanced the vision of offering high-quality supplemental products and service through diverse distribution outlets, buildingcontinued to build upon our market-leading position in supplemental health insurance to drive long-term shareholder value.

Pandemic Impact

At the onset of the COVID-19 global pandemic, the majority of the Company’s employees in Japan and the U.S. shifted to remote working environments with limited returns to office mainly in Japan undertaken as warranted by local conditions. Both Aflac Japan and Aflac U.S. took measures to address employee health and safety and increase employees’ ability to develop and maintain more flexible working conditions. The Company also provided financial support to agents and agencies with interest-free loans to help manage through this difficult period and granted grace periods for premium payments giving policyholders relief without fear of their coverage being cancelled. To support front-line efforts to combat the virus in both countries, the Company contributed more than a combined $10 million to organizations oriented around first-responders. In addition, the Company accelerated investments in digital tools to accommodate both our customers and distribution in a virtual environment. In line with business continuity planning, the Company established command centers to monitor and communicate developments, and operations remained stable throughout the year. Enterprise crisis management meetings were chaired by the President and COO with the Chair of the Audit and Risk Committee of the Board attending.

Aflac Japan and Aflac U.S. both experienced a significant decrease in sales due to the effects of the pandemic and related government responses like emergency orders, resulting in a steep decline in face-to-face meetings between sales people and customers. In response, both Aflac Japan and Aflac U.S. accelerated investments in digital initiatives to improve productivity, efficiency, and customer service over the long term. The pandemic weighed on revenue performance, however, profit margins and earnings-per-share remained strong as benefit ratios were positively impacted by lower routine medical claims and absorbed an increase in claims related to COVID-19. The Company also defended investment income despite economic conditions driving down interest rates. Finally, the Company also took prompt action to strengthen its capital and liquidity position should pandemic conditions trend negative, and continued to undertake de-risking activity in its investment portfolios adjusting to market conditions throughout the year.

Aflac Incorporated

On December 2, 2019, the Company gave guidance for 2020 consolidated adjusted earnings per diluted share of $4.30 to $4.50 using an exchange rate of 110 yen to the dollar, which on a currency-neutral basis and normalized for 2019 equated to approximately a 1% increase. On April 29, 2020, recognizing the challenges to production and potential volatility in core earnings drivers associated with the evolving nature of the global pandemic, the Company withdrew earnings guidance for 2020 with the release of its first quarter results. Ultimately, the Company reported adjusted earnings per diluted share of $4.96, or $4.92 excluding the effect of foreign currency, which were positively impacted by the release of valuation allowances on deferred foreign tax credits, which were allowed due to U.S. tax regulations released in the third quarter of 2020. Aside from the favorable tax outcome, earnings per share benefited from stable pre-tax profit margins, benefited by lower routine medical claims and cost control measures, and favorable investment income.

For the year, the Company generated a strong return on equity of 15.3% and our AROE, excluding the impact of foreign currency, for the full year was 15.0%. The combination of strength in pre-tax profit margins supported by generally favorable benefit ratios and investment income with strength in capital and cash flow supported the proactive return of capital in the form of share repurchase and common dividend increases.

Management and the Board are committed to ensuring comprehensive risk management and to safeguarding the Company’s financial strength. In 2020, core capital strength measures remained very strong including core metrics of holding company leverage within a conservative range of 20% to 25%, Aflac Japan’s SMR ratio above 900%, and Aflac U.S. RBC ratio above 500%. The Company’s strong capital and cash flow positions continue to support our financial strength ratings, which are among the highest in the industry, and our 38-year track record of increased Common Stock dividends.

Aflac U.S.

The Aflac U.S. sales team has worked to adjust its sales approach given the reduction in face-to-face sales since the onset of the pandemic. Key elements to this approach include realizing sales at the worksite through an enrollment call center, video enrollment through co-browsing and self-enrollment. The traditional agent sales team is also using virtual recruiting and training through video conferencing to maintain the recruiting pipeline. The Aflac U.S. broker sales team is focused on product enhancements due to COVID-19 as well as leveraging technology-based solutions to drive enrollment. Aflac U.S. has also accelerated investments in digital initiatives designed to improve long-term productivity, efficiency, and customer service.

32Aflac Incorporated
For 2023, the Company reported net earnings per diluted share of $7.78 and adjusted earnings per diluted share of $6.23, or $6.43 excluding the effect of foreign currency, which was the Company's best year in its history. Earnings per share reflected a decline in Aflac Japan net earned premiums as a result of reinsurance and limited pay policies reaching paid up status, and elevated expenses associated with the build of the growth platforms in the U.S., Aflac network dental and vision, group life and disability, and consumer markets.
For the year, the Company generated a strong return on equity of 22.1% and our AROE, excluding the impact of foreign currency, for the full year was 14.2%. Leverage fell below a conservative range of 20% to 25%.
Management and the Board are committed to ensuring comprehensive risk management and to safeguarding the Company’s financial strength. Aflac Japan ended the year with an SMR of 1,219%, and Aflac U.S. had a combined RBC ratio of 710%. The Company’s strong capital and cash flow continue to support our financial strength ratings, which are among the highest in the industry,$2.8 billion in share repurchase, and our 41-year track record of increased Common Stock dividends.
RETURN ON EQUITY
22.1%
ADJUSTED RETURN ON
EQUITY (AROE) EX-FX
14.2%
AFLAC JAPAN’S SMR RATIO
1,219%
AFLAC U.S. COMBINED RBC RATIO
710%

Table of Contents

Executive Compensation

Aflac U.S. management continued to focus on serving the benefit needs of small businesses with its extensive agent distribution channel, as well as the needs of larger employers by continuing to build relationships with brokers. The pandemic’s impact on sales also pressured premium growth rates in the U.S., which has been partially offset by lower lapse rates. While 2020 sales were depressed, the Company’s distribution platform has pivoted to utilizing digital means to drive sales and enrollment, thus gradually reducing the remaining gap between pre- and post-pandemic declines in sales.

While the Company has been known for its organic growth, 2020 was also marked by prudent investments to promote growth and to drive efficiencies. Aflac U.S. has set the direction for its strategy for the next five years and plans to increase its attractiveness in the large case market by accelerating an integrated platform and go-to-market strategy for a full suite of group benefits. Most notably, Aflac and Aflac New York, took an opportunity to accelerate growth through a measured buy-to-build transaction with the acquisition of Zurich North America’s U.S. group life disability and absence management business (“2020 Zurich business acquisition”) in November 2020 for total consideration of approximately $140 million. This strategy is also supported by the 2019 acquisition of Argus Dental and Vision. In 2020, we piloted Aflac’s new network dental and vision product in 10 states under limited distribution in preparation for a national launch in early 2021. Aflac U.S. is also in its second year of the build-out of its consumer markets for the digital direct-to-consumer sale of insurance, and sales made through that platform have continued to grow. While these investments were largely responsible for the elevated expense ratio, Aflac U.S.’s pretax profit margin ended the year in the middle of the forecasted range. Finally, in the fourth quarter of 2020, Aflac Incorporated made a $200 million strategic investment in Trupanion, a leading U.S. and Canadian pet insurer. The alliance is a multi-year build with planning in 2021 and then building-out Aflac and Trupanion co-branded product distribution in the worksite.

Aflac Japan

Similarly, to counter the challenging face-to-face sales environment brought on by the pandemic, Aflac Japan focused on generating new business through direct mail to existing and prospective customers, digital and web-based sales to groups, and a new smartphone-enabled insurance application that allows the customer and an Aflac Japan operator to see the same screen. In Japan, management continued to strengthen relationships with customers and agencies by focusing on a new cancer rider strategy. This rider strategy allowed Aflac Japan cancer policyholders a simple way of updating their existing coverage by adding a mid-term rider to their existing policy without having to lapse. Aflac Japan expects this simplified approach to appeal to younger customers and new sales agents, while also lowering new product refreshment costs and benefiting persistency. Cancer insurance sales results also reflected a sharp decline in the sale of cancer products as Japan Post Holdings Co., Ltd. (“Japan Post”) continued to focus on restoring customer trust after the internal investigation of the sale of Japan Post Insurance products through Japan Post Co., Ltd. and Japan Post Insurance Co., Ltd. While the investigation and eventual suspension of sale of Japan Post Insurance products did not involve the sale of Aflac Japan cancer policies, the events had a negative impact on cancer sales in the postal network.

During 2020, Aflac Japan also accelerated investments in digital and paperless initiatives designed to increase long-term productivity, efficiency, customer service and business continuity. The paperless initiative represents a ¥10 billion multi-year investment, that when completed, will result in ¥3 billion of annual savings, create a more nimble operating platform for disaster recovery purposes, and helps to reduce our carbon footprint in Japan. Aflac Japan is investing to increase operational efficiency while carrying out activities to expand sales of our existing products and also paying close attention to profitability and investment risk, which is especially important given the uncertainty ushered in by COVID-19.

Despite the competitive market for cancer and medical insurance products, the persistent low interest rate environment in Japan and higher expenses related to technology investments and marketing, Aflac Japan still delivered a strong pretax profit margin to the high end of the forecasted range.

Global Investments

Given the volatile market environment, our net investment income performed very well. Net investment income benefited from continued expansion of floating rate loan and alternative investments, which served to combat persistently lower interest rates in both the U.S. and Japan. Net investment income also benefited from our decision to hedge against falling interest rates, net of locking in hedge costs; tactical asset allocation decisions; and a significant increase in call income as issuers redeemed bonds due to lower refinancing rates.

Net investment losses were primarily comprised of allowances for credit losses, currency effect revaluation losses on our Aflac Japan U.S. dollar loans, and mark-downs on equity securities. Partially offsetting this was a net gain on security sales and our derivative hedging program.

Strategically, the Aflac Global Investments strategic alliance and investment in Varagon Capital Partners continued to perform well and contributed to corporate investment income during 2020.

2021 Proxy Statement33
  2023 HIGHLIGHTS
Aflac U.S. continued on a path to recovery by generating more than $1.5 billion in sales and the strongest fourth quarter in its history with $559 million in sales. While representing approximately 15% of our sales in 2023, the U.S. growth platforms, dental and vision, group life and disability and consumer markets, are key elements in our strategy to sell our core supplemental health policies.
Productivity of average weekly producers was at an all-time high.
Cancer insurance sales increased nearly 25% after the introduction of our new Cancer Protection Assurance policy in the second quarter of 2023.
Aflac network dental and vision and group life and disability sales were up 24% and 22%, respectively, for the year. In addition, approximately $0.78 of supplemental health and life products were sold with every dollar of dental and vision, and the life and disability platform had another successful renewal year, recording 99% premium persistency.


42AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Aflac Japan

Table of Contents

Executive Compensation

  2023 HIGHLIGHTS
Aflac Japan generated an extremely strong profit margin of 30.5%.
Persistency reflected the impact of individuals lapsing policies to update coverage at 93.4% for the year.
Aflac Japan’s sales grew 10.9% for the year.
Cancer insurance sales increased 26% with very significant contributions from Japan Post Company and Japan Post Insurance, as well as other alliances, Dai-ichi Life and Daido Life.
Strong fourth quarter 2023 medical sales were due to the mid-September launch of a new medical insurance product.
Aflac Japan revised WAYS and child endowment policies in November 2022, which contributed to the strong sales in the first half of 2023. The revision of the two products is part of a strategy to promote sales of third sector policies.
Aflac Japan kept general adjusted expenses below target due to company-wide cost-reduction efforts.
Global Investments
  2023 HIGHLIGHTS
The portfolio posted very strong performance with net investment income benefiting from the sharp uptick in interest rates and increasing yields within our floating rate portfolio of middle market and transitional real estate loans. Tactical asset allocation decisions contributed to our outperformance. These benefits more than offset the negative impact from translating yen net investment income due to the strengthening U.S. dollar.
In 2023, Aflac Global Investments produced adjusted net investment income of ¥365.6 billion for Aflac Japan and $820 million for Aflac U.S., which represented increases of 4.0% and 8.6%, respectively, from the prior year.
Our growing alternatives portfolio contributed $113 million of variable investment income in 2023, $10 million higher than 2022. We remain committed to a disciplined approach to building an alternatives portfolio.
Importantly, Aflac Global Investments has navigated volatile market conditions without realizing material losses, impairments, or credit losses while managing a $104.7 billion book value portfolio. This portfolio includes multiple public and private asset classes and a fixed maturities portfolio with an average single-A rating.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT43
Summary of Our Executive Compensation Program

As a leader in our industry segment, we recognize that a sound executive management compensation program is one element of why we are an employer of choice. Our executive compensation program directly links compensation incentives with our business goals and shareholder interests.

We consider annual incentive and long-term incentive compensation to be the most important compensation awarded because these pay elements represent the largest part of total rewards for executives and provide the strongest link to Company results and shareholder value creation. Moreover, incentive compensation enables us to attract, retain, motivate, and reward talented individuals who have the necessary skills to manage our growing global enterprise now and for the future. Due to our focus on incentive compensation, base salary is the smallest component of compensation for the NEOs.

KEY ELEMENTS OF OUR 2020 EXECUTIVE COMPENSATION PROGRAM

Key Elements of Our 2023 Executive Compensation Program
CEO pay mix
Pay Mix and Element
TermsTermsPerformance Measure(s)Objective(s)

Base Salary

BASE SALARY
03_424611-3_pie_basesalary.jpg
The fixed amount of annual cash compensation for performing day-to-day responsibilities. Generally reviewed biennially for potential increase based on a number of factors, including market levels, performance, and internal equity.Levels set based on market data, job scope, responsibilities, experience, and individual performance.

Attract and retain talent

Management Incentive Plan

MANAGEMENT INCENTIVE PLAN (“MIP”)

03_424611-3_pie_mip.jpg
Annual variable cash incentive compensation based on the achievement of predetermined annual performance goals.
Weighting of performance metrics varies based on NEO role

Performance metrics align with our business strategy, geographic segment goals, and key value drivers:

Corporate goal: adjusted earnings per diluted share, excluding the impact of foreign currency

U.S. goals: increase in new annualized premium, increase innet earned premium,

cost savings from transformation initiatives

Japan goals: new annualized premium, (excluding Japan Post sales), decrease innet earned premium, (third sector and first sector protection sales)

cost savings from transformation initiatives

Global Investments goals: net investment income; credit losses/impairments

Performance goals are rigorous and set to align the Company’s business plan with the expectation of achieving target performance.

Motivate executives and reward annual operational and strategic performance

Drive enterprise growth

Focus on key near-termnear-term drivers of long-term value for our business

Retain key talent

Exercise sound
risk-management practices

04_424611-3_gfx_89.jpg

Long-term Incentives
MIP Modifier can adjust total MIP compensation up or down by 5% based on achievement of sustainability goals.

LONG-TERM INCENTIVES (“LTI”)

pg47-pie_lti.jpg
Long-term variable equity awards granted annually in performance-based restricted stock (“PBRS”) (100% of LTI for the CEO and other NEOs) under the Company’s Long-Term Incentive Plan. PBRS vests based on three-year financial performance.performance and relative total shareholder return.
100% performance-based LTI with 3-year performance period
AROE,
Adjusted Return on Shareholders’ Equity (AROE) EX-FX
pg43_aroe.jpg
Risk-Based Capital (“RBC”), and (RBC)
pg43_rbc.jpg
Solvency Margin Ratio (“SMR”)(SMR)
pg43_smr.jpg
Relative TSR Modifier
AROE, RBC, and SMR are metrics that affect our long-term business strategy and operating environment. Payout is also contingent on a relative TSR modifier.modifier, which can adjust PBRS payouts up or down by 20%.

Motivate executives and reward long-term operational and strategic performance

Focus on key long-termlong-term value drivers for our business

Align executives’ interests with shareholders’ interests

Retain key talent

Exercise sound
risk-management practices

34Aflac Incorporated


44AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

Outcome of 20202023 Say-on-Pay Vote

The Company has a history and a well-earned reputation with its shareholders as a transparent organization. That commitment to transparency on all levels was a driving force behind our decision in 2008 to allow shareholders a “say-on-pay” advisory vote, years before such votes became mandatory for most public companies. In 2020, 98% of our shareholders voted in favor of our executive compensation program.

Consistent with our approach in prior years, the Company engaged in shareholder outreach efforts throughout 2020. The feedback from these conversations, together with a thorough analysis of best practices and guidance from our independent compensation consultant, was incorporated into the Compensation Committee’s regular review of our compensation programs.

Compensation program changes, if any, are made with a focus on ensuring that pay is aligned with Company performance and corporate strategy. We continually analyze our compensation program to ensure that we remain current in our approaches, a leader in executive compensation best practices, and cognizant of shareholder concerns. Moreover, we pride ourselves on incorporating ethics and transparency into everything we do, including compensation disclosure. Accordingly, we will continue our review and dialogue with investors to determine if additional changes are warranted.

After careful consideration, the Compensation Committee did not make any changes to our executive compensation program and policies, neither due to the impacts of COVID-19 nor as a result of the most recent say-on-pay vote in 2020. As noted in the Program Changes for 2021 section below, the Compensation Committee has made changes to the MIP formula to include an ESG modifier for 2021.

The Company has a history and a well-earned reputation with its shareholders as a transparent organization. That commitment to transparency on all levels was a driving force behind our decision in 2008 to allow shareholders a “say-on-pay” advisory vote, years before such votes became mandatory for most public companies. In 2023, over 97% of our shareholders voted in favor of our NEO executive compensation program.
Consistent with our approach in prior years, the Company engaged in shareholder outreach efforts throughout 2023. The feedback from these conversations, together with a thorough analysis of best practices and guidance from our independent compensation consultant, was incorporated into the Compensation Committee’s regular review of our compensation programs.
Compensation program changes, if any, are made with a focus on ensuring that pay is linked to Company performance and corporate strategy. We continually analyze our compensation program to ensure that we remain current in our approaches, a leader in executive compensation best practices, and cognizant of shareholder concerns. Moreover, we pride ourselves on incorporating ethics and transparency into everything we do, including compensation design and disclosure. Accordingly, we will continue our review and dialogue with investors to determine if additional changes are warranted.
After careful consideration, the Compensation Committee did not make any changes to our executive compensation program and policies for 2023 as a result of the most recent say-on-pay vote in 2023.
2023 SAY-ON-PAY SUPPORT
97.3%
03_424611-3_pie_support.jpg
Compensation Design and Philosophy

Strong Compensation Governance Policies and Leader in Best Practices

The Company has long been a leader in corporate governance best practices. Our executive compensation programs reflectprogram reflects the strong, long-standing governance policies outlined below.

What We Do 
pgxx_icon-whatwedo-01.jpg
pgxx_icon-whatwedontdo-01.jpg
What We Don’tDon't Do 

page21_check.jpg  First public company in the U.S. to provide shareholders with a say-on-pay vote (voluntary action starting in 2008, three years before such votes were required)

page21_check.jpg  Prioritize active engagement with our shareholders regarding our compensation program

page21_check.jpg  History of responding to our shareholders’ feedback

page21_check.jpg  Adherence to a rigorous pay-for-performance philosophy in establishing program design and targeted pay levels for NEOs

 Independent

page21_check.jpgIncorporate Sustainability goals into our short-term incentive plan (MIP)
page21_check.jpg  Compensation Committee oversees the program

page21_check.jpg  Independent compensation consultant is hired by and reports to the Compensation Committee

page21_check.jpg  Annual report by the independent compensation consultant to the full Board on CEO pay and performance alignment

page21_check.jpg  Long-standing stock ownership guidelines for executive officers and Non-employee Directors

page21_check.jpg  Long-standing clawback policy,

which was recently revised to reflect current regulatory requirements

page21_check.jpg  Double trigger requirements in all employment agreements with change-in-control provisions

pg44_crossmark.jpg  No golden parachute payments for CEO following a change in control

pg44_crossmark.jpg  Officers and Directors may not implement 10b5-1 plans unless approved by the Compensation Committee

pg44_crossmark.jpg  All employees are prohibited from hedging or engaging in short sales of Company stock

pg44_crossmark.jpg  Executive officers and Directors may not pledge Company stock

pg44_crossmark.jpg  No repricing underwater stock options

pg44_crossmark.jpg  No change-in-control excise tax gross-ups

2021 Proxy Statement35


Table of Contents

Executive Compensation


EXECUTIVE COMPENSATION2024 PROXY STATEMENT45
Process of Setting Executive Compensation

Roles and Responsibilities
Compensation Committee
with assistance from its Independent Compensation Consultant who
and input from
Management
who
reviews the Company's executive compensation plans
evaluates the performance of the CEO
determines and approves the CEO's compensation level
evaluates annually the performance of the other executive officers of the Company
reviews and approves the compensation level of other executive officers
reviews perquisites or other personal benefits to the Company's executive officers and Non-employee Directors
provides comparative company performance to assess proposed NEO compensation;
provides competitiveness evaluations of the Company’s executive compensation and benefit programs;
reviews plan design issues and recommends improvements;
reports on trends and developments in the marketplace;
provides assessments on the relationship between executive pay and performance;
provides assessments on proposed performance goals and ranges for incentive plans;
conducts training sessions for the Compensation Committee; and
proposes the compensation for Non-employee Directors.
recommends to the Compensation Committee the specific Company performance objectives
ensures performance objectives are aligned with corporate strategy, and thus will drive shareholder value and ensure financial soundness.
Independent Compensation Consultant

The Compensation Committee is directly responsible for the appointment, compensation and oversight of the work of any compensation consultant or other adviser retained by the Compensation Committee. The Compensation Committee has retained a nationally recognized compensation consultant, Mercer LLC (“Mercer”), to assist and advise the Compensation Committee in designing and refining the Company’s executive compensation program. Mercer typically assists in the following areas:

providing comparative company performance to determine NEO compensation;
evaluating the competitiveness of the Company’s executive compensation and benefit programs;
reviewing plan design issues and recommending improvements;
apprising the Compensation Committee of trends and developments in the marketplace;
assessing the relationship between executive pay and performance;
assessing proposed performance goals and ranges for incentive plans;
conducting training sessions for the Compensation Committee; and
proposing the compensation for Non-employee Directors.

Fees paid to Mercer for these services totaled $169,074$314,624 in 2020.2023. Management retained certain Mercer affiliates to provide additional services not pertaining to executive compensation during 2020,2023, and approved payments for those services totaling $24,705.$500,366. Those additional services included developing a strategic approach to create a more diverse sales channel network across the U.S. to support increased opportunities for revenue growth. In addition, as the Company grows the sales of its insurance products through brokers in the U.S., this has resulted in commission payments totaling $36,749,804$32,011,634 during 20202023 to the broker subsidiaries of Mercer. These subsidiaries are separate from the subsidiary that provides compensation consulting to the Company. As reported by Mercer to the Compensation Committee, the total payments from the Company represented less than 0.22%0.14% of Mercer’s parent company’s annual revenue. The Compensation Committee assessed Mercer’s independence pursuant to SEC rules and NYSE listing standards and concluded that no conflict of interest exists with respect to the work Mercer performs for the Compensation Committee.



46AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Importance of the Peer Group

The Compensation Committee sets target compensation for the NEOs at market competitive levels with the assistance of its independent compensation consultant. Factors considered include target pay levels in the market for comparable roles, the primary duties and responsibilities of the role at the Company, and the individual’s relevant experience and performance.

As discussed in this CD&A, the Compensation Committee considers our peer group when setting compensation amounts and targets. Each year, the Compensation Committee, with the assistance of its independent compensation consultant, reviews the composition of the peer group to ensure it remains appropriate. Key factors the Compensation Committee considers during this annual review include operating characteristics, revenue size, asset size, profitability, market value, and total number of employees. Based on the annual review, the Compensation Committee selects a peer group of companies that are engaged in businesses similar to that of the Company, are of a similar size as the Company, and compete against the Company for talent. InOverall, in terms of the size factors considered, the Company is positioned near the middle of this group.

2020 Peer Group
2023 PEER GROUP

The Allstate Corporation

Assurant, Inc.

Brighthouse Financial

  The Chubb Corporation

Limited

  CNO Financial Group, Inc.

Equitable Holdings

The Hartford Financial Services Group, Inc.

Humana Inc.

Lincoln National Corporation

Manulife Financial Corporation

MetLife, Inc.

Principal Financial Group, Inc.

The Progressive Corporation

Prudential Financial, Inc.

The Travelers Companies, Inc.

Unum Group

36Aflac Incorporated

Table of Contents

Executive Compensation

There were no changes to the 20202023 peer group from the peer group used in 2019.2022. The data below shows how the Company’s revenues, total assets, and market value compare to the peer group medians:

($ millions) Revenue(1) Total Assets(2) Market Value(2)
Aflac Incorporated $22,147 $165,086 $31,238
Peer Median $31,981 $125,987 $30,869
Percentile Rank for Aflac Incorporated vs. Peers 44th 54th 51st

(1)
($ millions)
Revenue(1)
Total Assets(2)
Market Value(2)
Aflac Incorporated$18,701 $126,724 $48,211 
Peer Median$36,121 $228,861 $36,631 
Percentile Rank for Aflac Incorporated vs. Peers39th43rd78th
(1)For the year ending December 31, 2020
(2)As of December 31, 2020

Performance-Based Compensation: How Performance Goals Are Set

The Board and the Compensation Committee believe it is important for the Company to manage the business to provide long-term valueyear ending December 31, 2023

(2)As of December 31, 2023
For 2024, minor changes have been made to our shareholders. Therefore, performance goals under the MIP and LTI programs involve metrics that drive shareholder returns, and payouts depend entirely upon the level of achievement of those goals. The following sections provide detailpeer group. See “Program Changes for 2024” which begins on how we select metrics under the MIP and LTI program, determine performance target amounts and other important considerations in setting these targets.

We have used the same methodology for setting MIP goals for many years. MIP segment metrics for Aflac U.S., Aflac Japan, and Global Investments are consistent with assumptions used in developing segment financial projections (described below) based on the Company’s best estimates for the coming year. The segment projections are consolidated into the corporate financial projection used to develop earnings per share guidance.

The goal-setting process generally proceeds in two stages.

page 57.


1.
EXECUTIVE COMPENSATION2024 PROXY STATEMENT47
Performance-Based Compensation: How Performance Goals Are Set
The Board and the Compensation Committee believe it is important for the Company to manage its business to provide long-term value to our shareholders. Therefore, performance goals under the MIP and LTI programs involve metrics that drive shareholder returns, and payouts depend entirely upon the level of achievement of those goals. The following sections provide detail on how we select metrics under the MIP and LTI program, determine performance target amounts and other important considerations in setting these targets.
While performance goals are continually evaluated and refreshed as appropriate, we have used the same methodology for setting MIP and LTI goals for many years. Segment metrics for Aflac U.S., Aflac Japan, and Global Investments are consistent with assumptions used in developing segment financial projections (described below) based on the Company’s best estimates for the coming year. The segment projections are consolidated into the corporate financial projection used to develop performance targets.
The goal-setting process generally proceeds in two stages:
1  RECOMMEND
The Company’s CEO President and COO, and CFO, in consultation with Mercer, recommend to the Compensation Committee the specific Company performance objectives that are aligned with corporate strategy, and thus will drive shareholder value and ensure financial soundness.
Recommended ranges are based, in part, on past performance results and scenario tests of the Company’s financial outlook as projected by a complex financial model.
The model projects the impact on various financial measures using different levels of total new annualized premium, investment returns, budgeted expenses, morbidity, persistency, return on equity, and persistency.capital ratios.
2.
2  ESTABLISH
The Compensation Committee refers to these modeled results to establish a target performance level, as well as a minimum and maximum level, for each performance measure. goal.
The target goal is not necessarily equidistant between the minimum and maximum goals. Instead, for certain key metrics the MIP payout curve is “sloped” to require significant above-target performance to achieve a maximum payout.
Correspondingly, the payout for a minimum result is one-half of the target payout, while the payout for the maximum goal (or better) is twice the target payout.
No payouts are made for performance below the minimum goal.
Interpolation is used to calculate incentive payouts for results between minimum and target goals or target and maximum goals.
The 20202023 MIP goals were approved by the Compensation Committee in March 2020.2023.

For 2020,2023, the Compensation Committee established the following metrics under the MIP:

Corporate Metric: Adjusted earnings per diluted share excluding foreign currency effect
U.S. Segment: New Annualized Premium and Earned Premium
Japan Segment: New Annualized Premium and Earned Premium
Global Investment Metrics: Net Investment Income (U.S. and Japan GAAP Segments only) and Credit Losses/Impairments

Corporate Metric: Adjusted earnings per diluted share excluding foreign currency effect
U.S. Segment: New Annualized Premium, Net Earned Premium, and Cost Savings from Transformation Initiatives
Japan Segment: New Annualized Premium and Net Earned Premium, and Cost Savings from Transformation Initiatives
Global Investment Metrics: Net Investment Income (U.S. and Japan GAAP Segments only) and Credit Losses/Impairments
Beginning in 2021, the Compensation Committee decided to incorporate a modifier into the MIP compensation formula. The modifier allows for a -5%, flat, or +5% adjustment to total MIP compensation for all MIP participants based on achieving specific critical path sustainability objectives for 2023.
Considerations in setting the target goal amount for each of these MIP metrics are described in more detail below.

2021 Proxy Statement37

Table of Contents

Executive Compensation

Importance of Measuring Management’s
Performance Excluding the Impact of Currency

Since 1991, the Company has communicated external earnings results that exclude foreign currency effects. Similarly, MIP objectives are set on a currency-neutral basis.

Aflac Japan’s performance is important to our results, as the Japan segment reflectsaccounted for approximately 68%60% of total adjusted revenues for the year ending December 31, 2020.2023. The Company’s reported U.S. generally accepted accounting principles (“GAAP”) revenue, earnings, assets, book value, and cash flow are affected by changes in the relative values of the yen and the dollar, which ischanges are outside management’s control. Recognizing that strengthening and weakening of the yen can affect the value of the Company’s shares, the Compensation Committee believes it is important to ensure that executives bear the same exposure to the yen/dollar exchange rate as our shareholders and that equity awards under the LTI program and stock ownership requirements serve to align management with shareholders. When setting the MIP objectives, the Compensation Committee strongly believes that management should not be unduly rewarded because of short-term movement in the yen/dollar exchange rate when the yen is strong or penalized in periods of yen weakening when those currency shifts influence key incentive compensation metrics.



48AFLAC INCORPORATEDEXECUTIVE COMPENSATION
MIP Target-Setting Considerations

In addition to currency neutrality, the Compensation Committee considers the prior year’s results, current business operating environment and the forecasts emerging from the Company’s strategic planning process when setting MIP objectives for each metric. For example,2023, the majority of the MIP performance metrics were structurally consistent with the 2022 performance objectives, including weightings with specific “sloping” targets, with ranges adjusted for the 2023 financial plan. Target ranges for Aflac U.S. and Japan budget metrics as well as the Global Investment metrics were widened and sloped. For all NEOs and MIP participants who are Executive Vice Presidents or Senior Vice Presidents, a new product launches and distribution expansion can materially affectmetric was added for costs savings resulting from Transformation Initiatives. As a result of our shareholder engagement discussions regarding tying our sustainability goals with business strategy, the Company’s sales resultsMIP modifier was continued in Japan from one year2023 to the next.further incentivize progress on key goals. In addition, low interest rates were expected to continue in 2020, especially in Japan. A low-rate environment would continue to pressure Aflac Japan’s net investment income, as private placement investments were called or matured, and lead the Company discontinued the practice of providing adjusted earnings guidance, but as set forth below the Company continues to continue actively managing down salesutilize an outlook of first sector savings-type products, which have returns that are more interest-rate sensitive.adjusted earnings per share in setting MIP goals. The goals for these metrics having been established before the onset of the global pandemic, are generally consistent with the Company’s public guidance as provideddisclosure during the 2019 December Outlook Call.

Corporate Metric

In 2019, the Company generated $3.3 billion in net earnings or $4.43 per diluted share, which was up 17.5% for the year. The Company also reported a 2.7% increase in adjusted earnings for the year, which were $3.3 billion, and adjusted earnings per diluted shareFinancial Analysts Briefing on a currency-neutral basis of $4.42, which was up 6.3%. These results were at the upper end of our upwardly revised guidance range of $4.35 to $4.45 a share, assuming the 2018 weighted-average exchange rate of 110.39 yen to the dollar. When looking at the Company’s currency-neutral adjusted EPS estimates for 2020 and normalizing for roughly $0.05 per share of items identified and called out in 2019, the range equated to relatively flat adjusted EPS growth for 2020. The Company’s forecast for enterprise-wide variable investment income was approximately $60 million or $0.05 per share for 2020. This outlook incorporated headwinds related to low interest rates, continued strength in benefit ratios, elevated expense ratios tied to the build-out of Aflac Dental & Vision and consumer markets, proactive de-risking activity and investments to address the challenges we face to grow the top line in both JapanNovember 15, 2022, and the U.S.subsequent fourth quarter 2022 earnings release and return of capital to shareholders. Of note, the U.S. investments to build Aflac Network Dental and Vision as well as the consumer markets business represented a 1% headwind to adjusted EPS alone.

U.S. and Japan Segment Metrics

In 2019, Aflac U.S. sales decreased 1.3% to $1.6 billion The 2019 sales results partially reflect a decline in recruiting and retention of commission-only agents in a strong economic environment. In addition, net earned premium increased 1.8% and benefited from persistency, which was 77.7% at the end of 2019.

Moving into 2020, Aflac U.S. expected sales growth to recover in the low- to mid-single digits. As a result, the Company expected Aflac U.S. to deliver stable sales growth in 2020 within a range of 3.5% to 6.0% as we continued to invest in the existing platforms, including product development and efforts to facilitate producer growth and productivity. The Company expected increased productivity and strong persistency would lead to 0.00% to 1.25% growth of net earned premium in 2020.

38Aflac Incorporated
conference call.
Metric
Performance
Measures
Factors Considered in Setting Goal Levels
Corporate Metric
Adjusted EPS
In 2022, the Company generated $4.4 billion in net earnings, up 4.4% for the year, or $6.93 per diluted share. The Company also reported a 7.9% decrease in adjusted earnings for the year, which were $3.6 billion, and adjusted earnings per diluted share on a currency-neutral basis of $6.08, which was up 4.8%. This increase was supported by the repurchasing of $2.4 billion (39.2 million) of the Company’s shares and lower adjusted earnings as pandemic conditions in Japan gradually improved but impacted operations throughout the year resulting in lower revenues and elevated benefit ratios. Meanwhile, pandemic conditions in the U.S. had largely subsided, and results reflected revenue pressure due to lower persistency and elevated expenses due to costs of initiatives to drive future earned premium growth and efficiency.
When looking at the Company’s currency-neutral adjusted EPS estimates for 2023 and normalizing for roughly $0.03 per share of items identified and called out in 2022, the 2023 adjusted earnings outlook included headwinds to revenue resulting from slow to recover pandemic pressures in Japan, higher hedge costs and elevated expense ratios. The elevated expense ratios were tied to the build-out of Aflac Dental & Vision and consumer markets and investments to address the challenges we face to grow the top line in both Japan and the U.S. These headwinds were offset by lower benefit ratio expectations in Japan reflecting return to normal claims assumptions as “deemed” hospitalization rules were lifted toward the end of 2022.
U.S. and Japan Segment Metrics
New Annualized Premium
Net Earned Premium
Cost Savings from Transformation initiatives
In 2022, Aflac U.S. sales increased 16.1% to $1.5 billion, reflecting significant contributions from both our existing voluntary business and our more recently acquired growth properties. However, persistency experienced a significant decline, with the largest contributor being a significant migration of workers within the workforce, resulting in a persistency rate of 77.3% at the end of 2022. Moving into 2023, our business focus continues to be building out our growth properties, while continuing to strengthen our distribution reach for our core voluntary products. The Company expects sales growth in 2023 and the Compensation Committee set a range of 4% to 14% increase in sales for the year. After considering current economic volatility, our expected sales growth and persistency initiatives, the Company expected net earned premium growth in the -1% to +4% range. A new metric for costs savings related to transformation initiatives with a range of $15 million to $35 million was added to further incentivize progress on key goals.
Similarly, in Japan, the focus was on post-pandemic recovery and realization of investment in product development. The Company expected sales to continue to improve in the second half of 2022, if conditions continued to allow more face-to-face interactions, Japan Post resumed proactive sales of Aflac Cancer insurance, and Aflac had a successful launch of a new cancer insurance policy in the second half of 2022. Moving into 2023, the Compensation Committee determined a relatively flat range for sales was appropriate for 2023 given the continued uncertainty around recovery. Additionally, net earned premium was expected to decline largely due to lower sales environment and limited pay third sector policies becoming paid-up. The Compensation Committee set a range of approximately ¥ 54.8 billion to ¥ 65.5 billion for sales including Japan Post and set a range of -8.25% to -5.00% for net earned premium. A new metric for cost savings related to transformation initiatives with a range of ¥ 3.2 billion to ¥ 4.6 billion was added to further align short-term management incentive compensation with an initiative to reduce run-rate expenses across the global enterprise.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT49

Metric
Performance
Measures
Factors Considered in Setting Goal Levels
Global Investment Metrics
Net Investment Income
Credit Losses/ Impairments
For 2023, Aflac Japan net investment income including hedge costs was expected to be lower than the prior year, driven by higher hedge costs and lower call income, partially offset by higher yields. The Company expected net investment income for Aflac U.S. to increase, reflecting higher yields. Our planning assumes a positive 10% return each year for variable net investment income for both Aflac Japan and Aflac US.
Target levels for credit losses and impairments are determined with consideration of current asset quality, current and expected market conditions, and potential trading activity to improve the overall health of the portfolio.
In order to properly balance income and risk, targets for 2023 were expressed as a range around budget based on a bottom-up review of asset allocation and cash flows. As in 2022, we continued to slope the ranges to require above budget targeted performance for maximum payout, while not encouraging excessive risk-taking.
MIP Modifier
Responsible Investing
Climate: Net Zero
Diversity, Equity & Inclusion (Japan)
Diversity, Equity & Inclusion (U.S.)
The objectives for the MIP Modifier continued to advance the Company’s progress toward longer-term sustainability goals that are important to its success. Having fully allocated the proceeds of the sustainability bond and received attestation for Scopes 1 and 2, as well as five categories of Scope 3 in 2022, the Company maintained four objectives for the MIP Modifier in 2023 that focused on sustainability and diversity, equity and inclusion.
First, the Company maintained its target for responsible investing of the general account (portfolio) by continuing to allocate at least 10% of “available investable cash,” which excludes funding to existing commitments, to support a transition to a lower carbon economy over time and address global issues, like economic mobility, gender inequality and social inequity.
As part of our longer-term objective to source 100% of electricity for our owned and controlled facilities from sustainable sources, the Company continued to target improvement in 2023 by setting a minimum target of sourcing 33% of electricity from sustainable sources.
In addition, the Company continued to target progress toward longer-term diversity, equity and inclusion within its leadership in both Japan and the U.S. For Japan, this translated into women filling at least 26.5% of Manager or General Manager positions with Staff within Aflac Life Insurance Japan (ALIJ), and this is part of ALIJ’s path to reach 30% or more by the end of 2025. As part of a longer-term goal to increase the overall diversity (i.e., female or person of color) of Senior Management 5% in the U.S. by 2026, the Company aimed to achieve at least 48% diverse Senior Management in 2023 after ending 2022 at 47%.

Table of Contents

Executive Compensation

Japan Post sales were expected to further decline in 2020 from the 2019 level, given that Japan Post was focused on restoring customer trust before restarting sales in earnest. As a result, the Compensation Committee determined to exclude Japan Post from sales in 2020 and that a lower range for sales was appropriate for 2020. Additionally, earned premium for third and first sector protection products were expected to decline largely due to both third and first sector policies becoming paid-up. The Compensation Committee set a range of ¥59.0 billion to ¥66.6 billion for sales excluding Japan Post and set a range of -1.1% to -0.2% for third sector and first sector protection earned premium.

Global Investments Metrics

For 2020, Aflac Japan net investment income including hedge costs was expected to modestly decline, driven by higher yielding calls and maturities with lower projected reinvestment yields, reducing stable net investment income. Partially offsetting this headwind, the Company planned increased net investment income from the build-out of the U.S. dollar floating rate portfolio and growth in the alternatives portfolio, which increased variable net investment income.

The Company also expected net investment income for Aflac U.S. to decline, partially reflecting lower yields as well as a reduction of assets as part of the RBC drawdown strategy, which modestly shifted net investment income from our Aflac U.S. segment to Aflac Incorporated.

In order to properly balance income and risk, targets for 2020 were expressed as a range around budget based on a bottom-up review of asset allocation and cash flows. As in 2019, we continued to slope the ranges to require above budget performance for maximum payout, while not encouraging excessive risk-taking.

Equity Granting Policies

Each year, typically in February, the Compensation Committee meets shortly after the Company’s fiscal year results are released to the public. At that time, the Compensation Committee reviews recommendations developed by the CEO President and COO, and CFO (with input from Mercer)Mercer as the Compensation Committee’s independent consultant) for setting amounts and metrics with respect to LTI awards of PBRS stock options, and time-based restricted stock. Option grants are awarded on the date of the meeting, and have a per share exercise price set at the closing price on the date of grant. The Company has never engaged in “backdating” of options. For PBRS, the specific Company performance objectives are aligned with long-term corporate strategy, and thus are intended to drive shareholder value and ensure financial soundness.

For 2020,2023, the Compensation Committee established the following metrics for the 2020 PBRS grant:

Adjusted Return on Shareholders’ Equity
Risk Based Capital
Solvency Margin Ratio

Adjusted Return on Shareholders’ Equity
Risk-Based Capital
Solvency Margin Ratio
In addition, relative Total Shareholder Return Relative(RTSR) to Peer Group (RTSR) acts as a modifier. The Company may periodically make additional equity grants during the course of the year, but as a matter of policy does not make equity grants in advance of material news releases.

2021 Proxy Statement39


50AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

2023 Executive Compensation

2020 Executive Compensation

Elements of Our Executive Compensation Program

Base Salary

The base salaries of our named executive officers are competitively positioned relative to comparable executives atexecutives in our peers andpeer group and in the broader insurance sector, generally targeting market median, but also reflect each individual’s scope of responsibilities and performance. The Compensation Committee uses comparative market data for salaries in reviewing and determining the CEO’s salary, and the CEO uses the market data to inform his recommendations to the Compensation Committee regarding the salaries of the other executive officers.

Mr. Amos has not received a salary increase in the last nineeleven years. Mr. Brodén, Mr. Crawford and Mr. CrawfordDyslin received base salary increases for their respective promotions effective January 1, 20202023 of approximately 12%14.5%, 5.0% and 13.8%19.0%, respectively, in light of the related increased responsibilities and leadership. Mr. Brodén and Mr. Crawford were promoted to Executive Vice President, CFO and President, COO, respectively, effective January 1, 2020. Mr. Kirsch did not receive a salary increase in 2020. Mrs. Tillman received a base salary increase of approximately 3% to align hertheir respective base salary competitively relative to similar roles in the market and to help secure her continued service and leadership for the Company.

market.

Named Executive Officer2023 Base Salary
($)
2022 Base Salary
($)
% Change 2023
vs. 2022
Daniel P. Amos1,441,100 1,441,100 0.0 %
Max K. Brodén750,000 655,000 14.5 %
Frederick J. Crawford997,500 950,000 5.0 %
Bradley E. Dyslin625,000 525,000 19.0 %
Audrey Boone Tillman740,000 740,000 0.0 %
Management Incentive Plan

All NEOs are eligible to participate in the MIP,Management Incentive Plan (MIP), an annual non-equity incentive plan, which was originally submittedapproved and adopted by the Compensation Committee of the Board in 2023 (“2023 MIP”). The 2023 MIP is a successor to and approvedthe predecessor MIP that, by shareholdersits terms, expired with the end of the 2022 bonus year. The essential attributes of the predecessor MIP are unchanged in 2012. The currentthe 2023 MIP, which, became effective January 1, 2018,unlike the predecessor MIP, was approvednot adopted subject to shareholder approval because of changes that were made to certain Internal Revenue Code provisions that cause shareholder approval to be unnecessary. The 2023 MIP will continue in effect until terminated by shareholders in 2017.

the Compensation Committee or the Board.

Target MIP

The Compensation Committee, with assistance from its independent compensation consultant, established target MIP levels for 20202023 for the NEOs. These targets, shown below, were determined to be competitive generally relative to market median targets for executives with comparable positions within our peer group. The target MIP payoutpayouts for Mr. BrodénAmos and Mr. Crawford wasBrodén were increased from 75% to 100%250% and 125% to 200%175%, respectively, based onto align their promotions effective January 1, 2020.

target MIP competitively relative to similar roles in the market. The targets for the other NEOs remained unchanged from 2022.

The MIP payouts for the NEOs cannot exceed two times their target.

Target MIP
Named Executive OfficerTarget MIP
(as percent of base salary)
Daniel P. Amos250 220%%
Max K. Brodén175 100%%
Frederick J. Crawford200 200%%
Eric M. KirschBradley E. Dyslin200 200%%
Audrey Boone Tillman120 120%

40Aflac Incorporated
%


Table of Contents

Executive Compensation


EXECUTIVE COMPENSATION2024 PROXY STATEMENT51
MIP Performance Metrics

The performance measures are weighted differently for each NEO and for all other officer levels in the Company. We vary the weightings to reflect how each position can and should influence the outcome of particular metrics.

Metric Compensation Rationale Daniel P.
Amos
 Max K.
Brodén
 Frederick J.
Crawford
 Eric M.
Kirsch
 Audrey
Boone
Tillman
Corporate Objective            

Adjusted earnings per diluted share on a consolidated basis for the Company (excluding foreign currency effect)

 

This is calculated as: Adjusted earnings, excluding the impact of foreign currency* ÷ Weighted-average diluted shares outstanding

 Growth in adjusted earnings per diluted share, excluding the impact of foreign currency, is computed using the average yen/dollar exchange rate for the prior year, which eliminates fluctuations from currency rates that can magnify or suppress reported results in dollar terms. 45.45% 42.00% 42.50% 22.50% 37.50%
Subtotal   45.45% 42.00% 42.50% 22.50% 37.50%
U.S. Segment            
New Annualized Premium (increase over 2019) New annualized premium is policies sold and converted during the reporting period. 9.09% 8.00% 10.00% 2.50% 15.625%
Earned Premium (increase over 2019)   9.09% 8.00% 10.00% 2.50% 15.625%
Subtotal   18.18% 16.00% 20.00% 5.00% 31.25%
Japan Segment            
New Annualized Premium (excluding Japan Post sales) Focuses on maintaining our leadership position in cancer and medical (third sector) insurance while also offering first sector protection products. Both third sector and first sector protection products are less interest-rate sensitive than savings-type products and have strong and stable margins. 13.64% 17.00% 15.00% 3.75% 15.625%
Earned Premium (decrease in third sector and first sector protection sales)   13.64% 17.00% 15.00% 3.75% 15.625%
Subtotal   27.28% 34.00% 30.00% 7.50% 31.25%
Global Investments            
Net Investment Income (U.S. and Japan GAAP Segments only) Recognizes the need to responsibly invest the premium and other cash flows to maximize the risk-adjusted performance of our portfolio, subject to our liability profile and capital requirements. 9.09% 8.00% 7.50% 45.00% 
Credit Losses/Impairments      20.00% 
Subtotal   9.09% 8.00% 7.50% 65.00% 
Total   100% 100% 100% 100% 100%

*Adjusted earnings, excluding the impact of foreign currency, is not calculated in accordance with GAAP. See the Appendix to this Proxy Statement for a definition for this non-GAAP financial measure and a reconciliation to the most directly comparable GAAP measure.

2021 Proxy Statement41
MetricCompensation Rationale
Daniel P.
Amos
Max K.
Brodén
Frederick J.
Crawford
Bradley E.
Dyslin
Audrey
Boone
Tillman
Corporate Objective
Adjusted earnings per diluted share on a consolidated basis for the Company (excluding foreign currency effect)Non-GAAP metric that reflects the overall profitability of the business and focuses management on a combination of top-line growth as well as prudent expense management.45.60 %40.00 %42.50 %20.00 %33.33 %
This is calculated as: Adjusted earnings, excluding the impact of foreign currency* ÷ Weighted-average diluted shares outstanding
Subtotal45.60 %40.00 %42.50 %20.00 %33.33 %
U.S. Segment
New Annualized Premium (increase over 2022)Metrics that focus on increasing insurance product sales in the US, while also driving market share growth in the insurance product lines we provide our customers.7.60 %8.00 %8.00 %2.50 %14.17 %
Net Earned Premium (increase over 2022)7.60 %8.00 %8.00 %2.50 %14.17 %
Cost Savings from Transformation Initiatives3.00 %5.00 %3.00 %5.00 %5.00 %
Subtotal18.20 %21.00 %19.00 %10.00 %0.33 %
Japan Segment
New Annualized PremiumFocuses on maintaining our leadership position in cancer and medical (third sector) insurance while also offering first sector protection products. Both third sector and first sector protection products are less interest-rate sensitive than savings-type products and have strong and stable margins.11.60 %12.57 %12.75 %3.75 %14.17 %
Net Earned Premium (decrease over 2022)11.60 %12.57 %12.50 %3.75 %14.17 %
Cost Savings from Transformation Initiatives7.00 %5.00 %7.00 %5.00 %5.00 %
Subtotal30.20 %30.14 %32.25 %12.50 %33.33 %
Global Investments
Net Investment Income (U.S. and Japan GAAP Segments only)Recognizes the need to responsibly invest the premium and other cash flows to maximize the risk-adjusted performance of our portfolio, subject to our liability profile and capital requirements.6.00 %8.86 %6.25 %40.00 %— 
Credit Losses/Impairments— — — 17.50 %— 
Subtotal6.00 %8.86 %6.25 %57.50 % 
Total100 %100 %100 %100 %100 %
MIP modifier allows for a –5%, flat, or +5% adjustment to total MIP compensation based on achieving specific critical path sustainability objectives for 2023.
*    Adjusted earnings, excluding the impact of foreign currency, is not calculated in accordance with GAAP. See Appendix A to this Proxy Statement for a definition for this non-GAAP financial measure and a reconciliation to the most directly comparable GAAP measure.


52AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

20202023 MIP Targets and Actual Performance

Corporate Metric

Adjusted earnings per diluted share on a currency-neutral basis for the full year came in at $4.92$6.43 per share, and the MIP definition of the metric reducedincreased the achieved result to $4.89. Adjusted earnings$6.56 on a currency-neutral basis, resulting in a maximum payout for 2023. The net increase of $0.13 based on the MIP definition was primarily due to variable net investment income being capped at +/-10% of our long-term return expectation. Actual results were impactedbelow the floor, resulting in a positive $0.12 adjustment. There was also a $0.01 adjustment for expenses associated with the acquisition and wind down of pet insurance in Japan.
U.S. Segment Metrics
Aflac U.S. sales increased 5.0%, which resulted in a slightly above minimum payout for 2023. Net Earned Premium increased by a lower effective tax rate1.9% in 2023, which resulted in an above target payout for 2023.
Japan Segment Metrics
Aflac Japan’s sales increased 10.9%, which resulted in an above target payout for 2023. Net Earned Premium declined primarily as a result of a favorable tax ruling allowing the Company to take credit for excess tax payments in Japan at a 28% corporate rate.

U.S. Segment Metrics

Aflac U.S. salesimpact of reinsurance transactions, paid-up policies and earned premium decreased 31.1% and 1.2%, respectively, in 2020, which resulted in zero MIP payout for these metrics. The pandemic dramatically impacted the sales and earned premium zero payouts.

Japan Segment Metrics

The pandemic’s impact on sales resulted in a zero payout for 2020. For earned premium, sales were the major driver for the near-minimum payout for the Aflac Japan metrics. Earned premium achievement was aided by persistency remaining strong during the period (Japan 2020 persistency improved 70 basis points). We attribute the improvement in Japan to lower “lapse and reissue” activity with no new products introduced.

deferred profit liability.

Global Investments Metrics

Net investment income performed very well duringInvestment Income achieved a volatile market environment, with central bank and fiscal stimulus dramatically improving the performance of all market sectors including much lower interest rates globally and higher stock market valuations throughout the year.maximum payout while Credit Losses/Impairments achieved slightly below a target payout. The main drivers of our performance were as follows:

our decision to hedge against falling interest rates paid off more than anticipated in the year, net of locking in hedge costs;
tactical asset allocation decisions balancing lower deployment in floating rate loans; and
significant increase in call income as issuers redeemed bonds due to lower refinancing rates.

Impact of higher short-term rates on cash and floating rate portfolio
Credit losses were negatively impacted by the severe downturn in commercial real estate resulting in realized losses from mortgage loans going through various stages of the foreclosure process.
Please refer to the 20202023 Business Overview section beginning on page 3140 for additional information.

MIP Modifier Metrics
ObjectivesNotable Achievements
Responsible Investing (Insurance subsidiary portfolios) — Allocate at least 10% of “available investable cash” to new Sustainable and DEI Investments and Commitments
page21_check.jpg  Allocated 11.8% ($358 million) of “available investable cash” in 2023 to Sustainable and DEI Investments

Climate: Net Zero — Source ≥ 33% of electricity used for owned and controlled facilities from renewable resources and submission of a formal path to 100% by 2030
icon_crossmark.jpg   Missed 2023 target: Sourced 30.5% from renewable resources.
Aflac U.S. solar production was less than anticipated due to cloudy weather and supply chain issues leading to a delay in the expansion of our U.S. solar array
Aflac Japan, which has achieved 100% renewable electricity at Aflac Square since March 2021, achieved a 16% reduction in electricity consumption compared to 2022
Diversity, Equity, & Inclusion (Japan) — Achieve “Women in Leadership” of at least 26.5% as part of Aflac Life Insurance Japan Ltd.’s path to reach 30% or more by 2025
page21_check.jpg   27% of Aflac Life Insurance Japan Ltd.’s manager / general manager positions held by women
Diversity, Equity & Inclusion(U.S.) — Increase overall U.S. diversity of Senior Management population by 1% as part of the objective to increase by 5% by 2026
page21_check.jpg   49.6% of overall U.S. senior management population is diverse, an increase of 2.6% in 2023
In addition to the review and approval of the achievement of these sustainability objectives by the Compensation Committee, the achievement was also reviewed and approved by the Corporate Social Responsibility and Sustainability Committee.
Based on the achievement of three of the four sustainability objectives in 2023, the MIP pool was not adjusted positively or negatively.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT53
Actual performance relative to 20202023 MIP targets was determined after the end of the year and presented to the Compensation Committee for discussion and approval at its February 20212024 meeting. After careful consideration, the Compensation Committee did not make any changes to our executive compensation program and policies due to the impacts of COVID-19. All metrics exclude the impact of the 2020 Zurich business acquisition, which did not materially impact revenue and earnings in 2020. For performance, linear interpolation was used to determine payouts for performance between the corresponding goals (i.e., minimum to target, or target to maximum). The following table shows the corporate and business segment metrics, objectives, and results for the 20202023 MIP awards.

42Aflac Incorporated
Minimum
Goal
Target
Goal
Maximum
Goal

Table of Contents

Executive Compensation

Minimum
Goal
2022 Payout
Percentages vs
Target
Goal
Maximum
Goal
2020 Payout
Percentages
vs Target
Corporate Metric:
Adjusted earningsEarnings per diluted shareDiluted Share on a consolidated basisConsolidated Basis for the Company
(excluding foreign currency effect) (Excluding Foreign Currency Effect)
(1)(3)
03_424611-3_barchart_ corporatemetric.jpg
200%200.00%
U.S. Segment Metrics:
Increase in New Annualized Premium
03_424611-3_barchart_ increase.jpg
0%60.00%
Increase in Net Earned Premium
03_424611-3_barchart_decrease.jpg
 0%115.71%
Cost Reduction from Transformation Initiatives
03_424611-3_barchart_costreduction.jpg
200.00%
Japan Segment Metrics:
New Annualized Premium in(in billions of Yen
(excluding Japan Post sales)yen)
03_424611-3_barchart_japanneannualized.jpg
0%111.67%
Decrease in Net Earned Premium (third sector and first sector protection sales)(as adjusted for MIP)
03_424611-3_barchart_japanearnedpremium.jpg
63.73%98.09%
Cost Reduction from Transformation Initiatives
03_424611-3_MIP awards_03_424611-3_barchart_japancostreduction.jpg
200.00%
Global Investments Metrics:
Net Investment Income
(U.S. and Japan GAAP segments only)(2)(3)Segments Only)(1)
03_424611-3_barchart_gaapsegment.jpg
200%200.00%
Credit Losses/Impairments (in millions)(4)(2)
03_424611-3_barchart_creditlosses.jpg
166.67%

(1)The target corresponds to the same 2019 base of $4.42 per diluted share (net of foreign currency effect).90.00%
(2)In February 2021, the Compensation Committee excluded the net investment income from the unplanned cash flow boosted by delaying dividends to the Company from subsidiaries during 2020 ($12 million) for all MIP participants. This change has no impact on the Global Net Investment Income payout.
(3)MIP Modifier:Excludes corporate and other portfolio income and includes only the U.S. and Japan Segments. Net call and make-whole income are included in the net investment income, but capped at $15 million on a consolidated level (call premium income less lost net investment income on reinvestment). Variable net investment income (externally managed private equity and real estate equity) is included within a range of -10% to +10% of variable net investment income. Adjusted for any corporate shift in U.S. dollar hedging strategy. Includes asset management equity income for investments within Aflac Incorporated. These exclusions and limits had no impact on the payout percentage.
(4)MIP ModifierThis measure excludes realized losses on securities sold for pre-approved tax purposes, Japan principal reserve matching and segregated portfolio asset liability management, corporate shift in RBC drawdown plan, switch trades in excess of $100 million in assets, and compliance with internal risk limits. Excludes accounting policy driven mark-to-market losses on equities, alternatives, and perpetual securities.

2021 Proxy Statement
03_424611-3_barchart_ESGmodifier.jpg
43
+0%

Table(1)Excludes corporate portfolio income. Variable net investment income (externally managed private equity and real estate equity) is included within a range of Contents

Executive Compensation

2020-10% to +10% of target variable net investment income. Adjusted for any corporate shift in U.S. dollar hedging strategy. Includes asset management equity income for investments within Aflac Incorporated. These exclusions and limits had no impact on the payout percentage.

(2)This measure excludes realized losses on securities sold for pre-approved tax purposes, Japan principal reserve matching and segregated portfolio asset liability management, corporate shift in RBC drawdown plan, switch trades in excess of $500 million in assets, and compliance with internal risk limits. Excludes accounting policy driven mark-to-market losses on equities, alternatives, and perpetual securities.


54AFLAC INCORPORATEDEXECUTIVE COMPENSATION
2023 MIP PAYOUTS

The table below reflects target and earned percentages of salary for each NEO for the MIP based on 20202023 performance results.

The Compensation Committee has the discretion in certain limited circumstances to adjust the MIP results related to particular performance measures if the Compensation Committee determines that a class of MIP participants would be unduly penalized or rewarded because a payout is incompatible with the performance measure. There were no adjustments to the NEOs’ MIP payouts for 2020,2023, and these awards were paid in February 2021.

 As a % of
base salary
NEOTarget Earned
Daniel P. Amos220% 259%
Max K. Brodén100% 111%
Frederick J. Crawford200% 219%
Eric M. Kirsch200% 341%
Audrey Boone Tillman120% 102%

2024.

As a % of
base salary
NEOTargetEarned
Daniel P. Amos250 %402 %
Max K. Brodén175 %277 %
Frederick J. Crawford200 %316 %
Bradley E. Dyslin200 %336 %
Audrey Boone Tillman120 %170 %
For additional information about the MIP, please refer to the 20202023 Grants of Plan-Based Awards table below, which shows the threshold, target, and maximum award amounts payable under the MIP for 2020,2023, and the 20202023 Summary Compensation Table, which shows the actual amount of non-equity incentive plan compensation paid to the NEOs for 2020.

2023.

Long-Term Incentives

OVERVIEW OF LTI PROGRAM

The Compensation Committee administers the Long-Term Incentive Plan. In February 2020,2023, the Compensation Committee authorized grants of LTI variable equity awards to executive officers, including NEOs, in the form of PBRS. All eligible non-executive officers received time-based restricted stock units.

units (“RSUs”).

In determining the number of shares of PBRS to be granted to NEOs, the Compensation Committee is advised by its independent compensation consultant. The Compensation Committee’s decision is informed by market data regarding comparable executive positions within the Company’s peer group and the broader insurance sector, and each NEO’s tenure and performance. Based on these considerations, the Compensation Committee determines award levels that it believes are competitive within the Company’s peer group and the broader insurance sector, generally targeting the market median, and will be effective at aligning the NEO’s compensation with performance and the interests of our shareholders. Future payouts (if any) on the February 20202023 PBRS awards will be based on the Company’s performance from 20202023 through 20222025 and will vary between 0% and 200% of the target number of shares of PBRS granted, which is consistent with typical market practices.

LTI awards will vest three years from the issuance date, generally subject to combined service and satisfaction of performance conditions and final Compensation Committee authorization.

TARGET LTI AWARDS

The pay program for the CEO follows a market-based approach. The Company granted the CEO his target annual LTI award in February 20202023 at a market-competitive level, based primarily on peer group market data. Specifically, the CEO’s target LTI was set at an amount that approximates the 50th 50th percentile LTI of his fellowthe CEOs atin the Company’s peerspeer group for 2020.2023. This resulted in the CEO’s target LTI being 589%693% of his base salary.

44Aflac Incorporated

Table of Contents

Executive Compensation

20202023 annual LTI award targets as a percent of base salary for the other NEOs were as shown below:

NEOTarget LTI (as percent
of base salary)
Max K. Brodén175%250 %
Frederick J. Crawford250%300 %
Eric M. KirschBradley E. Dyslin200%175 %
Audrey Boone Tillman250%260 %

LTI PERFORMANCE METRICS

The PBRS will vest based on the Company’s achievement on three measures—AROE, RBC, and SMR—for the cumulative three-year performance period beginning January 1, 20202023 and ending December 31, 2022.2025. As described below, each metric has been assigned a weight that determines its effect on the LTI payout. Once a payout is calculated based on the weighted average achievement on these three metrics, that amount will be modified (up to +/-20%) based on our total shareholder return relative to the members of our peer group. We refer to this fourth metric as relative total shareholder return, or RTSR.



EXECUTIVE COMPENSATION2024 PROXY STATEMENT55
As noted in the descriptions below, in designing the LTI program, the Compensation Committee recognizes the importance of maximizing profitability and return on equity to shareholders, but also believes it is appropriate to pursue those objectives within the context of a solid risk framework.

MetricCompensation Committee RationaleWeighting

Adjusted Return on Shareholders’ Equity (AROE)

We define AROE (or currency neutral AROE) as:

Adjusted Earnings, excluding the impact of foreign currency ÷ Adjusted Book Value*

Enables shareholders to evaluate our financial achievements relative to other organizations in terms of how effectively we use capital to generate earnings

We believe this metric has a significant influence on the value our shareholders place on the Company.

Company
70%
Risk-Based Capital (RBC)

Current regulatory solvency measure in the U.S.
Capital adequacy is a significant concern for the financial markets and shareholder confidence.

confidence

Current regulatory solvency measureCritical metric determining cash flow capacity in the U.S.

support of Common Stock dividend and share repurchase
15%
Solvency Margin Ratio (SMR)

Principal capital adequacy measure in Japan
Capital Adequacyadequacy is a significant concern for the financial markets and shareholder confidence.

confidence

Principal capital adequacy measureCritical metric determining cash flow capacity in Japan

support of Common Stock dividend and share repurchase
15%
Total Shareholder Return Relative to Peer Group (RTSR)
Align LTI payouts with relative performance to peer group
Modifier

(up to ± 20%)

*AROE, adjusted earnings, excluding the impact of foreign currency, and adjusted book value are not calculated in accordance with GAAP. See the Appendix to this Proxy Statement for definitions for these non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

2020

*AROE and adjusted earnings, excluding the impact of foreign currency, and adjusted book value are not calculated in accordance with GAAP. See Appendix A to this Proxy Statement for definitions for these non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
2023 LTI PERFORMANCE TARGETS

The following illustrates the terms of the 20202023 PBRS grant.

(1)Excludes the 2022 adoption of new GAAP accounting for long-duration contracts.
(2)Excludes impact of unrealized gains on available for sale securities.
(3)RBC measured on an Aflac-only basis and excludes the impact of the 2020 Zurich business acquisition of approximately 25 percentage points.

2021 Proxy Statement45
Maximum
Performance Level
Target
Performance Level
Threshold
Performance Level
2023-
2025
3-yr. avg. currency-neutral
AROE
goal
16.0%13.0%11.0%
3-yr. avg. RBC(1) goal
500%400%350%
3-yr. avg. SMR(2) goal
700%600%500%
Payout (% of Target)200%100%50%
×
3-yr. RTSR percentile
rank vs. peer group
75th percentile or greater
Between 25th and
75
th percentile
25th percentile or lower
RTSR Modifier to
Earned Amounts
1.20x1.00x0.80x
Payoutu2026

Table

(2)Excludes impact of Contents

Executive Compensation

For financial performance (AROE, SMR, and RBC), linear interpolation will be used to determine payouts for performance between the corresponding goals (i.e., threshold to target, or target to maximum).
For RTSR, adjustments of 1.20x or 0.80x will be made only if the Company’s RTSR is in the upper or lower quartile, respectively, versus our peers. There will not be any adjustments to the payout if RTSR falls between the 25th and 75th percentiles of the peers.
Maximum potential payouts will be capped at 200% of target.

unrealized gains on available for sale securities.

For financial performance (AROE, SMR, and RBC), linear interpolation will be used to determine payouts for performance between the corresponding goals (i.e., threshold to target, or target to maximum).
For RTSR, adjustments of 1.20x or 0.80x will be made only if the Company’s RTSR is in the upper or lower quartile, respectively, versus our peer group. There will not be any adjustments to the payout if RTSR falls between the 25th and 75th percentiles of the peer group.
Maximum potential payouts will be capped at 200% of target.
The goals for these metrics are generally consistent with the Company’s public guidancedisclosure previously provided during annual December Outlook Calls.

2018-2020the 2022 Financial Analysts Briefing.



56AFLAC INCORPORATEDEXECUTIVE COMPENSATION
2021-2023 Performance Period

In February 2021,2024, the NEOs received payouts with respect to the performance shares that were granted in February 20182021 for the three year-performance period ended December 31, 2020.2023. These awards were paid at 155.9%200% times the target number of shares initially awarded based on the three-year average results for each of the currency neutral AROE, SMR, and RBC metrics. The Company’s TSR performance relative to peersthe peer group was in the 63rd 96th percentile rank, and therefore thea 1.20x modifier was applied to earned amounts as shown in the table below. Although the financial results combined with the RTSR modifier resulted in a 205% payout, payouts were not modified.

(1)The performance metric operating return on equity (“OROE”), excluding the impact of foreign currency, was renamed in 2018 to AROE (calculation has not changed).
(2)RBC measured on an Aflac-only basis and results exclude the impact of the 2020 Zurich business acquisition.

capped at 200% of the target number of shares initially granted pursuant to the terms of the PBRS grants.

ABA*B=CDC*D
Performance Objective 2021 to 2023WeightingsActual Attainment
(3 year average)
Earned
Percent of
Target
Percent of Target*
Weighting = Earned
Amounts
RTSR
Modifier
Payout Percentage
(Earned Percent*
Modifier)
(4)
Aflac Incorporated AROE(1)
70%15.0%158.7%111.1%
RBC(2)
15%675%200%30.0%
SMR(3)
15%917%200%30.0%
Total171.1%1.20205.0%
(1)Excludes the 2023 adoption of new GAAP accounting for long-duration contracts.
(2)RBC measured on an Aflac-only basis.
(3)Excludes impact of unrealized gains on AFS securities.
(4)Maximum Payout capped at 200%.
The final shares awarded, excluding dividends, to the NEOs in February 20212024 for the 20182021 to 20202023 performance period were:

46Aflac Incorporated
NEOTarget Number
of Shares Awarded
Actual number of
Shares Awarded
Daniel P. Amos
bar_neo_AmosD.jpg
Max K. Brodén
bar_neo_BrodenM.jpg
Frederick J. Crawford
bar_neo_CrawfordF.jpg
Audrey Boone Tillman
bar_neo_TillmanA.jpg
Special Awards
From time to time, we may make special awards in the form of RSUs to recognize major milestones, to secure leadership stability, or to achieve other strategic objectives. On February 9, 2023, the Compensation Committee awarded an RSU grant to Mr. Brodén to recognize his leadership and critical position with the Company as we move forward. Mr. Brodén joined the Company over six years ago and serves a critical role for leading enterprise-wide corporate development, investor and rating agency relations and corporate finance. When granting this award, the Compensation Committee recognized his leadership over the Company’s capital management and the Bermuda reinsurance platform. The grant will vest on the third anniversary of the grant date generally subject to continued service throughout the vesting period. For more information regarding the special awards, see the 2023 Grant of Plan-Based Awards table on page 63.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT57

Table of Contents

Executive Compensation

Program Changes for 2021

2024

The Company continually analyzes our compensation program to ensure that we remain current in our approaches, a leader in executive compensation best practices, and cognizant of shareholder feedback. The feedback from these conversations, together with a thorough analysis of best practices and guidance from our independent compensation consultant, was incorporated into the Compensation Committee’s regular review of our compensation practices.

After this review,

Following the Compensation Committee decidedCommittee's annual review of both current and potential peer companies, one change was made to incorporate an ESG modifier into the MIP compensation formulagroup for 2021. The ESG modifier allows for a -5%, flat, or +5% adjustment to total MIP compensation for all MIP participants based on achieving specific critical path ESG objectives for 2021. In addition, recognizing volatility associated with the ongoing pandemic in the U.S. and Japan, MIP thresholds2024: Corebridge Financial will be widened around target levels while maintaining sloping on certain metrics.

added to the 2024 peer group since it fits the size and operating characteristics of the Company’s other current peers.

Other Compensation

The retirement, deferral, and savings plans described in the tables below were established in order to provide competitive post-terminationpost-termination benefits for officers and employees, including the NEOs, in recognition of their service and contributions to the Company.

Defined Benefit Pension Plans

As described further in “Pension Benefits” below, the Company maintains tax-qualified, noncontributory defined benefit pension plans covering substantially all U.S. employees, including the NEOs, who satisfy the eligibility requirements. The Company also maintains nonqualified supplemental retirement plans covering some of the NEOs. No change has been madeIn June 2023, the Company amended the U.S. defined benefit plan to freeze future benefits under the pension plans and the benefit level remains the same as last year.

plan for all participants effective January 1, 2024.

Executive Deferred Compensation Plan

The NEOs, together with other U.S.-based eligible executives, are entitled to participate in the Executive Deferred Compensation Plan (“EDCP”). Messrs. Amos, Brodén, Crawford and Mrs. Tillman are the onlyAll NEOs currently participatingparticipate in this plan. The EDCP is discussed in more detail below under “Nonqualified Deferred Compensation.”

No change was made to the EDCP in 2023.

401(k) Savings and Profit Sharing Plan

The Company maintains a tax-qualified 401(k) Savings and Profit Sharing Plan (the “401(k) Plan”) in which all U.S.-based employees, including the U.S.-based NEOs, are eligible to participate on the same terms. The Company provides matching contributions equal to 100% of each employee’s contributions up to 4% of the employee’s eligible annual cash compensation. Employee contributions made to the 401(k) Plan are 100% vested.

Employees vest in Company contributions at the rate of 20% for each complete year of service. After five years of service, employees are fully vested in all Company contributions.

The Company provideshistorically has provided a nonelective contribution to the 401(k) Plan of 2% of eligible annual cash compensation for employees who elected to opt out of the future benefits of the U.S. defined benefit plan and for U.S. employees who started working for the Company after September 30, 2013, the date on which the U.S. defined benefit plan was frozen with respect to new participants. Messrs. Brodén and Crawford are the only NEOs who are eligible to receive a nonelective contribution. Effective January 1, 2021, the Company increased this nonelective contribution to 4% of annual compensation.

Employees vest Effective January 1, 2024, the nonelective 401(k) employer contribution was extended to U.S. employees who were participants in Company contributions at the ratedefined benefit plan prior to the freeze of 20% for each complete year of service. After five years of service, employees are fully vested in all Company contributions.

future benefits on January 1, 2024.

Other Benefits

The Company provides NEOs with other benefits that we believe are reasonable, competitive, and consistent with our overall executive compensation program. For details, see the “All Other Compensation” column in the 20202023 Summary Compensation Table on page 50.61. The Company maintains medical and dental insurance, group life insurance, accidental death insurance, cancer insurance, and disability insurance programs for all employees, as well as paid time off, leave of absence, and other similar policies. The U.S.-basedU.S.-based NEOs and other officers are eligible to participate in these programs along with, and on the same basis as, the Company’s other salaried employees. In addition, the NEOs are eligible to receive reimbursement for medical examination expenses.

For security and time-management reasons, certain officers of the Company occasionally travel on corporate aircraft for business and personal purposes. Personal travel on corporate aircraft and security services are provided where considered by the Board to be in the best interest of the Company and its business objectives.

2021 Proxy Statement47


58AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

Additional Executive Compensation Plan Practice and Procedures

Stock Ownership Guidelines; Hedging and Pledging Restrictions

The Company believes its executivesenior officers and Directors should have a significant equity interest in the Company and has enforced stock ownership guidelines for executivesenior officers and Non-employee Directors for almostmore than two decades. The stock ownership guidelines, as most recently amended on February 14, 2019,15, 2024, are as follows:

PositionOwnership guidelineWhat CountsWhat Does Not Count
Chairman of the Board/CEO
8xbase salary
Ownership includes all shares beneficially owned by the officer or Non-employee Director, as well as time-based, unvested restricted shares.PBRS and stock options (vested or unvested) do not count toward these stock ownership guidelines.
President of Aflac Incorporated
5xbase salary
Chairman/Vice Chairman/President of Aflac U.S.
4xbase salary
Chairman/Vice Chairman/President of Aflac Japan
4xbase salary
All other executive officersSection 16 Officers
3xbase salary
Non-Section 16 Executive Vice Presidents and Senior Vice Presidents
1x base salary
Vice Chairman of Aflac Japan
1x base salary
Non-employee Directors4x
5xannual cash retainer
Compliance Period
Officers have four years from their hire or promotion date to satisfy their respective stock ownership requirements.
Non-employee Directors have five years from the date first elected to the Board to satisfy these requirements.  
Upon any increase in these stock ownership guidelines or an increase in base salary or annual cash retainer, impacted individuals will have an additional two years from the effective date of the change to comply with the increased requirements. 
Compliance StatusEach current NEO and Non-employee Director has stock ownership that exceeds the ownership guidelines or is working toward meeting the requisite guideline within the allowed time frame. Progress toward meeting the guidelines is reviewed regularly and reported to the Board.

Officers have four years from their hire or promotion date to satisfy their respective stock ownership requirements. Non-employee Directors have five years from the date first elected to the Board to satisfy these requirements. Upon any increase in these stock ownership guidelines or an increase in base salary or annual retainer, impacted individuals will have an additional two years from the effective date of the change to comply with the increased requirements.

Ownership includes all shares held by the officer or Director and the individual’s spouse, as well as time-based, unvested restricted shares. PBRS and stock options (vested or unvested) do not count toward these stock ownership guidelines.

Each current NEO and Director has stock ownership that exceeds the ownership guidelines or is working toward meeting the requisite guideline within the allowed time frame. Progress toward meeting the guidelines is reviewed regularly and reported to the Board.

The Company’s insider trading policy prohibits our Non-employee Directors, officers and other covered individuals from purchasing financial instruments (including derivatives and exchange funds), or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of our Common Stock (collectively, “hedges”), or entering into a 10b5-1 plan unless that plan is approved by the Compensation Committee. In addition, executive officers and Non-employee Directors are prohibited from pledging the Company’s stock. All other covered individuals under the Company’s insider trading policy must obtain preapproval from the policy’s compliance officer before pledging Company stock as collateral for a margin account or other loan. The Company’s anti-hedging policy prohibits all other employees from engaging in hedges after February 13, 2020.

hedges.

Employment Agreements

The Company has employment agreements with the NEOs (other than Mr. Brodén)Dyslin) and certain other executives in key roles. The agreements generally address role and responsibility; rights to compensation and benefits during active employment; termination in the event of death, disability, or retirement; termination for cause or without cause; and resignation by the employee. Some agreements also contain termination and related pay provisions in the event of a change in control. These change-in-control provisions do not apply unless there is both a change in control and either a termination by the Company without cause or a resignation by the executive for good reason. This is commonly referred to as a “double trigger” requirement. No agreement provides for excise tax gross-ups. Further, each agreement stipulates that the subject executive may not compete with the Company for a prescribed period following termination of employment, or disclose confidential information. Mr. Amos has voluntarily waived all “golden parachute” and other severance components in his employment agreement. The payments that may be made under each NEO’s employment agreement upon termination of employment under specified circumstances are described in more detail below under “Potential Payments Upon Termination or Change in Control.”

On October 30, 2023, the Company entered into the LOA with Mr. Crawford, which amended Mr. Crawford’s existing employment agreement (the “Existing Employment Agreement”). Pursuant to the LOA, Mr. Crawford will retire from service as an employee of the Company on September 30, 2024, and the Existing Employment Agreement will not be renewed after its term ends on April 30, 2024. Effective January 1, 2024, Mr. Crawford will serve as Executive Vice President of the Company through his retirement date.
Pursuant to the LOA, the PBRS grants Mr. Crawford received in February 2022 and February 2023 will vest, subject to the applicable performance criteria, in February 2025 and February 2026, respectively, as if he had remained employed through the applicable vesting periods. As of October 30, 2023, Mr. Crawford is no longer eligible to receive grants of equity during his employment with the Company. Mr. Crawford will be subject to, among other things, certain confidentiality, non-compete and non-solicitation obligations. Mr. Crawford will continue to be eligible to receive a contribution to the Company’s EDCP, and upon his retirement on September 30, 2024, his EDCP will become fully vested. He will also receive a lump sum payment of $36,537 toward the cost of COBRA continuation coverage for 18 months after his retirement date.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT59
Change-in-Control Policy and Severance Agreements

The Company has no formal change-in-control or severance policy. However, as noted above,some individual employment agreements (as noted above) and the executive severance plan incorporate provisions related to these matters.

48Aflac Incorporated
change in control.
Severance Plan

Table of Contents

Executive Compensation

The Company maintains an executive severance plan (“ESP”) that provides severance compensation to certain senior level employees. The ESP is designed to alleviate the financial hardships that may be experienced by executive employee participants whose employment is involuntarily terminated by the Company for any reason other than Cause or disability, or voluntarily terminated by the employee for Good Reason, as those terms are defined in the ESP. Mr. Dyslin is the only NEO covered by the ESP.
Compensation Recovery (“Clawback”) Policy

The Company has long maintained a “clawback” policy to ensure that allows the Compensation CommitteeCompany is able to review any adjustment or restatementrecover compensation paid to certain officers in appropriate circumstances. That policy has now been revised as required to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act of performance measures2010, SEC rules, and determine whether that adjustment or restatement warrants modifying or recovering non-equity incentive awards. If it is deemed that such a modification or recovery is appropriate, the NYSE listing requirements. The Compensation Committee is charged with determining whether such recovery is required, the amount of recoveryto be recovered and the officer group to be affected.

The Compensation Committee and the Board will continue to monitor developments in this area to consider practices as they evolve.

Compensation Risk Assessment
Following the end of 2009, the SEC required public company proxy filings to include disclosures on any practices and policies related to compensation posing material risk to a company. This assessment serves as a review of the practices and policies surrounding compensation and governance to evaluate if any material risk is placed on an organization and is reviewed by the Compensation Committee as part of its standard oversight responsibilities. For purposes of the Company’s compensation risk assessment, the following nine “standard’ program design elements/categories were analyzed:
Compensation Risk Considerations
Pay mix
Balanced approach between cash and equity
MIP and LTI (PBRS) plan designs and target levels are benchmarked annually to relevant market comparables
Performance metrics
MIP and LTI (PBRS) metrics provide a balance between short-term, mid-term, and longer-term performance objectives - -use of multiple metrics ensures performance on one metric is not “over-emphasized”
MIP’s metrics reflect a balanced, multi-faceted approach to performance assessment: (1) Corporate objectives (adjusted EPS), (2) US and Japan business segment objectives (new annualized premium; net earned premium), (3) Global Investments metrics (net investment income; credit loss/impairments), and (4) sustainability-related goals
PBRS program focuses on Adjusted Return on Shareholders’ Equity (AROE) EX-FX, RBC, and SMR. Relative TSR modifier to financial results provides a “market check” for alignment with shareholders
Business unit leaders are linked to overall Company performance via plan designs
Goal Setting and Payout Curves
Rigorous goal-setting process conducted by 100% independent Compensation Committee, with final metrics, goals, and payouts approved by the Compensation Committee
Payouts for both MIP ($s) and PBRS (# of shares/units) programs are capped at 200% of target - - 200% of target maximum payout levels are within typical market practices


60AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Payment Timing & Adjustments
Payments for both MIP and LTI (PBRS) programs are approved following review of performance results by Compensation Committee
Adjustments to actual results are defined and include reasonable items, with consistent treatment from year to year
Equity Incentives
Equity-based LTI grants provide alignment with multi-year performance horizon and long-term value creation
PBRS’s design includes multiple metrics, ensuring that performance is measured holistically versus placing emphasis on a single metric’s performance
Target grant levels are benchmarked regularly to assess competitiveness
Run rate and overhang are reviewed regularly to ensure appropriate management and usage of equity share pool
Stock incentive plans prohibit option repricing or buy-outs without stockholder approval
Risk mitigation policies
The Company maintains the following policies:
     — Meaningful stock ownership guidelines
     — Clawback policy
     — Anti-hedging policy
     — Anti-pledging policy
     — Caps on incentive plan payments (relative to target amounts) – described previously
Individual Performance Assessment
Individual performance is assessed in certain limited circumstances to adjust MIP results; individual performance is also a factor when determining size of target LTI grants
Inappropriate behavior and unacceptable risk-taking are incorporated into an individual’s compensation evaluation process
Certain Tax and Accounting Implications of Executive Compensation

In evaluating the Company’s executive compensation structure, the Compensation Committee considers the tax and accounting treatment, balancing the effects on the individual and the Company. The Compensation Committee believes that the potential deductibility and the accounting treatment of the compensation payable under those programs should be only one of a number of relevant factors taken into consideration, and not the sole or primary factor, in establishing the cash and equity compensation programs for the executive officers. Section 162(m) of the Internal Revenue Code (“Section 162(m)”) generally limits to $1.0 million the amount of remuneration that the Company may deduct in any calendar year for certain executive officers. Prior to 2018, the Company structured annual incentive awards and long-term incentive awards with the intention of meeting the exception to this limitation for “performance-based” compensation, as defined in Section 162(m) of the Code, so that these amounts could be fully deductible for income tax purposes. The performance-based exception was eliminated effective as of January 1, 2018, and compensation paid to the NEOs in excess of $1.0 million will generally not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November 2, 2017. While the Compensation Committee continues to considerconsiders the effect of the Section 162(m) deduction limit and financial accounting implications when designing the Company’s compensation programs, the Compensation Committee’s primary focus in its compensation decisions will remain on most productively furthering the Company’s business objectives and not on whether the compensation is deductible.deductible or its accounting treatment. Accordingly, the Compensation Committee will continue to maintain flexibility and the ability to pay competitive compensation by not requiring all compensation to be deductible.

The Compensation Committee did not make significant changesdeductible or to the Company’s executive compensation program for 2020 in responsebe subject to the tax code changes.

any particular accounting treatment.

Compensation Committee Report

The Compensation Committee has reviewed and discussed the preceding CD&A with management and, based on that review and discussion, has recommended to the Board to include the CD&A in this Proxy Statement.

Compensation Committee


Joseph L. Moskowitz, Chair

Georgette D. Kiser

Katherine T. Rohrer

2021 Proxy Statement49


EXECUTIVE COMPENSATION2024 PROXY STATEMENT61

Table of Contents

Executive Compensation

Executive Compensation Tables

2020

2023 Summary Compensation Table

The following table provides information concerning total compensation earned or paid for 20202023 and, to the extent required by the SEC disclosure rules, 20192022 and 20182021 to our CEO, CFO, and the three other most highly compensated executive officers who were serving as executive officers during 2020.at the end of 2023. These five officers are referred to as our NEOs in this Proxy Statement.

Name and
Principal Position
 Year Salary(1)
 ($)
 Bonus
($)
 Stock
Awards(2)
($)
 Option
 Awards(2)
($)
 Non-equity
Incentive
 Plan
Compensation
($)
 Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings(3)
 ($)
 All Other
Compensation(4)
($)
 Total
($)
  Total
without
 Change in
Pension
Value*
($)
 
Daniel P. Amos  2020  1,441,100    8,471,063    3,734,173  8,514,587  452,804  22,613,727   14,099,140 
Chairman and CEO  2019  1,441,100    8,272,062    4,002,594    393,096  14,108,852   14,108,852 
   2018  1,441,100     8,922,142    4,638,345  2,166,871  366,940  17,535,398   15,368,527 
Max K. Brodén**  2020  560,000    978,137    620,672    195,451  2,354,260   2,354,260 
Executive Vice President, CFO and Treasurer                                
Frederick J. Crawford  2020  825,000    2,058,586    1,807,738    439,337  5,130,661   5,130,661 
President, COO  2019  725,000    3,066,265    1,104,981    322,446  5,218,692   5,218,692 
   2018  725,000    4,905,453    1,391,688    366,214  7,388,355   7,388,355 
Eric M. Kirsch  2020  650,000    1,297,533    2,219,400  64,131  30,615  4,261,679   4,197,548 
Executive Vice  2019  650,000    1,338,520    2,291,995  80,568  29,729  4,390,812   4,310,244 
President, Global Chief Investment Officer; President, Aflac Global Investments  2018  593,800     2,248,570     2,150,087  22,820  28,620  5,043,897   5,021,077 
Audrey Boone Tillman  2020  700,000    1,746,677    713,650  1,910,129  11,560  5,082,016   3,171,887 
Executive Vice  2019  680,000    1,400,319    850,830  2,636,646  38,695  5,606,490   2,969,844 
President, General Counsel  2018  670,333    1,429,765    1,121,759  1,135,561  13,739  4,371,157   3,235,596 

*Total without Change in Pension Value represents total compensation, as determined under applicable SEC rules, minus the change in pension value reported in the Change in Pension Value and Nonqualified Deferred Compensation Earnings column. This additional column has been included to show the effect that the year-over-year change in pension value had on total compensation as determined under applicable SEC rules. The amounts reported in the Total without Change in Pension Value column differ from the amounts reported in the Total column required under SEC rules and are not a substitute for total compensation. The change in pension value, as discussed in footnote 3 below, is subject to many external variables that are not related to the Company’s performance.
**Mr. Brodén was promoted to CFO on January 1, 2020, and became an NEO on that date.
(1)In each of the three years above, includes $441,100 deferred for Mr. Amos. This amount is included in the 2020 Nonqualified Deferred Compensation table below. See “Elements of Our Executive Compensation Program — Base Salary” in the Compensation Discussion and Analysis section of this Proxy Statement for information about adjustments to base salaries in 2020.
(2)In accordance with the SEC’s reporting requirements, we report all equity awards at their full grant date fair value under ASC 718 at target-level performance for PBRS, which is the probable achievement level of the performance conditions. The Company’s valuation assumptions are described in Note 12, “Share-Based Compensation,” in the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2020. See “Elements of Our Executive Compensation Program — Long-Term Incentives” in the Compensation Discussion and Analysis section of this Proxy Statement for additional information about these long-term incentives and their terms. Assuming achievement of performance goals at the maximum level, the aggregate grant date fair value of the PBRS would be: Daniel P. Amos, $16,942,126; Max K. Brodén, $1,956,274; Frederick J. Crawford, $4,117,172; Eric M. Kirsch, $2,595,066; Audrey Boone Tillman, $3,493,354. See page 53 for a more detailed discussion of our outstanding equity grants compared to fair market value as of December 31, 2020.
(3)No amount in this column is attributable to above-market earnings on deferred compensation. The change in pension value was driven largely by the decrease in discount rate from 3.25% in 2019 to 2.68% in 2020. Messrs. Brodén and Crawford are not eligible to participate in the Company’s defined benefit plans because the plans were frozen to new participants before they joined the Company. See the “Pension Benefits” section and the accompanying table beginning on page 54 for a more detailed discussion of the retirement plans.
(4)Additional information regarding all other compensation is provided in detail in the “All Other Compensation” and “Perquisites” table below.

50Aflac Incorporated
Name and
Principal Position
Year
Salary(1)
($)
Bonus
($)
Stock
Awards
(2)
($)
Option
Awards
(2)
($)
Non-equity
Incentive
Plan
Compensation
($)
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
(3)
($)
All Other
Compensation
(4)
($)
Total
($)
Total
without
Change in
Pension
Value*
($)
Daniel P. Amos
Chairman and CEO
20231,441,100 10,270,666 5,796,333 2,720,265 474,889 20,703,253 17,982,988 
20221,441,100 9,495,081 4,548,167 — 291,943 15,776,291 15,776,291 
20211,441,100 9,122,025 4,809,396 — 355,712 15,728,233 15,728,233 
Max K. Brodén
Executive Vice President,
CFO
2023750,000 2,428,668 2,075,603 — 479,749 5,734,020 5,734,020 
2022655,000 1,724,741 1,303,206 — 356,238 4,039,185 4,039,185 
2021620,000 2,292,401 1,128,701 — 304,452 4,345,554 4,345,554 
Frederick J. Crawford
President and COO
2023997,500 3,078,084 3,153,222 — 967,690 8,196,496 8,196,496 
2022950,000 3,000,921 2,599,237 — 589,982 7,140,140 7,140,140 
2021908,333 2,149,596 2,649,889 — 558,729 6,266,547 6,266,547 
Bradley E. Dyslin
Executive Vice President,
Global Chief
Investment Officer;
President, Aflac
Global Investments
2023625,000 1,125,293 2,100,111 49,952 426,855 4,327,211 4,277,259 
Audrey Boone Tillman
Executive Vice President,
General Counsel
2023740,000 1,979,004 1,254,524 2,509,620 27,508 6,510,656 4,001,036 
2022740,000 2,025,875 1,045,629 — 20,435 3,831,939 3,831,939 
2021700,000 1,823,926 1,100,700 — 17,493 3,642,119 3,642,119 
*Total without Change in Pension Value represents total compensation, as determined under applicable SEC rules, minus the change in pension value reported in the Change in Pension Value and Nonqualified Deferred Compensation Earnings column. This additional column has been included to show the effect that the year-over-year change in pension value had on total compensation as determined under applicable SEC rules. The amounts reported in the Total without Change in Pension Value column differ from the amounts reported in the Total column required under SEC rules and are not a substitute for total compensation. The change in pension value, as discussed in footnote 3 below, is subject to many external variables that are not related to the Company’s performance.
(1)In each of the three years above, includes $441,100 deferred for Mr. Amos. This amount is included in the 2023 Nonqualified Deferred Compensation table below. See “Elements of Our Executive Compensation Program — Base Salary” in the Compensation Discussion and Analysis section of this Proxy Statement for information about adjustments to base salaries in 2023.
(2)In accordance with the SEC’s reporting requirements, we report all equity awards at their full grant date fair value under ASC 718 at target-level performance for PBRS, which is the probable achievement level of the performance conditions. The Company’s valuation assumptions are described in Note 12, “Share-Based Compensation,” in the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2023. See “Elements of Our Executive Compensation Program — Long-Term Incentives” in the Compensation Discussion and Analysis section of this Proxy Statement for additional information about these long-term incentives and their terms. Assuming achievement of performance goals at the maximum level, the aggregate grant date fair value of the PBRS would be: Daniel P. Amos, $20,541,332; Max K. Brodén, $3,857,310; Frederick J. Crawford, $6,156,169; Bradley Dyslin, $2,250,587; Audrey Boone Tillman, $3,958,008. See page64 for a more details of our outstanding equity grants compared to fair market value as of December 31, 2023.
(3)No amount in this column is attributable to above-market earnings on deferred compensation. Messrs. Brodén and Crawford are not eligible to participate in the Company’s defined benefit plans because the plans were frozen to new participants before they joined the Company. See the “Pension Benefits” section and the accompanying table beginning on page 65 for a more detailed discussion of the retirement plans.
(4)Additional information regarding all other compensation is provided in detail in the “All Other Compensation” and “Perquisites” tables below.


62AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

20202023 All Other Compensation

The following table identifies the amount of each item included for 20202023 in the All Other Compensation column in the 20202023 Summary Compensation Table.

Name Perquisites and
 Other Personal
 Benefits(1)
 ($)
  Company
 Contributions
 to 401(k) Plan
 ($)
  Company
 Contribution
 to Nonqualified
 Deferred
 Compensation(2)
 ($)
  Total
 ($)
 
Daniel P. Amos  441,404   11,400      452,804 
Max K. Brodén  1,250   17,100   177,101   195,451 
Frederick J. Crawford  27,326   17,100   394,911   439,337 
Eric M. Kirsch  19,215   11,400      30,615 
Audrey Boone Tillman  160   11,400      11,560 

(1)Perquisites are more fully described in the Perquisites table.
(2)Includes $177,101 and $394,911 of a Company deferred compensation contribution for Messrs. Brodén and Crawford, respectively. This amount is included in the 2020 Nonqualified Deferred Compensation table.

2020

Name
Perquisites and
Other Personal
Benefits
(1)
($)
Company
Contributions
to 401(k) Plan
($)
Company
Contribution
to Nonqualified
Deferred
Compensation
($)
Total
($)
Daniel P. Amos461,689 13,200 — 474,889 
Max K. Brodén29,509 26,400 423,840 479,749 
Frederick J. Crawford318,682 26,400 622,608 967,690 
Bradley E. Dyslin4,888 13,200 408,767 426,855 
Audrey Boone Tillman14,308 13,200 — 27,508 
(1)Perquisites

are more fully described in the Perquisites table.

2023 Perquisites
The following table identifies the incremental cost to the Company of each perquisite included for 20202023 in the All Other Compensation table.

Name Personal Use of
 Company Aircraft(1)
 ($)
  Security
 Services(2)
 ($)
  Other(3)
 ($)
  Total Perquisites
 and Other Personal
 Benefits(4)
 ($)
 
Daniel P. Amos  259,490   181,914      441,404 
Max K. Brodén        1,250   1,250 
Frederick J. Crawford  26,878   420   28   27,326 
Eric M. Kirsch        19,215   19,215 
Audrey Boone Tillman        160   160 

(1)Incremental cost for the personal use of corporate aircraft is the calculated standard hourly cost rate based upon actual operating expenses for corporate aircraft, including fuel costs, airport fees, catering, in-flight phone, crew travel expenses, and maintenance cost. This rate is recalculated annually. The personal use of corporate aircraft has been authorized by the Board for security reasons and to maximize the effectiveness of the executives’ time.
(2)Incremental costs for security services include the salaries and benefits of security officers and the actual costs of any security equipment, monitoring, and maintenance fees.
(3)Amounts included in the Other column are charges incurred by Mr. Kirsch totaling $19,215 for personal tax return preparation and financial planning.
(4)The Company did not gross up for tax purposes any of the other perquisites described in this table.

2021 Proxy Statement51
Name
Personal Use of
Company
Aircraft(1)
($)
Security
Services
(2)
($)
International
Assignment
Allowance(3)
($)
Tax Related
Reimbursements(4)
($)
Other(5)
($)
Total Perquisites
and Other
Personal
Benefits
(6)
($)
Daniel P. Amos205,733 249,621 — — 6,335 461,689 
Max K. Brodén— — — — 29,509 29,509 
Frederick J. Crawford18,840 420 212,612 62,879 23,931 318,682 
Bradley E. Dyslin— — — — 4,888 4,888 
Audrey Boone Tillman5,275 — — — 9,033 14,308 
(1)Incremental cost for the personal use of corporate aircraft is the calculated standard hourly cost rate based upon actual operating expenses for corporate aircraft, including fuel costs, airport fees, catering, in-flight phone, crew travel expenses, and maintenance cost. This rate is recalculated annually. The personal use of corporate aircraft has been authorized by the Board for security reasons and to maximize the effectiveness of the executives’ time.
(2)Incremental costs for security services include the salaries and benefits of security officers and the actual costs of any security equipment, monitoring, and maintenance fees.
(3)This amount includes Company provided housing (in the amount of $141,528), which includes rent and utilities. All expenses were incurred as a direct result of Mr. Crawford's overseas assignment in Tokyo, Japan which ended on December 31, 2023. Certain amounts were paid in yen and all are converted to dollars by dividing the actual yen denominated payments by the 2023 weighted average exchange rate of 140.57 yen to the dollar.
(4)Amount included in the tax related reimbursements for Mr. Crawford represents Japan taxes and tax gross-up payments, which are designed to satisfy tax obligations arising solely as a result of his international assignment.
(5)Amounts included in the Other column include charges incurred by Mr. Amos for guest travel, by Mr. Brodén totaling $28,920 for personal tax return preparation and/or financial planning and guest travel, by Mr. Crawford for guest travel and personal tax return preparation and/or financial planning, by Mr. Dyslin for guest travel and Company paid gym membership fees and by Mrs. Tillman for guest travel and entertainment.
(6)The Company did not gross up for tax purposes any of the perquisites described in this table.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT63

Table of Contents

Executive Compensation

20202023 Grants of Plan-Based Awards

The following table provides information with respect to the 20202023 grants of plan-based awards to the NEOs.

                       All Other    
     Estimated Possible Payouts  Estimated Future Payouts  Stock Awards:  Grant Date 
     Under Non-Equity  Under Equity  Number of  Fair Value 
     Incentive Plan Awards(1)  Incentive Plan Awards(2)  Shares of  of Stock and 
Name and Grant  Threshold  Target  Maximum  Threshold  Target  Maximum  Stock or Units  Option Awards 
Principal Position Date  ($)  ($)  ($)  (#)  (#)  (#)  (#)  ($) 
Daniel P. Amos  2/13/2020            80,893   161,785   323,570      8,471,063 
   N/A   1,585,210   3,170,420   6,340,840                
Max K. Brodén  2/13/2020            9,341   18,681   37,362      978,137 
   N/A   280,000   560,000   1,120,000                 
Frederick J. Crawford  2/13/2020            19,658   39,316   78,632      2,058,586 
   N/A   825,000   1,650,000   3,300,000                
Eric M. Kirsch  2/13/2020            12,391   24,781   49,562      1,297,533 
   N/A   650,000   1,300,000   2,600,000                
Audrey Boone Tillman  2/13/2020            16,680   33,359   66,718      1,746,677 
   N/A   420,000   840,000   1,680,000                

(1)The amounts shown in Estimated Possible Payouts Under Non-Equity Incentive Plan Awards reflect the payout levels for the NEOs under the Company’s MIP, based on the potential achievement of certain performance goals approved by the Compensation Committee on March 2, 2020. For additional information, please see “Elements of Our Executive Compensation Program—Management Incentive Plan” beginning on page 40. For each Company performance goal, a minimum, target, and maximum performance level is specified. The amount paid for each performance goal depends on the results attained.
(2)The amounts shown under Estimated Future Payouts Under Equity Incentive Plan Awards for February 13, 2020 reflect the number of shares of PBRS. Those shares incorporate restrictions that will lapse upon the attainment of performance goals set by the Compensation Committee. Awards vest on the third anniversary of the grant date, based on the attainment of the cumulative three-year average target performance goals for Company AROE and the RBC and SMR ratios. For the cumulative three-year average performance period from 2020 to 2022, shares of PBRS will vest at 50% of target if the Company attains the minimum goals and at 200% if the Company reaches or exceeds the maximum goals. Earned amounts may then be modified based on the Company’s TSR performance versus peers. All NEOs possess the same rights as all other holders of Common Stock in respect of the shares underlying the PBRS, including all incidents of ownership (except the right to transfer the shares while they remain subject to forfeiture) and the right to vote such shares. The dividends accrued on the PBRS will be reinvested in Common Stock at the same dividend rate received by other holders of Common Stock. Those additional restricted shares will be held in book entry form in the custody of the Company subject to the same terms and conditions attributable to the original grant until such time as all restrictions have lapsed on the shares of Common Stock with respect to which the dividend was accrued.

52Aflac Incorporated
Estimated Possible Payouts
Under Non-Equity
Incentive Plan Awards
(1)
Estimated Future Payouts
Under Equity
Incentive Plan Awards
(2)
All Other
Stock Awards:
Number of
Shares of
Stock or
Units
(#)
Grant Date
Fair Value
of Stock and
Option Awards
($)
NameGrant
Date
Threshold
($)
Target
($)
Maximum
($)
Threshold
(#)
Target
(#)
Maximum
(#)
Daniel P. Amos2/9/2023— — — 71,703 143,405 286,810 — 10,270,666 
N/A1,801,375 3,602,750 7,205,500 — — — — — 
Max K. Brodén2/9/2023— — — 13,465 26,929 53,858 — 1,928,655 
2/9/2023— — — — — — 7,181 500,013 
N/A656,250 1,312,500 2,625,000 — — — — — 
Frederick J. Crawford2/9/2023— — — 21,489 42,978 85,956 — 3,078,084 
N/A997,500 1,995,000 3,990,000 — — — — — 
Bradley E. Dyslin2/9/2023— — — 7,856 15,712 31,424 — 1,125,293 
N/A625,000 1,250,000 2,500,000 — — — — — 
Audrey Boone Tillman2/9/2023— — — 13,816 27,632 55,264 — 1,979,004 
N/A444,000 888,000 1,776,000 — — — — — 
(1)The amounts shown in Estimated Possible Payouts Under Non-Equity Incentive Plan Awards reflect the payout levels for the NEOs under the Company’s MIP, based on the potential achievement of certain performance goals approved by the Compensation Committee on March 22, 2023. For additional information, please see “Elements of Our Executive Compensation Program—Management Incentive Plan” beginning on page 50. For each Company performance goal, a minimum, target, and maximum performance level is specified. The amount paid for each performance goal depends on the results attained.
(2)The amounts shown under Estimated Future Payouts Under Equity Incentive Plan Awards for February 9, 2023 reflect the number of shares of PBRS granted. Those shares incorporate restrictions that will lapse upon the attainment of performance goals set by the Compensation Committee. Awards vest on the third anniversary of the grant date, based on the attainment of the cumulative three-year average target performance goals for Company AROE and the RBC and SMR ratios. For the cumulative three-year average performance period from 2023 to 2025, shares of PBRS will vest at 50% of target if the Company attains the minimum goals and at 200% if the Company reaches or exceeds the maximum goals. Earned amounts may then be modified based on the Company’s TSR performance versus our peer group, but not in excess of the 200% vesting described above. All NEOs possess the same rights as all other holders of Common Stock in respect of the shares underlying the PBRS, including all incidents of ownership (except the right to transfer the shares while they remain subject to forfeiture) and the right to vote such shares. The dividends accrued on the PBRS will be reinvested in Common Stock at the same dividend rate received by other holders of Common Stock. Those additional restricted shares will be held in book entry form in the custody of the Company subject to the same terms and conditions attributable to the original grant until such time as all restrictions have lapsed on the shares of Common Stock with respect to which the dividend was accrued.


64AFLAC INCORPORATEDEXECUTIVE COMPENSATION

Table of Contents

Executive Compensation

20202023 Outstanding Equity Awards at Fiscal Year-End

The following table provides certain information with respect to the equity awards outstanding at the 20202023 fiscal year-end for the NEOs.

  Option Awards  Stock Awards 
                         Equity Incentive 
                         Plan Awards: 
                   Number of  Market  Number of  Market or 
                   Shares or  Value of  Unearned  Payout Value 
                   Units  Shares or  Shares, Units  of Unearned 
    Number of Securities           of Stock  Units of  or Other  Shares, Units 
    Underlying  Option     Stock  That Have  Stock That  Rights That  or Other Rights 
  Option Unexercised Options  Exercise  Option  Award  Not  Have Not  Have Not  That Have Not 
  Grant Exercisable  Unexercisable  Price  Expiration  Grant  Vested(1)  Vested(2)  Vested  Vested(2) 
Name Date (#)  (#)  ($)  Date  Date  (#)  ($)  (#)  ($) 
Daniel P.                    2/13/18           423,748(3)   18,844,074 
Amos                    2/14/19           347,169(4)   15,438,605 
                     2/13/20           332,690(5)   14,794,724 
Max K. Brodén 6/26/17  4,668       38.755   6/26/27                     
                     2/13/18           26,213(3)   1,165,692 
                     2/14/19           27,224(4)   1,210,651 
                     2/14/19   1,081   48,072         
                     2/13/20           38,415(5)   1,708,315 
Frederick J. 7/01/15  42,696       31.215   7/01/25                     
Crawford 2/09/16  45,068       28.965   2/09/26                     
                     2/13/18           90,496(3)   4,024,357 
                     8/14/18   68,499   3,046,151         
                     2/14/19           78,324(4)   3,483,068 
                     11/12/19   22,977   1,021,787         
                     2/13/20           80,848(5)   3,595,311 
Eric M. Kirsch 2/09/16  38,230       28.965   2/09/26                     
                     2/13/18           59,298(3)   2,636,982 
                     12/11/18   24,627   1,095,163         
                     2/14/19           56,176(4)   2,498,147 
                     2/13/20           50,959(5)   2,266,147 
Audrey Boone 2/14/12  13,900       24.280   2/14/22                     
Tillman 2/12/13  13,900       24.750   2/12/23                     
  2/11/14  13,194       31.205   2/11/24                     
  8/12/14  3,086       29.665   8/12/24                     
  2/10/15  24,744       30.725   2/10/25                     
  2/09/16  19,314       28.965   2/09/26                     
                     2/13/18           67,905(3)   3,019,735 
                     2/14/19           58,770(4)   2,613,502 
                     2/13/20           68,598(5)   3,050,553 

(1)The RSU awards include accrued but unpaid dividend equivalents payable in additional RSUs calculated at the normal dividend rate and settled in shares of our Common Stock only upon distribution of the vested award.
(2)Based on the per share closing price of our Common Stock of $44.47 as of December 31, 2020.
(3)Represents PBRS granted in connection with the 2018-2020 performance cycle and vested on February 12, 2021, plus accrued dividends. Since our performance as of the end of the performance period exceeded the target performance measures, these awards are shown at maximum (200% of target), plus accrued dividends. These awards vested at 155.9% of target, plus accrued dividends, based on the actual performance certified by the Compensation Committee on February 11, 2021.
(4)Represents PBRS granted in connection with the 2019-2021 performance cycle. Since our performance as of the end of the last fiscal for this performance cycle exceeded the target performance measures, these awards are shown at maximum (200% of target), plus accrued dividends. However, the amount, if any, of these awards that will be paid out will depend upon the actual performance over the full performance period and the Compensation Committee’s certification of the performance after completion of the performance cycle, which should occur in the first quarter of 2022.
(5)Represents PBRS granted in connection with the 2020-2022 performance cycle. Since our performance as of the end of the last fiscal for this performance cycle exceeded the target performance measures, these awards are shown at maximum (200% of target), plus accrued dividends. However, the amount, if any, of these awards that will be paid out will depend upon the actual performance over the full performance period and the Compensation Committee’s certification of the performance after completion of the performance cycle, which should occur in the first quarter of 2023.

2021 Proxy Statement53
Option AwardsStock Awards
Equity Incentive Plan Awards:
Option
Grant
Date
Number of Securities
Underlying Unexercised
Options
Option
Exercise
Price
($)
Option
Expiration
Date
Stock
Award
Grant Date
Number
of Shares
or Units of
Stock That
Have Not
Vested
(#)
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
(2)
($)
Number of
Unearned
Shares, Units
or Other
Rights
That Have
Not Vested
(#)
Market or
Payout
Value of
Unearned
Shares, Units
or Other Rights
That Have Not
Vested
(2) ($)
NameExercisable
(#)
Unexercisable
(#)
Daniel P. Amos2/11/21401,671 (3)33,137,858 
2/10/22288,922 (4)23,836,065 
2/09/23293,557 (5)24,218,453 
Max K. Brodén6/26/174,668 38.755 6/26/27
2/11/2156,907 (3)4,694,828 
2/10/2252,481 (4)4,329,683 
2/09/2355,125 (5)4,547,813 
4/29/2119,712 (1)1,626,240 
2/09/237,350 (1)606,375 
Frederick J. Crawford2/11/2194,654 (3)7,808,955 
2/10/2291,314 (4)7,533,405 
2/9/2387,978 (5)7,258,185 
Bradley E. Dyslin2/11/213,442 (1)283,965 
3/25/2110,450 (1)862,125 
2/10/2214,419 (6)1,189,568 
2/09/2332,163 (5)2,653,448 
Audrey Boone
Tillman
2/11/1413,194 31.205 2/11/24
8/12/143,086 29.665 8/12/24
2/10/1524,744 30.725 2/10/25
2/09/1619,314 28.965 2/09/26
2/11/2180,314 (3)6,625,905 
2/10/2261,645 (4)5,085,713 
2/09/2356,564 (5)4,666,530 
(1)The time-based RSU awards include accrued but unpaid dividend equivalents payable in additional RSUs calculated at the normal dividend rate and settled in shares of our Common Stock only upon distribution of the vested award.
(2)Based on the per share closing price of our Common Stock of $82.50 on December 29, 2023.
(3)Represents PBRS granted in connection with the 2021-2023 performance cycle and vested on February 11, 2024, plus accrued dividends. These awards vested at 200% of target, plus accrued dividends, based on the actual performance certified by the Compensation Committee on February 15, 2024.
(4)Represents PBRS granted in connection with the 2022-2024 performance cycle. Since our performance as of the end of 2023 exceeded the target performance measures, these awards are shown at maximum (200% of target), plus accrued dividends. However, the amount, if any, of these awards that will be paid out will depend upon the actual performance over the full performance period and the Compensation Committee’s certification of the performance after completion of the performance cycle, which should occur in the first quarter of 2025.
(5)Represents PBRS granted in connection with the 2023-2025 performance cycle. Since our performance as of the end 2023 exceeded the target performance measures, these awards are shown at maximum (200% of target), plus accrued dividends. However, the amount, if any, of these awards that will be paid out will depend upon the actual performance over the full performance period and the Compensation Committee’s certification of the performance after completion of the performance cycle, which should occur in the first quarter of 2026.
(6)Represents PBRSU granted in connection with the 2022-2024 performance cycle. Since our performance as of the end 2023 exceeded the target performance measures, these awards are shown at maximum (150% of target), plus accrued dividends. However, the amount, if any, of these awards that will be paid out will depend upon the actual performance over the full performance period and the Compensation Committee’s certification of the performance after completion of the performance cycle, which should occur in the first quarter of 2025.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT65

Table of Contents

Executive Compensation

Stock Award
Grant Date
Stock Award Vesting Schedule
02/13/18,11/21, 02/14/1910/22 and 02/13/2009/23Cliff vesting on the third anniversary of the grant date based on the attainment of the cumulative three-year average target
performance goals for AROE, SMR, and RBC for three consecutive calendar years beginning with the year of grant. For the
three-year period, stock will vest at 50% if the threshold of the three ratios is achieved, and 200% if the maximum is attained.
Earned amounts can then be modified based on the Company’s TSR performance versus peersour peer group (maximum payout up to 200%).
08/14/18, 12/02/11/1821For the RSU grant, vesting ratably on the first, second and 11/12/19third anniversaries of the grant date.
03/25/21 and 04/29/21Cliff vesting on the third anniversary of the grant date.
02/14/1909/23For the restricted stock unitRSU grant, cliff vesting on the third anniversary of the grant date; an additional vesting condition requiring regulatory approval for the Japan Post Holdings alliance was achieved.date.

2020

2023 Option Exercises and Stock Vested

The following table provides information with respect to options exercised and stock awards vested during 20202023 for each of the NEOs.

  Option Awards  Stock Awards 
  Number of     Number of    
  Shares Acquired  Value Realized  Shares Acquired  Value Realized 
  on Exercise  on Exercise  on Vesting  on Vesting 
Name (#)  ($)  (#)  ($) 
Daniel P. Amos          505,046   26,671,464 
Max K. Brodén          1,430   49,600 
Frederick J. Crawford          131,596   6,520,220 
Eric M. Kirsch          71,418   3,771,599 
Audrey Boone Tillman  3,454   56,215   59,659   3,007,503 

NameOption AwardsStock Awards
Number of
Shares
Acquired
on Exercise
(#)
Value
Realized
on Exercise
($)
Number of
Shares
Acquired
on Vesting
(#)
Value
Realized
on Vesting
($)
Daniel P. Amos274,713 19,507,370 
Max K. Brodén31,721 2,252,508 
Frederick J. Crawford87,764 3,373,233 66,759 4,740,557 
Bradley E. Dyslin6,453 454,427 
Audrey Boone Tillman56,644 4,022,290 
Pension Benefits

The Company maintains a tax-qualified, noncontributory defined benefit pension plan that covercovers the NEOs other than Messrs. Brodén and Crawford, and nonqualified supplemental retirement plans covering the NEOs other than Messrs. Brodén, Crawford and Kirsch.Dyslin. All of these plans were frozen before Messrs. Brodén and Crawford joined the Company.

In June 2023, the Company amended the U.S. defined benefit plan to freeze future benefits under the plan for all participants effective January 1, 2024.

The Company does not credit extra years of service under any of its retirement plans, unless required by employment agreements upon certain termination events. Mr. Amos is eligible to receive immediate retirement benefits, which fall under the provisions of the U.S. tax-qualified plan and the Retirement Plan for Senior Officers. For Mr. Kirsch,Dyslin, retirement benefits fall under the U.S. tax-qualified plan. Mrs. Tillman is eligible to receive immediate retirement benefits, which fall under the provisions of the U.S. tax-qualified plan and the U.S. Supplemental Executive Retirement Plan.

Qualified Defined Benefit Pension Plan

The Aflac Incorporated Defined Benefit Pension Plan (“Plan”) is a funded tax-qualified retirement program that covers all eligible U.S.-based employees. Benefits under the Plan are calculated in accordance with the following formula:

1% of average
final
monthly

compensation
x×years of credited

service up to

25 years
++0.5% of average
final
monthly

compensation
x×years of credited
service
in excess of

25 years

54Aflac Incorporated

Table of Contents

Executive Compensation

For purposes of the Plan, final average monthly compensation is the participant’s highest average compensation (salary and non-equity incentive plan compensation) during any five consecutive years of service within the ten consecutive plan years of service immediately preceding retirement. Participants are eligible to receive full retirement benefits upon attaining a retirement age of 65 or, if earlier, when their years of credited service plus age equals or exceeds 80. Participants with at least fifteen years of credited service are eligible to receive reduced retirement benefits upon reaching an early retirement age of 55. The Plan was frozen to new employees hired, or former employees rehired, on or after October 1, 2013.

In June 2023, the Company amended the U.S. defined benefit plan to freeze future benefits under the plan for all participants effective January 1, 2024.

Benefits payable under the Plan are not subject to adjustment for Social Security benefits or other offsets. The benefits are paid monthly over the life of the participant, with joint and survivor options available at actuarially reduced rates. The maximum annual retirement benefit was limited, in accordance with Section 415 of the Internal Revenue Code, to $230,000$265,000 for 2020.2023. The maximum annual compensation that may be taken into account when calculating retirement benefits was limited, in accordance with Section 401(a)(17) of the Internal Revenue Code, to $285,000$330,000 for 2020.2023. The limitation amounts for future years will be indexed for cost-of-livingcost-of-living adjustments.



66AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Executive Retirement Plan

The Company’s U.S. Supplemental Executive Retirement Plan (“SERP”) is an unfunded and unsecured obligation of the Company and is not a tax-qualified plan. The SERP provides retirement benefits to certain officers of the Company in addition to those provided by the qualified Plan. Participation in the SERP is limited to certain key employees as periodically designated by the Compensation Committee. Currently, Mrs. Tillman is the only NEO who participates in the SERP. To be eligible for benefits under the SERP, participants generally must be employed with the Company or a subsidiary at age 55. The SERP was frozen to new participants effective January 1, 2015.

2015 and additional accruals were frozen as of December 31, 2023, provided that actively employed participants may continue to accrue service toward eligibility for early retirement benefits or delayed early retirement benefits.

The SERP includes a four-tiered benefit formula that provides for a benefit based on final three-year average compensation (base salary and non-equity incentive plan compensation) earned for a calendar year as described below. The annual benefit varies based on the participant’s age at retirement: 40% is paid to someone who retires between the ages of 55 and 59, 50% is paid to someone who retires between the ages of 60 and 64, and 60% is paid to someone who retires at or after the age of 65. Mrs. Tillman has met the SERP retirement benefit level of 40%. A reduced 30% benefit is available to participants with at least fifteen years of service who terminate employment prior to age 55.

Benefits generally are payable in the form of an annuity for the life of the participant. The participant may elect to receive reduced lifetime benefits, in which case any surviving spouse will receive a benefit equal to 50% of the amount paid to the participant. Benefits are calculated based upon the average annual compensation for the three consecutive calendar years out of the final ten consecutive calendar years of employment that yield the highest average. Benefits under the SERP are subject to offset for amounts paid under the qualified Plan.

Retirement Plan for Senior Officers

The CEO is the only active employee who participates in the Retirement Plan for Senior Officers (“RPSO”)., which is an unfunded and unsecured obligation of the Company and is not a tax-qualified plan. Participants in the RPSO receive full compensation (base salary and MIP) for the first twelve months after retirement. Thereafter, a participant may elect to receive annual lifetime retirement benefits equal to 60% of final compensation (base salary plus non-equity incentive), or 54% of final compensation with 50% of final compensation to be paid to a surviving spouse for a specified period after death of the participant. Final compensation is deemed to be the higher of either (i) the compensation paid during the last twelve months of active employment with the Company, or (ii) the highest compensation received in any calendar year of the last ten years preceding the date of retirement.

Generally, no benefits are payable until the participant accumulates ten years of credited service at age 60, or twenty years of credited service. Reduced benefits may be paid to a participant who retires (other than for disability) before age 65 with less than twenty years of credited service. Mr. Amos has 4750 years of credited service, meaning he is fully vested for retirement benefits under the RPSO. The RPSO was frozen to new participants on January 1, 2009.

2009 and additional accruals were frozen as of December 31, 2023.

All benefits under the RPSO are subject to annual cost-of-living increases as approved by the Compensation Committee. Retired participants and their spouses also are entitled to receive full medical expense benefits for their lifetimes. The benefits payable under the RPSO are not subject to Social Security or qualified Plan offsets.

2021 Proxy Statement55

Table of Contents

Executive Compensation

20202023 Pension Benefits

The following table provides certain information regarding the Company’s pension benefits at December 31, 20202023 and for the year then ended.

Name Plan Name Number of Years
Credited Service
(#)
 Present Value
of Accumulated
Benefit*
($)
 Change from
Prior Year
($)
 Payments During
Last Fiscal Year
($)
Daniel P. Amos Retirement Plan for Senior Officers 47 59,682,833 8,360,659 
  Aflac Incorporated Defined Benefit Pension Plan 47 1,873,910 153,928 
Eric M. Kirsch Aflac Incorporated Defined Benefit Pension Plan 9 348,028 64,131 
Audrey Boone Tillman Supplemental Executive Retirement Plan 25 11,745,399 1,739,319 
  Aflac Incorporated Defined Benefit Pension Plan 25 1,365,297 170,810 

NamePlan NameNumber of Years
Credited Service
(#)
Present Value
of Accumulated
Benefit*
($)
Change from
Prior Year
($)
Payments During
Last Fiscal Year
($)
Daniel P. AmosRetirement Plan for Senior Officers50 47,873,711 2,474,253 — 
Aflac Incorporated Defined Benefit Pension Plan50 2,106,695 246,012 — 
Bradley E. DyslinAflac Incorporated Defined Benefit Pension Plan12 287,170 49,952 — 
Audrey Boone TillmanSupplemental Executive Retirement Plan28 10,614,845 2,452,488 — 
Aflac Incorporated Defined Benefit Pension Plan28 1,084,460 57,132 — 
*    Assumptions used to calculate pension benefits are based on GAAP assumptions, as more fully described in Note 14, “Benefit Plans,” in the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2023, except that, for all NEOs other than Mr. Amos, the assumed retirement age is the earliest retirement age for unreduced benefits and, for Mr. Amos, who has exceeded such age, is his actual expected retirement age as determined for GAAP purposes.


*
EXECUTIVE COMPENSATIONAssumptions used to calculate pension benefits are based on GAAP assumptions, as more fully described in Note 14, “Benefit Plans,” in the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2020, except that, for all NEOs other than Mr. Amos, the assumed retirement age is the earliest retirement age for unreduced benefits and, for Mr. Amos, who has exceeded such age, is his actual expected retirement age as determined for GAAP purposes.2024 PROXY STATEMENT67

Nonqualified Deferred Compensation

The following table provides information on the NEOs’ participation in the Aflac Incorporated Executive Deferred Compensation Plan (“EDCP”).

2020

2023 Nonqualified Deferred Compensation

Name Executive
Contributions in
Last Fiscal Year
($)
 Registrant
Contributions in
Last Fiscal Year
($)
 Aggregate
Earnings (Loss) in
Last Fiscal Year(3)
($)
 Aggregate
Withdrawals/
Distributions
($)
 Aggregate
Balance at Last
Fiscal Year-End(4)
($)
Daniel P. Amos(1)  441,100 1,933,612  12,565,798
Max K. Brodén(2)  177,101 135,689  579,124
Frederick J. Crawford(2)  394,911 205,632  2,014,785
Eric M. Kirsch     
Audrey Boone Tillman 42,000  126,014  1,670,394

(1)The Company contribution of $441,100, which is a portion of Mr. Amos’ salary, is compensation deferred at the direction of the Compensation Committee and is included in the Salary column of the Summary Compensation Table for the current year. The funds are 100% vested.
(2)The $177,101 and $394,911 deferred compensation for Messrs. Brodén and Crawford, respectively, represents unvested Company-funded executive employer contributions in the amount of 15% of their annual compensation (base salary plus MIP). The funds for 2020 were credited to the EDCP in March 2021. This is an annual contribution approved by the Compensation Committee since Messrs. Brodén and Crawford are not eligible to participate in the Pension Plan or any other executive retirement plan. Annual contributions will be 100% vested on the earlier of (i) the later of 15 years of employment or 5 years participation, (ii) age 65, (iii) change in control, (iv) death, or (v) disability. The amount shown in the table is included in the Summary Compensation Table for the current year in the All Other Compensation column. Additionally, previous years’ deferrals included in the Aggregate Balance column were reported as compensation in prior periods.
(3)The Company does not pay or credit above-market earnings on amounts deferred by or on behalf of executives.
(4)The amounts reported represent balances from the EDCP and include various amounts previously reported in the Summary Compensation Table as Salary, Non-equity Incentive Plan Compensation or All Other Compensation.

NameExecutive
Contributions
in Last Fiscal Year
($)
Registrant
Contributions
in Last Fiscal Year
($)
Aggregate
Earnings (Loss)
in Last Fiscal Year
(3)
($)
Aggregate
Withdrawals/
Distributions
(4)
($)
Aggregate
Balance at Last
Fiscal Year-End
(5)
($)
Daniel P. Amos(1)
— 441,100 2,485,400 — 15,420,305 
Max K. Brodén(2)
886,924 423,840 459,846 — 3,150,908 
Frederick J. Crawford(2)
— 622,608 185,996 — 3,796,177 
Bradley E. Dyslin(2)
— 408,767 771,921 (185,298)4,752,644 
Audrey Boone Tillman44,400 — 443,358 — 2,529,880 
(1)The Company contribution of $441,100, which is a portion of Mr. Amos’ salary, is compensation deferred at the direction of the Compensation Committee and is included in the Salary column of the Summary Compensation Table for the current year. The funds are 100% vested.
(2)The $423,840, $622,608 and $408,767 deferred compensation for Messrs. Brodén, Crawford, and Dyslin, respectively, represents unvested Company-funded contributions in the amount of 15% of their annual compensation (base salary plus MIP). The funds for 2023 were credited to the EDCP in March 2024. This is an annual contribution approved by the Compensation Committee since Messrs. Brodén, Crawford and Dyslin are not eligible to participate in the Company’s executive retirement plans. Annual contributions will be 100% vested on the earlier of (i) the later of 15 years of employment or 5 years participation, (ii) age 65, (iii) change in control, (iv) death, or (v) disability. The amount shown in the table is included in the Summary Compensation Table for the current year in the All Other Compensation column. Additionally, previous years’ deferrals included in the Aggregate Balance column were reported as compensation in prior periods. Pursuant to the terms of the LOA entered into with Mr. Crawford on October 30, 2023, Mr. Crawford’s EDCP will become fully vested upon his retirement on September 30, 2024. For more information regarding the employment letter of agreement, see “Employment Agreements” on page 58.
(3)The Company does not pay or credit above-market earnings on amounts deferred by or on behalf of executives.
(4)Distributions for Mr. Dyslin were made in accordance with his elections under the EDCP on amounts deferred from his compensation.
(5)The amounts reported represent balances from the EDCP and include various amounts previously reported in the Summary Compensation Table as Salary, Non-equity Incentive Plan Compensation or All Other Compensation.
The EDCP allows certain U.S.-based officers, including the NEOs (the “Participants”), to defer up to 75% of their base salaries and their annual non-equity incentive awards. The Company may make discretionary matching or other discretionary contributions in such amounts, if any, that the Compensation Committee may determine each year.

56Aflac Incorporated

TablePortions of Contents

Executive Compensation

Thethe EDCP isare subject to the requirements of Section 409A of the Internal Revenue Code.Code (“Section 409A”) with respect to deferred amounts that became earned and vested on or after January 1, 2005. Deferred amounts earned and vested prior to 2005 (“grandfathered” amounts) under the EDCP are not subject to Section 409A’s requirements and continue to be governed generally under the terms of the EDCP and the tax laws in effect before January 1, 2005. All NEOs have met the applicable vesting requirements with the exception of Messrs. Brodén, Crawford and Crawford.

Dyslin.

The amounts in the Aggregate Balance at Last Fiscal Year-End column include investment earnings (and losses) determined under phantom investments. Account balances may be invested in phantom investments selected by Participants from an array of investment options that substantially mirror the funds available under the Company’s 401(k) Plan, except for Common Stock. Participants can change their investment selections (unless prohibited by the fund) in the same manner that applies to participants in the 401(k) Plan.

Each year, when Participants elect whether to defer compensation under the EDCP for the following year, they also elect the timing and form of future distributions arising from those deferrals, with a separate election permitted for each type of deferral (i.e., salary and non-equity incentive award). Specifically, a Participant may elect distributions beginning in a specific year (even if employment has not then ended) or beginning six months after the termination of employment. Participants may choose to have any distribution made in a lump sum or in up to ten annual installments. Employee deferrals are 100% vested. Distributions attributable to discretionary contributions are made in the form and at the time specified by the Company.

A Participant may delay the timing and form of distributions attributable to deferrals as long as the change is made at least twelve months before the initial distribution date. With respect to non-grandfathered amounts, new elections also must satisfy the additional requirements of Section 409A. In general, Section 409A provides that distributions may not be accelerated (other than for hardships) and any delayed distribution may not begin earlier than five years after the original distribution date.

Deferral amounts for which no distribution elections have been made are distributed in a lump sum six months after a Participant separates from service.



68AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Potential Payments Upon Termination or Change in Control

The Company has employment agreements with each of the NEOs with the exception of Mr. Brodén.Dyslin, who is the only NEO participant in the Company’s Executive Officer Severance Plan. Except as described below, the employment agreements are similar in nature and contain provisions relating to termination, disability, death, and a change in control of the Company.

Mr. Amos has voluntarily waived all “golden parachute” and other severance components in his employment agreement. The elimination and absence, respectively, of these potential payments are reflected in the 20202023 Potential Payments Upon Termination or Change in Control table.

For each remaining NEO (other than Mr. Brodén)Dyslin), the Company remains obligated to continue compensation and benefits for the scheduled term of the agreement if the NEO’s employment is terminated by the Company without “good cause” or by the NEO with “good reason.” The remaining term for each of these NEOs as of December 31, 20202023 is as follows: Mr. Brodén, 28 months, Mr. Crawford, 30 months; Mr. Kirsch, 244 months; and Mrs. Tillman, 29 1/3 months. In addition, upon a termination by the Company without “good cause” or by any of the NEOs (including Mr. Amos) for “good reason,” all outstanding equity awards become fully vested, except that equity awards of the NEOs subject to Company performance will remain subject to that performance. Mrs. Tillman will not be entitled to continued compensation once she earns the maximum benefit under the SERP, but she has not yet earned the maximum SERP benefit. Messrs. Brodén, Crawford, and Kirsch do not participate in the SERP.

If an NEO’s employment is terminated by the Company for “good cause,” or by the NEO without “good reason,” the Company generally is obligated to pay compensation and benefits only to the extent accrued by the date of termination. Under the employment agreements of the NEOs (other than Mr. Brodén)Dyslin), “good cause” generally means the Company has determined that any of the following have occurred or exist: (i) the willful failure by the NEO to substantially perform assigned management duties (other than due to sickness, injury, or disability); (ii) intentional conduct by the NEO causing substantial injury to the Company; or (iii) the NEO’s conviction of or plea of guilty to a felony. “Good reason” (except in the case of Mr. Brodén)Dyslin) unrelated to a change in control generally is defined to include (i) a material breachreduction in the NEO’s base salary or bonus opportunity, which is not made for all similarly situated executives; (ii) a termination of the employment agreement other than as permitted by the Company in regard to compensationits terms; or benefits, or termination of the employment agreement; (ii) a material diminution or change in the NEO’s title, duties, or authority; (iii) a material relocation of the Company’s principal offices (or in Mr. Kirsch’s case, the Company’s principal New York office or his own office; or (iv) the failure of the Company’s successor to assume the employment agreement.offices. Upon voluntary termination without “good reason” or termination by the Company for “good cause,” an NEO (other than Mr. Brodén)Dyslin) is prohibited for a two-year period from directly or indirectly competing with the Company.

2021 Proxy Statement57

Table of Contents

Executive Compensation

The NEOs’ employment agreements provide that compensation and benefits continue for certain specified periods in the event the NEO becomes totally disabled. Upon the death of an NEO, the NEO’s estate is to be paid an amount, over a three-year period, equal to the NEO’s base salary and any non-equity incentive awards actually paid during the last three years of the NEO’s life. In addition, all outstanding equity awards will be honored and vest upon the date of death or disability.

Upon a “change in control” of the Company, employment agreements for the NEOs (other than Messrs. Amos and Brodén)Dyslin) are extended for an additional three-year period.period beginning with the month in which the change in control occurs. If, following a “change in control,” the employment of an NEO (other than Messrs. Amos and Brodén)Dyslin) is terminated by the Company without “good cause” or by the NEO for “good reason,” the Company must pay to the NEO, among other payments but in lieu of any further salary payments, a lump-sum severance payment equal to three times the sum of the NEO’s base salary and non-equity incentive award under the MIP (as paid during periods specified in the agreement). “Good reason” for the 24-month period immediately following a change in control generally is defined to include (i) a material breach of the employment agreement by the Company in regard to compensation or benefits, or termination of the employment agreement; (ii) a material diminution or change in the NEO’s title, duties, or authority; (iii) a material relocation of the Company’s principal offices; or (iv) the failure of the Company’s successor to assume the employment agreement. Amounts payable upon a “change in control” will be reduced to the extent they are not deductible by the Company for income tax purposes. If, following a “change in control,” the employment of an NEO is terminated by the Company without “good cause” or by the NEO for “good reason,” all of that NEO’s outstanding equity awards (except in the case of Messrs. Amos and Brodén)Dyslin) will become fully vested, and all performance criteria will be considered satisfied at the maximum performance level.

A “change in control” generally is deemed to occur when (i) a person or group acquires ownership of 50% or more of the Common Stock; (ii) a person or group acquires ownership of 30% or more of the Common Stock over a consecutive twelve-month period; (iii) during any period of twelve consecutive months, a majority of individuals who constitute the Board are replaced without endorsement by a majority of the Board members at the beginning of the period; or (iv) a person or group acquires ownership of 40% or more of the total gross fair market value of the Company’s assets.



EXECUTIVE COMPENSATION2024 PROXY STATEMENT69
Mrs. Tillman is a fully vested participant in the SERP and is the only NEO in the SERP. Under the SERP, in the event the Company terminates a participant’s employment within two years after a “change in control” other than for cause,“Cause,” or a participant terminates employment during such period for “good reason,” the participant will become 100% vested in her retirement benefits and entitled to receive a lump-sum amount equal to the actuarial equivalent of the annual retirement benefit to which she would have been entitled had she remained in the employ of the Company until (i) age 55 (in the case of a participant who is not yet 55); (ii) age 60 (in the case of a participant who is at least 55, but not yet 60); or (iii) age 65 (in the case of a participant who is at least 60, but not yet 65), as the case may be. A “change in control” will be deemed to occur under the same circumstances described above, but only with respect to the Company. “Cause” for this purpose generally means (i) the participant’s continued failure to substantially perform her duties with the Company (other than due to illness or after a participant gives notice of termination of employment for “good reason”) after a written demand for substantial performance is delivered to the participant by the Board, (ii) the participant’s engaging in conduct materially injurious to the Company, or (iii) the participant’s conviction of, or plea of guilty or no contest to, a felony or crime involving moral turpitude. “Good reason” is generally defined for this purpose to include various adverse changes in employment status, duties, or compensation and benefits following a “change in control.”

Mr. Dyslin is a participant of the Company’s Executive Officer Severance Plan. Under this executive severance plan, Mr. Dyslin will incur an eligible termination, and therefore will be eligible to receive benefits under the executive severance plan, if he incurs a separation from service, because (i) his employment is involuntarily terminated by the Company for any reason other than “Cause” or disability; or (ii) he terminates his employment due to “Good Reason.” Upon Mr. Dyslin’s eligible termination that occurs outside of the 24-month period immediately following a Change in Control, he will receive an amount equal to 150% of the total of (i) his base salary, and (ii) the dollar amount of his annual MIP bonus for the year in which his termination date occurs with performance deemed at target, plus a cash payment equal to the product of (i)the dollar amount of his annual performance bonus for the year in which his termination date occurs based on his performance at target and on the actual performance of the Company for the year in which his termination date occurs and (ii) a fraction, the numerator of which is the number of days during the annual performance period for such bonus through and including his termination date, and the denominator of which is 365. He will also be eligible to receive a cash amount equal to the COBRA continuation coverage premiums that would be payable by him for the first 18 months of the COBRA continuation period, determined as if (i) he were to elect COBRA continuation coverage for himself and his spouse and dependents, to the extent such individuals were covered under the Aflac group medical, dental and/or vision coverage as of his termination date, and (ii) the cost of such COBRA coverage is measured as of his termination date assuming such cost remains constant during such 18-month period. “Cause” unrelated to a Change in Control generally means (i) confession to, pleas of nolo contendere to, or conviction of, a felony or other crime involving dishonesty; (ii) certification of materially inaccurate financial or other information pertaining to the Company with actual knowledge of such inaccuracies; (iii) material violation of the Company’s policies, the directions of the Board or CEO, or any agreement relating to the restrictive covenants; (iv) habitual and material negligence in the performance of duties; and (v) material non-compliance with obligations to devote all working time to the Company’s business (other than approved vacations and other time off); (vi) willful or deliberate misconduct or fraud in the performance of duties for the Company that substantially injures or damages the Company; or (vii) willful or deliberate failure to substantially perform duties, except due to sickness, injury or disability. “Good Reason” unrelated to a Change in Control generally is defined to include (i) a material reduction in the executive’s base salary or bonus opportunity; or (ii) a relocation beyond 25 miles from the participants current office location.
Upon an executive’s eligible termination that occurs on or within the 24-month period immediately following a Change in Control, he will receive an amount equal to 300% of the total of (i) his Base Salary as of his termination date, and (ii) the dollar amount of MIP Bonus for the year in which his termination date occurs with performance deemed to be at target, plus an amount equal to the product of (i) the dollar amount of his annual performance bonus for the year in which his termination date occurs with his and the Company’s performance deemed to be at target, and (ii) a fraction, the numerator of which is the number of days during the annual performance period for the bonus through and including his termination date, and the denominator of which is 365. All of his shares of unvested time-based equity awards will vest upon his termination date. All of his shares of unvested performance-based equity awards will vest as of his termination date with such number determined based on the assumptions that his and the Company’s performance under such awards are achieved at target on his termination date. All of his unvested time-based restricted stock units issued under the LTIP will vest upon his termination date. All of his unvested performance-based stock units will vest as of his termination date with such number determined based on the assumptions that his and the Company’s performance under such awards are achieved at target on his termination date. He will also be eligible to receive a cash amount equal to the COBRA continuation coverage premiums that would be payable by him for the first 36 months of the COBRA continuation period, determined as if (i) he were to elect COBRA continuation coverage for himself and his spouse and dependents, to the extent such individuals were covered under the Aflac group medical, dental and/or vision coverage as of his termination date, (ii) COBRA could extend for 36 months, and (iii) the cost of such COBRA coverage is measured as of his termination date assuming such cost remains constant during such 36-month period. Amounts payable upon a Change in Control will be reduced to the extent they are not deductible by the Company for income tax purposes, provided, the after-tax value of such reduced amount is greater than the full amount of his severance payments after reduction for all taxes (including excise taxes). “Cause” related to a Change in Control generally means (i) confession to, pleas of nolo contendere to, or conviction of, a felony or other crime involving dishonesty; (ii) willful or deliberate misconduct or fraud in the performance of duties for


70AFLAC INCORPORATEDEXECUTIVE COMPENSATION
the Company that substantially injures or damages the Company; or (iii) willful or deliberate failure to substantially perform executive’s duties, except due to sickness, injury or disability. “Good Reason” related to a Change in Control generally is defined to include (i) a material reduction in the executive’s base salary or bonus or equity award opportunity; (ii) a material diminution in the executive’s authority, duties and responsibilities, (iii) the assignment of duties and responsibilities significantly inconsistent with those the executive had immediately before a Change in Control, (iv) a material diminution of the authority or responsibilities of the executive’s supervisor, (v) a material diminution in the executive’s budget, (vi) a relocation beyond 25 miles from the participants current office location, or (vii) failure to maintain the severance plan unchanged. For purposes of the severance plan, “Change in Control” generally is deemed to occur when (i) a person or group acquires ownership of 50% or more of the Common Stock; (ii) a person or group acquires ownership of 50% or more of the Common Stock over a consecutive twelve-month period; (iii) during any period of twelve consecutive months, a majority of individuals who constitute the Board are replaced without endorsement by a majority of the Board members at the beginning of the period; or (iv) a person or group acquires ownership of 60% or more of the total gross fair market value of the Company’s assets.
The following table reflects the amount of compensation payable to each of the NEOs in the event of termination of such executive’s employment under various termination scenarios. The amounts shown assume in all cases that the termination was effective on December 31, 2020,2023, and, therefore, include amounts earned through such time and estimates of the amounts that would be paid to the NEOs upon their termination. Because a number of factors affect the nature and amount of any benefits actually paid, amounts paid or distributed may be different from those shown below. Mr. Amos and Mrs. Tillman are the only NEOs who are eligible to receive immediate retirement benefits. See “Pension Benefits” and “Nonqualified Deferred Compensation” above for more information.

As noted in the following table, the benefits provided, and requirements imposed vary with the circumstances under which the termination occurs.

58Aflac Incorporated


EXECUTIVE COMPENSATION2024 PROXY STATEMENT71
2023 Potential Payments Upon Termination or Change in Control

Table

Before Change in Control
NameBenefit
Company
Termination
without “Good
Cause” or
by Employee
for “Good
Reason”
(1)
($)
Company
Termination
for “Good
Cause”
(2)
($)
Voluntary
Termination
without “Good
Reason” and No
Competition
(3)
($)
Voluntary
Termination with
Competition
(4)
($)
Death(5)
($)
Disability(6)
($)
Change
in Control
Termination
without “Good
Cause” or
for “Good
Reason”
(7)
($)
Daniel P.
Amos
Salary— — — — 4,323,300 2,161,650 — 
Non-equity Incentive Award(8)
— — — — 13,091,736 5,796,333 — 
Severance— — — — — — — 
Retirement(9)
47,873,711 47,873,711 47,873,711 — 25,375,913 47,893,511 47,873,711 
Health & Welfare Benefits(10)
1,595,073 1,595,073 1,595,073 — 89,946 1,622,712 1,595,073 
Equity Awards(11)
81,192,313 — 56,973,885 56,973,885 81,192,313 81,192,313 81,192,313 
Totals130,661,097 49,468,784 106,442,669 56,973,885 124,073,208 138,666,519 130,661,097 
Max K. BrodénSalary1,750,000 — — — 2,025,000 1,125,000 — 
Non-equity Incentive Award(8)
4,843,074 — — — 3,052,579 2,075,603 — 
Severance— — — — — — 8,476,809 
Retirement(9)
61,600 — — — 1,709,831 2,385,191 1,709,831 
Health & Welfare Benefits(10)
30,228 — — — — 19,432 38,864 
Equity Awards(11)
15,804,918 — — — 15,804,918 15,804,918 15,804,918 
Totals22,489,820 — — — 22,592,328 21,410,144 26,030,423 
Frederick J.
Crawford
Salary332,500 — — — 2,855,833 1,496,250 — 
Non-equity Incentive Award(8)
1,051,074 — — — 7,056,864 3,153,222 — 
Severance— — — — — — 12,452,166 
Retirement(9)
8,800 — — — 3,796,176 4,769,688 3,796,176 
Health & Welfare Benefits(10)
6,295 — — — — 28,326 56,651 
Equity Awards(11)
22,600,469 — 22,600,469 — 22,600,469 22,600,469 22,600,469 
Totals23,999,137 — 22,600,469 — 36,309,342 32,047,954 38,905,462 
Bradley E. DyslinSalary— — — — — — — 
Non-equity Incentive Award— — — — — — — 
Severance2,500,000 — — — — — 4,375,000 
Retirement— — — — 408,767 408,767 408,767 
Health & Welfare Benefits(10)
35,488 — — — — — 70,977 
Equity Awards(11)
2,119,766 — — — 3,265,853 3,265,853 3,265,853 
Totals4,655,254 — — — 3,674,620 3,674,620 8,120,597 
Audrey Boone
Tillman
Salary1,808,889 — — — 2,180,000 1,110,000 — 
Non-equity Incentive Award(8)
3,062,413 — — — 2,859,979 1,254,524 — 
Severance— — — — — — 5,983,572 
Retirement(9)
32,267 — 10,614,845 — 4,829,627 10,634,645 10,614,845 
Health & Welfare Benefits(10)
57,352 — — — — 35,193 70,387 
Equity Awards(11)
16,378,031 — 11,711,501 11,711,501 16,378,031 16,378,031 16,378,031 
Totals21,338,952 — 22,326,346 11,711,501 26,247,637 29,412,393 33,046,835 
(1)Messrs. Brodén and Crawford, and Mrs. Tillman are entitled to salary continuation and non-equity incentive award payments for the remaining term of Contents

Executive Compensation

2020 POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL

    Before Change in Control      
Name  Benefit Company
Termination
without “Good
Cause” or
by Employee
for “Good
Reason”(1)
($)
 Company
Termination
for “Good
Cause”(2)
($)
 Voluntary
Termination
without “Good
Reason” and No
Competition(3)
($)
 Voluntary
Termination with
Competition(4)
($)
 Death(5)
($)
 Disability(6)
($)
 Change
in Control
Termination
without “Good
Cause” or
for “Good
Reason”(7)
($)
Daniel P. Amos Salary     4,323,300  2,161,650  
  Non-equity     14,587,697 3,734,173 
  Incentive Award(8)              
  Severance       
  Retirement(9) 59,682,833 59,682,833 59,682,833  32,967,208 59,763,854 59,682,833
  Health & Welfare Benefits(10) 2,426,412 2,426,412 2,426,412  200,464 2,449,715 2,426,412
  Equity Awards(11) 49,077,359  34,282,635 34,282,635 49,077,359 49,077,359 49,077,359
  Totals 111,186,604 62,109,245 96,391,880 34,282,635  101,156,028  117,186,751 111,186,604
Max K. Brodén Salary       
  Non-equity Incentive Award(8)       
  Severance       
  Retirement(9)     411,456 411,456 
  Health & Welfare Benefits(10)       
  Equity Awards(11)     4,132,819 4,132,819 
  Totals     4,544,275 4,544,275 
Frederick J. Salary 2,062,500    2,275,000 1,237,500 
Crawford Non-equity Incentive Award(8) 4,519,345    4,140,500 1,807,738 
  Severance       5,789,943
  Retirement(9) 42,750    2,014,786 2,632,802 2,014,786
  Health & Welfare Benefits(10) 44,419     26,652 53,303
  Equity Awards(11) 15,170,674    15,170,674 15,170,674 15,170,674
  Totals 21,839,688    23,600,960 20,875,366 23,028,706
Eric M. Kirsch Salary 1,300,000    1,893,800 975,000 
  Non-equity Incentive Award(8) 4,438,800    6,652,524 2,219,400 
  Severance       8,825,985
  Retirement(9) 41,556     79,434 
  Health & Welfare Benefits(10) 29,561     22,171 44,341
  Equity Awards(11) 8,496,394    8,496,394 8,496,394 8,496,394
  Totals 14,306,311    17,042,718 11,792,399 17,366,720
Audrey Boone Salary 1,711,111    2,050,333 1,050,000 
Tillman Non-equity Incentive Award(8) 1,744,478    2,802,433 713,650 
  Severance       4,652,490
  Retirement(9) 22,800    5,138,359 11,803,095 12,886,227
  Health & Welfare Benefits(10) 43,433     26,652 53,304
  Equity Awards(11) 8,683,835  5,633,282 5,633,282 8,683,835 8,683,835 8,683,835
  Totals 12,205,657  5,633,282 5,633,282 18,674,960 22,277,232 26,275,856

(1)Messrs. Crawford and Kirsch and Mrs. Tillman are entitled to salary continuation and non-equity incentive award payments for the remaining term of their respective employment agreements. Mr. Amos voluntarily gave up his right to such payments. Health and welfare benefits would continue for the remainder of the contract term, except for Mr. Amos, who is entitled to health and welfare benefits under the RPSO.

2021 Proxy Statement59
their respective employment agreements. Mr. Amos voluntarily waived his right to such payments. Health and welfare benefits would continue for the remainder of the contract term, except for Mr. Amos, who is entitled to health and welfare benefits under the RPSO. Upon severance without a change in control, Mr. Dyslin would be entitled to an amount equal to 150% of the total of (i) his Base Salary, and (ii) the dollar amount of his annual MIP Bonus for the year in which his Termination Date occurs with performance deemed to be at target. Mr. Dyslin would also be entitled to a cash amount equal to the COBRA continuation coverage premiums that would be payable by him for the first 18 months of the COBRA continuation period.
(2)Termination for good cause eliminates the salary continuation and non-equity incentive award obligation for the remainder of the contract period and causes a forfeiture of the executive’s participation in any supplemental retirement plan (except for Mr. Amos).
(3)Voluntary termination by the executive without good reason eliminates the salary continuation and non-equity incentive award obligations for the remainder of the contract term. In addition, nonvested equity awards will be forfeited, except in the case of Mr. Amos and Mrs. Tillman, who are retirement-eligible under the terms of the Company’s equity agreements and will vest in all equity awards granted at least one year before the date his or her employment terminates (subject to satisfaction of performance goals). Mr. Crawford’s nonvested equity awards will remain outstanding upon voluntary termination by the executive without good reason according to his agreement dated October 30, 2023.


72AFLAC INCORPORATEDEXECUTIVE COMPENSATION
(4)Any executive who competes with the Company after termination will forfeit the right to any further salary and non-equity incentive award payments and any benefits under the RPSO. In addition, nonvested equity awards will be forfeited, except in the case of Mr. Amos and Mrs. Tillman, who are retirement-eligible under the terms of the Company’s equity agreements and will vest in all equity awards granted at least one year before the date his or her employment terminates (subject to satisfaction of performance goals).
(5)When an executive dies (other than Mr. Dyslin), the executive’s estate is entitled to receive terminal pay (paid in equal installments over 36 months) equal to the amount of the executive’s base pay and non-equity incentive award paid in the previous 36 months, or, if the executive was employed less than 36 months, the amount the executive would have been paid if he or she had survived for the full 36-month period. Additionally, retirement benefits in this column include the present value of the accumulated benefit obligation for a surviving spouse annuity under the RPSO for Mr. Amos. Messrs. Brodén, Crawford and Dyslin participate in the Company-funded EDCP, which will vest at death. The NEOs and other officers also are eligible for life insurance benefits along with, and on the same basis as, the Company’s other salaried employees.
(6)Disability benefits are payable for 18 months or, if shorter, until the end of the term of the applicable agreement, while the executive (other than Mr. Dyslin) remains employed during his/ her disability. For all NEOs, any disability benefits paid in the form of salary continuation or non-equity incentive awards (as shown in the table) would be offset by the maximum annual amount allowed ($144,000) under the Company-sponsored disability income plan. Messrs. Brodén, Crawford and Dyslin participate in the Company-funded EDCP, which would vest at disability.
(7)Upon termination after a change in control, Messrs. Brodén and Crawford, and Mrs. Tillman would each be entitled to a lump-sum severance payment of three times the sum of (i) annual base salary in effect immediately prior to the change in control, and (ii) the non-equity incentive award paid in the year preceding the termination date or the year preceding the change in control, whichever amount is higher. Mr. Amos has waived his entitlement to receive a severance payment. Mr. Dyslin would be entitled to an amount equal to 300% of the total of (i) his Base Salary as of his Termination Date, and (ii) the dollar amount of MIP Bonus for the year in which his Termination Date occurred with performance deemed to be at target.
(8)The non-equity incentive award amounts on this line do not include the 2023 non-equity incentive awards that were paid to the NEOs in February 2024 and which were nonforfeitable as of December 31, 2023, under all circumstances other than termination for competition.
(9)Amounts in this row generally include (i) the present value of the applicable benefits payable under the RPSO and the SERP, and (ii) certain additional amounts determined under the executive’s employment agreement in lieu of continued participation in the Company’s broad-based retirement plans. However, amounts included in this column reflecting benefits payable under the SERP may differ from the amounts shown in the Pension Benefits table due to reduced SERP benefits payable upon termination for “good cause” or death.
(10)Amounts in this row generally represent the estimated lump-sum present value of all premiums that would be paid by the Company for applicable health and welfare benefits. The value shown for Mr. Amos includes his post-employment medical benefits under the RPSO for his life and the life of his spouse, the value of certain other welfare benefits, and non-medical fringe benefits (including office space) for his life. These amounts would not be payable if Mr. Amos engages in any activity that competes with the Company. The value of health coverage for each of Messrs. Brodén and Crawford, and Mrs. Tillman is the monthly cost of Company-paid premiums for active employee coverage under the health plan, multiplied by the number of months of Company-paid continued coverage for which the executive is eligible as determined under his employment agreement. For Mr. Dyslin, the amounts represent the COBRA continuation coverage premiums that would be payable by him.
(11)Amounts in this row represent the estimated value of accelerated vesting of stock options and restricted stock awards. The value for stock options was determined as follows: the excess of the per share closing price on the NYSE on the last business day of the year over the per share option exercise price, multiplied by the number of unvested option shares. The value for restricted stock awards was determined by multiplying the number of unvested stock awards by the same per share closing price used for options. The values of these awards that are performance-based assume maximum performance goals were achieved.


EXECUTIVE COMPENSATION2024 PROXY STATEMENT73

Table of Contents

Executive Compensation

(2)Termination for good cause eliminates the salary continuation and non-equity incentive award obligation for the remainder of the contract period and causes a forfeiture of the executive’s participation in any supplemental retirement plan (except for Mr. Amos). In addition, all equity awards, whether vested or unvested, are forfeited.
(3)Voluntary termination by the executive without good reason eliminates the salary continuation and non-equity incentive award obligations for the remainder of the contract term. In addition, nonvested equity awards will be forfeited, except in the case of Mr. Amos and Mrs. Tillman, who are retirement-eligible under the terms of the Company’s equity agreements and will vest in all equity awards granted at least one year before the date his or her employment terminates (subject to satisfaction of performance goals).
(4)Any executive who competes with the Company after termination will forfeit the right to any further salary and non-equity incentive award payments and any benefits under the RPSO. In addition, nonvested equity awards will be forfeited, except in the case of Mr. Amos and Mrs. Tillman, who are retirement-eligible under the terms of the Company’s equity agreements and will vest in all equity awards granted at least one year before the date his or her employment terminates (subject to satisfaction of performance goals).
(5)When an executive dies, the executive’s estate is entitled to receive terminal pay (paid in equal installments over 36 months) equal to the amount of the executive’s base pay and non-equity incentive award paid in the previous 36 months, or, if the executive was employed less than 36 months, the amount the executive would have been paid if he or she had survived for the full 36-month period. Additionally, retirement benefits in this column include the present value of the accumulated benefit obligation for a surviving spouse annuity under the RPSO for Mr. Amos. Messrs. Brodén and Crawford participate in the Company-funded EDCP, which will vest at death. The NEOs and other officers also are eligible for life insurance benefits along with, and on the same basis as, the Company’s other salaried employees.
(6)Disability benefits are payable for 18 months or, if shorter, until the end of the term of the applicable agreement, while the executive remains employed during his/ her disability except for Mr. Brodén. For all NEOs, any disability benefits paid in the form of salary continuation or non-equity incentive awards (as shown in the table) would be offset by the maximum annual amount allowed ($144,000) under the Company-sponsored disability income plan. Mr. Brodén and Crawford participate in the Company-funded EDCP, which would vest at disability.
(7)Upon termination after a change in control, Messrs. Crawford and Kirsch and Mrs. Tillman would each be entitled to a lump-sum severance payment of three times the sum of (i) annual base salary in effect immediately prior to the change in control, and (ii) the non-equity incentive award paid in the year preceding the termination date or the year preceding the change in control, whichever amount is higher. Mr. Amos has waived his entitlement to receive a severance payment.
(8)The non-equity incentive award amounts on this line do not include the 2020 non-equity incentive awards that were paid to the NEOs in February 2021 and which were nonforfeitable as of December 31, 2020, under all circumstances other than termination for competition.
(9)Amounts in this row generally include (i) the present value of the applicable benefits payable under the RPSO and the SERP, and (ii) certain additional amounts determined under the executive’s employment agreement in lieu of continued participation in the Company’s broad-based retirement plans. However, amounts included in this column reflecting benefits payable under the SERP may differ from the amounts shown in the Pension Benefits table due to reduced SERP benefits payable upon termination for “good cause” or death.
(10)Amounts in this row generally represent the estimated lump-sum present value of all premiums that would be paid by the Company for applicable health and welfare benefits. The value shown for Mr. Amos includes his post-employment medical benefits under the RPSO for his life and the life of his spouse, the value of certain other welfare benefits, and non-medical fringe benefits (including office space) for his life. These amounts would not be payable if Mr. Amos engages in any activity that competes with the Company. The value of health coverage for each of Messrs. Crawford and Kirsch and Mrs. Tillman is the monthly cost of Company-paid premiums for active employee coverage under the health plan, multiplied by the number of months of Company-paid continued coverage for which the executive is eligible as determined under his employment agreement.
(11)Amounts in this row represent the estimated value of accelerated vesting of stock options and restricted stock awards. The value for stock options was determined as follows: the excess of the per share closing price on the NYSE on the last business day of the year over the per share option exercise price, multiplied by the number of unvested option shares. The value for restricted stock awards was determined by multiplying the number of unvested stock awards by the same per share closing price used for options. The values of these awards that are performance-based assume maximum performance goals were achieved.

CEO Pay Ratio

The Company believes that executive pay should be internally consistent and equitable to motivate the Company’s employees and create shareholder value. To demonstrate the Company’s commitment to that principle, and as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act and SEC rules adopted thereunder, we are disclosing the ratio of the annual total compensation of the Chairman and CEO, Mr. Daniel P. Amos, to the annual total compensation of the individual we have identified as the median employee for this purpose.

As determined in accordance with applicable SEC rules, for 2020,2023, the last completed fiscal year:

The annual total compensation of the CEO, as reported in the 2023 Summary Compensation Table included on page 61, was $20,703,253; and 
The annual total compensation of the median employee determined on this same basis was $63,898.
The annual total compensation of the CEO, as reported in the 2020 Summary Compensation Table included on page 50, was $22,613,727; and
The annual total compensation of the median employee determined on this same basis was $63,740.

Based on this information, the ratio of the annual total compensation of our Chief Executive Officer to the median of the annual total compensation of all employees is 355324 to 1.

60Aflac Incorporated

Table of Contents

Executive Compensation

SEC rules permit us to identify our median employee once every three years so long as there has not been a change in our employee population or employee compensation arrangements during the 20202023 fiscal year that we reasonably believe would significantly impact our pay ratio disclosure. There has not been a significant change in our employee population or employee compensation arrangements from 2019.2022. Therefore, the CEO pay ratio for the 20202023 fiscal year is calculated using the same median employee identified with respect to the 20192022 fiscal year.

The steps described below were performed in 20192022 to identify the annual total compensation of the median employee. The Company first determined the compensation for all the Company’s employees other than the CEO as of December 31, 2019,2022, taking into account the annual sum of cash wages, overtime, and bonus from payroll records, in each case determined without regard to cost-of-living adjustments. As of such date, the Company’s employee population consisted of approximately 12,31112,735 individuals working at Aflac Incorporated and its consolidated subsidiaries, with 43%44% of these individuals located in the United States and 57%55% located in Japan. We excluded 146 employees of Argus Holdings, LLC, which the Company acquired during fiscal 2019 in a transaction that closed on November 7, 2019 and 69 employees of Tsusan Co., Ltd, which Aflac Japan acquired on May 8, 2019. The employee population above includes part-time and temporary employees as of December 31, 20192022 (excluding employees on unpaid leave as of December 31, 2019)2022), as compared to the employee population disclosed in the December 31, 2019,2022, Form 10-K, which includes only full-time employees. For employees located in Japan, the compensation in Japanese yen was converted to U.S. dollars using the annual weighted average exchange rate of Japanese yen to U.S. dollars of 109.07130.17 to 1 on December 31, 2019.

2022.

To calculate the CEO pay ratio for 2020,2023, the Company identified the elements of such employee’s compensation for the entirety of 20202023 in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K (the basis for determining annual total compensation as reported in the Summary Compensation Table), resulting in annual total compensation in the amount of $63,740.

$63,898.

Mr. Amos has been CEO of the Company since 1990 and Chairman since 2001. His long-standing tenure, coupled with normal changes in the calculation of his pension due to discount rate changes, causes his pension value (when calculated according to Item 402(c)(2)(x) of Regulation S-K) to vary greatly from year to year, which couldmay cause large changes in the ratio.



74AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Pay Versus Performance
The following table shows the total compensation for the past four fiscal years for our NEOs as set forth in the Summary Compensation Table, the “Compensation Actually Paid” (or “CAP”) to our CEO, and, on an average basis, our other NEOs, our TSR, the TSR of the S&P Life & Health Insurance index over the same period, our net income, and our principal financial measure for compensation purposes, Adjusted Return on Equity. CAP figures do not reflect the actual amount of compensation earned by or paid to our NEOs during the applicable year. For information regarding the decisions made by our Compensation Committee in regard to the NEOs’ compensation for each fiscal year, please see the Compensation Discussion & Analysis section of this Proxy Statement reporting pay for the fiscal years covered in the Pay Versus Performance table.
Year
Summary
Compensation Table
Total for PEO(1)
Compensation
Actually Paid to
PEO(2)(7)
Average Summary
Compensation Table
Total for Non-PEO
NEOs(3)
Average
Compensation
Actually Paid to
Non-PEO
NEOs(2)(7)
Value of Initial Fixed $100
Investment Based On:
Net
Income*(5)
Adjusted
Return on
Equity(5)(6)
Total Shareholder
Return
Peer Group Total
Shareholder
Return(4)
2023$20,703,253 $40,403,440 $6,192,096 $8,502,767 $172.49 $142.87 $4,659 14.2 %
2022$15,776,291 $32,797,790 $5,168,408 $8,807,465 $146.94 $136.53 $4,418 13.9 %
2021$15,728,233 $27,847,653 $4,757,806 $7,213,661 $116.29 $123.73 $4,231 15.9 %
2020$22,613,727 $13,548,137 $4,207,154 $2,770,566 $86.42 $90.52 $4,778 15.0 %
*    in Millions
(1)The Principal Executive Officer (“PEO”) in fiscal years 2023, 2022, 2021, and 2020 is Daniel P. Amos.
(2)Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and the same assumptions that were used for stock options granted that year. Performance-based restricted share grant date fair values are calculated using ASC 718 at target-level performance. The Company’s valuation assumptions are described in Note 12, “Share-Based Compensation,” in the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2023. Adjustments have been made using the stock price and performance accrual modifier as of year-end and as of the date of vest, as applicable.
(3)The NEOs included in the calculation of average NEO compensation in fiscal year 2023 are Max K. Brodén, Frederick J. Crawford, Bradley E. Dyslin, and Audrey Boone Tillman. NEOs included in the calculation for fiscal years 2022, 2021, and 2020 are Max K. Brodén, Frederick J. Crawford, Eric M. Kirsch, and Audrey Boone Tillman.
(4)The peer group used for Total Shareholder Return is the S&P Life & Health Insurance index.
(5)Amounts for years 2021 and 2022 have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.
(6)Adjusted Return on Equity (AROE) is defined as Adjusted Earnings, excluding the impact of foreign currency, divided by Adjusted Book Value. AROE, Adjusted Earnings excluding the impact of foreign currency, and Adjusted Book Value are not calculated in accordance with GAAP. See Appendix A to this Proxy Statement for definitions for these non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
(7)SEC rules require certain adjustments be made to the Summary Compensation Table totals to determine the Compensation Actually Paid as reported in the Pay vs. Performance Table. CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. In general, CAP is calculated as Summary Compensation Table total compensation adjusted to reflect certain changes in the fair market value of outstanding equity awards as of December 31 of the applicable year or, if earlier, the vesting date (rather than the grant date), and an adjustment for the aggregate value of service costs and prior service costs of pension benefits. No adjustment is made for dividends as dividends are factored into the fair market value of the award. The following table details these adjustments:
YearExecutive(s)
Summary
Compensation
Table Total
Subtract change
in actuarial
present value of
pension
Subtract grant
date fair value of
stock awards
granted during
the fiscal year
Add aggregate
value of service
costs and prior
service costs of
pension
benefits
Add year-end
value of stock
awards
granted
during the
fiscal year
Add change in
value of stock
awards
granted in
prior years
Add change in
value of
vested stock
awards
granted in
prior years
Compensation
Actually Paid
2023CEO$20,703,253 ($2,720,265)($10,270,666)$0$12,953,190 $19,993,385 ($255,457)$40,403,440 
Other NEOs$6,192,096 ($1,279,786)($2,152,762)$15,143 $2,708,968 $3,055,883 ($36,775)$8,502,767 
2022CEO$15,776,291 $0($9,495,081)$0$11,062,631 $14,073,792 $1,380,157 $32,797,790 
Other NEOs$5,168,408 $0($2,212,712)$16,124 $2,578,010 $2,958,342 $299,293 $8,807,465 
2021CEO$15,728,233 $0($9,122,925)$0$11,817,648 $8,615,430 $809,267 $27,847,653 
Other NEOs$4,757,806 ($20,722)($1,905,211)$16,359 $2,418,346 $1,507,483 $439,600 $7,213,661 
2020CEO$22,613,727 ($8,514,587)($8,471,063)$0$7,297,544 $683,122 ($60,606)$13,548,137 
Other NEOs$4,207,154 ($987,130)($1,520,233)$18,459 $1,309,629 ($116,934)($140,379)$2,770,566 


EXECUTIVE COMPENSATION2024 PROXY STATEMENT75
The following graphs illustrate the relationship between CAP and financial performance measures in the Pay Versus Performance table:
CAP vs. Company and Peer Group TSR

3426

CAP vs. Company Net Income
3431
CAP vs. Adjusted Return on Equity
3435
Seven Most Important Company Performance Measures for Determining NEO Compensation:
Adjusted Return on Shareholders’ Equity
U.S. Segment Net Earned Premium
Japan Segment Net Earned Premium
Adjusted Earnings per diluted Share (excluding foreign currency effect)
Japan Segment New Annualized Premium
Net Investment Income - Aflac Global Investments
U.S. Segment New Annualized Premium


76AFLAC INCORPORATEDEXECUTIVE COMPENSATION
Equity Compensation Plan Information

The following table provides information with respect to compensation plans under which our equity securities are authorized for issuance to our employees or Non-employee Directors, as of December 31, 2020.

Plan Category Number of Securities
to be Issued
Upon Exercise
of Outstanding
Options, Warrants
and Rights
(a)
 Weighted-Average
Exercise Price
of Outstanding
Options, Warrants
and Rights
(b)
 Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation
Plans Excluding Securities
Reflected in Column(a)
(c)
 
Equity Compensation Plans Approved by Shareholders 3,045,335     $30.25     37,981,226*
Equity Compensation Plans Not Approved by Shareholders    
Total 3,045,335 $30.25 37,981,226 

*Of the shares listed in column (c), 33,738,935 shares are available for grant other than in the form of options, warrants, or rights (i.e., in the form of restricted stock or restricted stock units).

2021 Proxy Statement61
2023.
Plan CategoryNumber of Securities
to be Issued
Upon Exercise
of Outstanding
Options, Warrants
and Rights
(a)
Weighted-Average
Exercise Price
of Outstanding
Options, Warrants
and Rights
(b)
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation
Plans Excluding Securities
Reflected in Column(a)
(c)
Equity Compensation Plans Approved by Shareholders1,050,774$32.90 34,752,112*
Equity Compensation Plans Not Approved by Shareholders— 
Total1,050,774$32.90 34,752,112
*    Of the shares listed in column (c), 19,497,621 shares are available for grant other than in the form of options, warrants, or rights (i.e., in the form of restricted stock or RSUs).


2024 PROXY STATEMENT77
AUDIT MATTERS

Table of Contents

Audit Matters
pg9_proposal3.jpg
Proposal 3
pg72_duck2.jpg
Ratification of Auditors
In February 2021,2024, the Audit and Risk Committee voted to appoint KPMG LLP, an independent registered public accounting firm, to perform the annual audit of the Company’s consolidated financial statements for fiscal year 2021,2024, subject to ratification by the shareholders. Although ratification of the Audit and Risk Committee’s appointment of KPMG LLP by the shareholders is not required, the Board values the opinions of our shareholders and believes that shareholder ratification of the appointment is a good corporate governance practice. In the event of a negative vote on this proposal, the Audit and Risk Committee will reconsider its selection.
 The Board of Directors and the Audit and Risk Committee recommend a  vote FOR the ratification of the selection of KPMG LLP.

Representatives of KPMG LLP are expected to attend the 20212024 Annual Meeting of Shareholders. These representatives may make a statement if they desire to do so, and will be available to respond to appropriate questions.

Audit Fees and Other Fees

The aggregate fees for professional services rendered to the Company by KPMG LLP for the two most recent calendar years were as follows:

  2020
($)
 2019
($)
Audit fees — Audit of the Company’s consolidated financial statements for the years ended December 31(1) 8,280,126 8,806,395
Audit-related fees(2) 753,200 802,700
Tax fees(3) 43,170 2,106
All Other fees  
Total fees: 9,076,496 9,611,201

(1)Includes $777,078 and $1,043,848, respectively, for the 2020 and 2019 audits of Aflac Japan regulatory financial statements.
(2)Includes fees relating to audits of the Company’s benefit plans, service organization control reports, accounting consultations in connection with proposed transactions or emerging accounting standards and other attestation reports.
(3)Tax fees include all services performed by professional staff in the independent Accountant’s tax division for tax return and related compliance services, except for those tax services related to the integrated audit.

2023
($)
2022
($)
Audit fees — Audit of the Company’s consolidated financial statements for the years ended December 31(1)
10,255,467 10,835,331 
Audit-related fees(2)
942,500 889,500 
Tax fees(3)
100,000 160,000 
All Other fees(4)
— — 
Total fees:11,297,967 11,884,831 
(1)Includes $975,873 and $989,522, respectively, for the 2023 and 2022 audits of Aflac Japan regulatory financial statements.
(2)Includes fees relating to audits of the Company’s benefit plans, service organization control reports, accounting consultations in connection with proposed transactions or emerging accounting standards and other attestation reports.
(3)Tax fees include all services performed by professional staff in the independent auditor’s tax division for tax return and related compliance services, except for those tax services related to the integrated audit.
(4)“All other fees” includes all fees paid that are not audit, audit-related, or tax services.
Pre-Approval Policies and Procedures

The Audit and Risk Committee of the Board has considered whether the provision of the non-audit professional services is compatible with maintaining KPMG LLP’s independence and has concluded that it is. The Audit and Risk Committee pre-approves all audit and non-audit services provided by KPMG LLP in accordance with SEC rules, subject to the de minimis exceptions for non-audit services.

62Aflac Incorporated


78AFLAC INCORPORATEDAUDIT MATTERS

Table of Contents

Audit Matters

Audit and Risk Committee Report

Committee Membership and Governance
The Audit and Risk Committee of the Company’s Board is composed of four Directors. The Board has determined that each member of the Audit and Risk Committee is independent as defined by the NYSE listing standards and SEC rules, is financially literate, and qualifies as an audit committee financial expert as defined by SEC rules.
The Audit and Risk Committee operates under a written charter adopted by the Board. The charter, which is reviewed annually and complies with all current regulatory requirements, is available on the Company’s website, www.aflac.com, by clicking on “Investors,” then “Governance,” then “Governance Documents,” then “Audit & Risk Committee.”

Meetings in 2023
In 2020,2023, the Audit and Risk Committee met twelvenine times. During these meetings committee members reviewed and discussed a variety of topics with management, KPMG (the Company’s independent registered public accounting firm), the internal auditors, the chief risk officer, the general counsel, the global security and chief information security officer, and others, including the Company’s earnings releases and SEC filings related to quarterly and annual financial statements, statutory insurance financial statement filings, and the Company’s system of internal control over financial reporting, including information security policies.
The Audit and Risk Committee has discussed with, and received regular status reports from, the Company’s director of internal audit and KPMG on the overall scope and plans for their audits of the Company. The Audit and Risk Committee met with the internal auditors and KPMG, with and without management present, to discuss the results of their examinations, their evaluations of the Company’s internal controls, and the overall quality of the Company’s financial reporting.

Oversight of Internal Controls over Financial Reporting
The Audit and Risk Committee has monitored the Company’s compliance with Section 404 of the Sarbanes-Oxley Act regarding the reporting related to internal control over financial reporting. The monitoring process has included regular reports and representations by financial management of the Company, the internal auditors, and by KPMG. The Audit and Risk Committee also has reviewed the certifications of Company executive officers contained in the Annual Report on Form 10-K for the year ended December 31, 2020,2023, as well as reports issued by KPMG related to its audit of the consolidated financial statements and the effectiveness of internal control over financial reporting.

Oversight of Independent Registered Accounting Firm
The Audit and Risk Committee is responsible for the appointment, compensation, retention, and oversight of the Company’s independent registered public accounting firm. In accordance with SEC rules and KPMG’s policies, audit partners are subject to rotation requirements to limit the number of consecutive years an individual partner may provide service to the Company. The maximum number of consecutive years of service as lead audit partner is five years. The process for selecting the lead audit partner for the Company pursuant to this rotation policy involves a meeting between the Chair of the Audit and Risk Committee and prospective candidates, as well as discussions with the full Audit and Risk Committee and with management.
The Audit and Risk Committee evaluates the performance of KPMG, including the senior members of the audit engagement team, each year and determines whether to re-engage KPMG or to consider other audit firms. In doing so, the Audit and Risk Committee considers considers:
the quality and efficiency of the services provided;
the firm’s global capabilities, particularly in the U.S. and Japan;
its technical expertise;
its tenure as the Company’s independent registered public accounting firm (KPMG has served in this capacity since 1963); and
its knowledge of the Company’s operations and industry.
Based on this review and discussions with members of senior management, the Audit and Risk Committee concluded it was in the best interest of the Company and the shareholders to recommend KPMG to the Board to serve as the Company’s independent registered public accounting firm during 2020.2023. Although the Audit and Risk Committee has the sole authority to appoint the independent auditors, the Audit and Risk Committee will continue its long-standing practice of recommending that the Board ask the shareholders to ratify this appointment for 20212024 (see Ratification of Appointment of Independent Registered Public Accounting Firm (Proposal 3)).



AUDIT MATTERS2024 PROXY STATEMENT79
Required Disclosures
The Audit and Risk Committee also discussed with KPMG those matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the PCAOB) and the Commission.
The Audit and Risk Committee received the written disclosures and the lettercommunications from KPMG required by applicable requirements of the PCAOB regarding the independent auditors’ communications with the Audit and Risk Committee concerning independence, and has discussed with KPMG its independence.
The Audit and Risk Committee considered with KPMG whether the provision of non-audit services provided by it to the Company during 20202023 was compatible with its independence.

In performing all of these functions the Audit and Risk Committee acts in an oversight capacity.
The Audit and Risk Committee reviews the Company’s quarterly and annual reports on Form 10-Q and Form 10-K prior to filing with the SEC.
In its oversight role, the Audit and Risk Committee relies on the work and assurances of the Company’s management, which has the primary responsibility for establishing and maintaining adequate internal control over financial reporting and for preparing the financial statements and other reports, and of KPMG, which is engaged to audit and report on the consolidated financial statements of the Company and the effectiveness of the Company’s internal control over financial reporting.
In reliance on these reviews and discussions, and the reports of KPMG, the Audit and Risk Committee has recommended to the Board, and the Board has approved, that the audited financial statements to be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020,2023, for filing with the SEC.

For additional information, see the “The Audit and Risk Committee” section on page 14.

24.

Audit and Risk Committee


Karole F. Lloyd, Chair


W. Paul Bowers


Georgette D. Kiser


Joseph L. Moskowitz

2021 Proxy Statement63

Table of Contents

Audit Matters

Related Person Transactions

The Company recognizes that transactions between the Company and any of its Directors or executives can present potential or actual conflicts of interest and create the appearance that decisions are based on considerations other than the best interests of the Company and its shareholders. Accordingly, consistent with our Code of Business Conduct and Ethics, it is the Company’s preference to avoid such transactions. Nevertheless, there are situations where such transactions may be in, or not inconsistent with, the best interests of the Company and its shareholders. Therefore, the Company has adopted a written policy that requires the Audit and Risk Committee to review and, if appropriate, to approve or ratify any such transactions. Pursuant to the policy, the Audit and Risk Committee will review any transaction in which the Company is or will be a participant and the amount involved exceeds $120,000 in any fiscal year, and in which any of the following had, has, or will have a direct or indirect material interest: (i) a Director or Director nominee, (ii) an executive officer, (iii) a holder of more than 5% of the Company’s outstanding shares, (iv) an immediate family member of any of these persons, or (v) any firm, corporation, or other entity in which one of these persons is employed or is a general partner or principal or in a similar position, or in which such person has a 5% or greater beneficial interest. During its review, the Audit and Risk Committee considers a number of factors, including whether the related person transaction is on terms no less favorable to the Company than may reasonably be expected in arm’s-length transactions. The Audit and Risk Committee will only approve or ratify those transactions that it determines in good faith are in, or are not inconsistent with, the best interests of the Company and its shareholders.

Each of the following ongoing transactions has been reviewed and ratifiedapproved by the Audit and Risk Committee:

In 2013, Aflac Japan (then operating as a branch of Aflac) entered a lease for office space at the Marunouchi Center Building in Tokyo, Japan, which is owned by Chuo Real EstateChuo-Nittochi Co., Ltd. The current lease has a term of 2 years.ends May 31, 2024. Mr. Toshihiko Fukuzawa, who serveswhose service on the Company’s Board concluded on May 1, 2023, has been a Senior Advisor of Chuo-Nittochi Co., Ltd., since June 2022. He was appointedthe Deputy President and Representative Director of Chuo-Nittochi Co., Ltd., from April 2021 to June 2022. Previously, Mr. Fukuzawa served as President and CEO of Chuo Real Estate Co., Ltd., a predecessor in interest to Chuo-Nittochi Co., Ltd., from July 2018.2018 to March 2021. The lease was in place prior to Mr. Fukuzawa’s service with Chuo Real Estate Co., Ltd., and he had no involvement in negotiations of the lease or in Aflac Japan’s decision to lease space in the Marunouchi Center Building. Mr. Fukuzawa receives no compensation from either the Company or Chuo Real Estate Co., Ltd. related to the lease. At the 20202023 weighted average rate of 106.86140.57 yen to the dollar, Aflac Japan paid the yen equivalent of $2,286,691$2,063,120 in rent under the lease during the 20202023 calendar year.



80AFLAC INCORPORATEDAUDIT MATTERS
Mr. Max K. Brodén is the Executive Vice President, Chief Financial Officer and Treasurer of the Company. His spouse, Sabrina Pasini Brodén, has been employed with Aflac since January 2019. Prior to her employment with Aflac,that, she was an independent consultant in the marketing department. She is currently a CustomerSenior Manager, Lead Generation and User Experience Consultant.Experience. In 2020,2023, her total compensation, including salary, bonuses commissions to the employment agency and other benefits, was $128,087.$187,196. The compensation for Sabrina Pasini Brodén is commensurate with that of her peers.

In 2023, Mr. J. Todd Daniels iswas the Executive Vice President, Chief Financial Officer of Aflac Japan. His spouse, Amy Jarreau Daniels, has been an employee of Aflac since April 2014. She is currently employed as a Sales Manager I. In 2020,2023, her total compensation, including salary, bonuses and other benefits, was $722,879.$775,767. The variable compensation structure for Amy Jarreau Daniels is commensurate with that of her peers.

On

As previously reported, on December 19, 2018, the Company, and Aflac Japan and Japan Post Holdings Co., Ltd. (“Japan Post Holdings”) entered into a Basic Agreement regarding the “Strategic Alliance Based on Capital Relationship.” Pursuant to the Basic Agreement, Japan Post Holdings committed to acquire approximately 7% of the outstanding shares of the Company’s Common Stock via a trust and to treat the Company as an equity-method affiliate after application of time-phased voting rights (see the “10-for-1 rule” (the rule included in the Company’s Articles“Description of Incorporation, as amended, pursuant to which, and subject to certain limited exceptions, each Common Share is entitled to ten votes after it has been heldVoting Rights” section below for 48 consecutive months by the same beneficial owner)additional information). Further, Japan Post Holdings and Aflac Japan agreed to reconfirm existing initiatives regarding cancer insurance and make reasonable efforts to further develop initiatives related to the continued growth of cancer insurance sales, such as positioning Aflac Japan cancer insurance as a product as important as Japan Post Insurance Co., Ltd (“JPI”) products in the sales strategies of Japan Post Holdings, Japan Post Co., Ltd. (“JPC”) and JPI, and promoting cancer insurance sales and managing promotion based on established sales targets. Under the Basic Agreement, Japan Post Holdings and Aflac Japan also agreed to consider new joint initiatives, including leveraging digital technology in various processes, cooperating in new product development to promote customer-centric business management, cooperating in domestic and/or overseas business expansion and joint investment in third party entities and cooperating with regard to asset management.

64Aflac Incorporated

Table of Contents

Audit Matters

On February 28, 2019, the Company entered into a Shareholders Agreement (the “Shareholders Agreement”) with Japan Post Holdings; J&A Alliance Holdings and certainCorporation, solely in its capacity as trustee (the Trustee) of its affiliates. Pursuant to the Shareholders Agreement, Japan Post Holdings agreed to cause the J&A Alliance Trust, a New York voting trust (the “Trust”); and General Incorporated Association J&A Alliance (“General Incorporated”). Pursuant to the Shareholders Agreement, the Trustee agreed to use commercially reasonable efforts to acquire, through open market or private block purchases in the United States, beneficial ownership of approximately 7% of the Company’s Common Stock in connection with the Basic Agreement. According to a Schedule 13G/A filed by Japan Post Holdings with the SEC on January 6, 2021, as of December 31, 2020 the Trust had beneficially acquired 7.45% of the number of shares of Common SharesStock outstanding on October 19, 2020. Japan Post Holdings is the sole beneficiary of the Trust.

General Incorporated, Yoshiyuki Koiwa, and Kenji Sano may each be deemed to share voting power over the shares of Common Stock owned directly by J&A Alliance Holdings Corporation, in its capacity as the trustee of the Trust, because (i) General Incorporated owns J&A Alliance Holdings Corporation and (ii) Yoshiyuki Koiwa and Kenji Sano each own 50% of the equity interests in General Incorporated. Japan Post Holdings may be deemed to share investment power over the shares of Common Stock owned directly by the Trustee, due to its role as the sole settlor and beneficiary of the Trust. The foregoing persons, other than the Trustee, have expressly disclaimed beneficial ownership of the shares held directly by the Trustee. The Trust has agreed not to beneficially own more than the greater of 10% of the Company’s outstanding shares and such shares representing 22.5% of the voting rights in the Company. In light of the fact that the shares acquired by the Trust, like all Aflac Incorporated shares of Common Stock, will be eligible for 10-for-1 voting rights after being held for 48 consecutive months, the Shareholders Agreement further provides for voting restrictions that effectively limit the trustee’s voting rights to no more than 20% of the voting rights in the Company and further restrict the trustee’s voting rights with respect to certain change in control transactions. Japan Post Holdings will not have a Board seat on the Company’s Board of Directors and will not have rights to control, manage or intervene in the management of the Company. The Shareholders Agreement shall remain in effect unless terminated by mutual written consent of Japan Post Holdings and the Company or upon the Trust disposing of all of its shares of Company Common Stock, or otherwise ceasing to beneficially own any shares of Company Common Stock.
Since 2008, the Company and Aflac Japan have maintained various commercial and contractual arrangements with Japan Post Holdings and certain of its affiliates. Under these arrangements, affiliates of Japan Post Holdings conduct the sale of Aflac Japan cancer insurance policies in Japan and, among other things, provide supplemental support necessary or beneficial to effectuating the sale and servicing of such policies. Aflac Japan’s cancer insurance policies issued pursuant to these contractual arrangements constituted approximately 4.4%4.9% of Aflac Japan’s earned premium for 2020,2023, representing approximately 3.1%3.0% of Aflac Incorporated’s total consolidated earned premium for 2020.2023. In exchange for facilitating such sales and other services including JPI’s acting as reinsurer for a certain percentage of the underwriting risk for Aflac Japan cancer insurance sold by JPC and JPI, affiliates of Japan Post Holdings collectively received approximately $101$78 million in commission and other payments from Aflac Japan and its affiliates during 2020.

2021 Proxy Statement65
2023.


2024 PROXY STATEMENT81
STOCK OWNERSHIP

Table of Contents

Stock Ownership

Beneficial Ownership of the Company’s Securities

As of February 23, 2021,27, 2024, no person was the owner of record or, to the knowledge of the Company, beneficial owner of more than 5% of the outstanding shares of Common Stock or of the available votes of the Company other than as shown below.

Name and Address of Beneficial Owner Title of Class
Common
Stock
 Amount of
Beneficial
Ownership
Shares
 Amount of
Beneficial
Ownership
Votes
 Percent of
Class
 Percent of
Available
Votes
 
J&A Alliance Holdings Corporation*
1007 Fukoku Seimei Building
2-2-2 Uchisaiwai-cho, Chiyoda-ku
Tokyo 100-0011, Japan
 1 Vote Per
Share
 52,300,000 52,300,000 7.6 4.7 
BlackRock, Inc.*
55 East 52nd Street
New York, NY 10055
 1 Vote Per
Share
 45,522,910 45,522,910 6.6 4.1 
The Vanguard Group*
100 Vanguard Boulevard
Malvern, PA 19355
 1 Vote Per
Share
 59,888,649 59,888,649 8.7 5.4 
State Street Corporation*
State Street Financial Center
One Lincoln Street
Boston, MA 02111
 1 Vote Per
Share
 34,135,472 34,135,472 5.0 3.1 

*The above information is derived from Schedule 13G filings filed with the Securities and Exchange Commission, dated January 6, 2021, by J&A Alliance Holdings Corporation, dated January 29, 2021, by BlackRock, Inc., dated February 10, 2021, by The Vanguard Group, and dated February 12, 2021, by State Street Corporation. According to the Schedule 13G filings: J&A Alliance Holdings Corporation, has shared voting power with respect to 52,300,000 shares; BlackRock, Inc., has sole voting power with respect to 39,235,646 shares and sole dispositive power with respect to 45,522,910 shares; The Vanguard Group has shared voting power with respect to 1,080,868 shares, sole dispositive power with respect to 56,940,688 shares and shared dispositive power with respect to 2,947,961 shares; and State Street Corporation has shared voting power with respect to 30,600,239 shares and shared dispositive power with respect to 34,107,499 shares.

66Aflac Incorporated

Name and Address of Beneficial OwnerTitle of Class
Common Stock
Amount of
Beneficial
Ownership
Shares
Amount of
Beneficial
Ownership
Votes
Percent of
Class
(2)
Percent of
Available
Votes
(3)
The Vanguard Group(1)
100 Vanguard Boulevard
Malvern, PA 19355
1 Vote Per Share52,438,841 52,438,841 9.13.8
J&A Alliance Holdings Corporation,
as trustee of J&A Alliance Trust(4)
1007 Fukoku Seimei Building
2-2-2 Uchisaiwai-cho, Chiyoda-ku
Tokyo 100-0011, Japan
1 Vote Per Share52,300,000 523,000,000 9.120.0
BlackRock, Inc.(1)
50 Hudson Yards
New York, NY 10001
1 Vote Per Share42,164,887 42,164,887 7.3 3.0 

Table

(2)    Percent of Contents

Class is calculated by dividing the number of shares of Common Stock Ownership

beneficially owned by the number of outstanding shares of Common Stock as of the Record Date.

(3)    Percent of Available Votes is an assumed figure calculated by dividing the number of respective voting rights by the total number of available votes based on the Company’s records of outstanding shares of Common Stock as of February 27, 2024 (record date). Shares of Common Stock held in “street” or “nominee” name are presumed to be entitled to one vote per share. The actual total number of available votes, which is dependent upon affidavits received from holders of shares held in “street” or “nominee’ name, will be determined and certified by the Inspector of Election at the Annual Meeting. See the “Description of Voting Rights” and the “Quorum and Vote Requirements” sections below for additional information.
(4)    Pursuant to the Shareholders Agreement, the Trust has agreed not to beneficially own more than the greater of 10% of the Company’s outstanding shares of Common Stock and such shares representing 22.5% of the voting rights in the Company. The Shareholders Agreement further provides for voting restrictions that require the Trust to vote (1) all shares representing voting rights in excess of 20% of the voting rights in the Company and (ii) all of its shares in connection with a change in control transaction, in each case, in a manner proportionally equal to votes of shares not beneficially owned by the Trust. Without these restrictions, the calculated Percent of Available Votes would have been 37.5% as of February 27, 2024 (record date), See the “Related Person Transactions” section above for additional information.
Security Ownership of Directors

The following information is provided with respect to each Director and Director nominee:

Name Shares of Common Stock
Beneficially Owned on
February 23, 2021(1)
 Percent of
Outstanding
Shares
 Voting Rights on
February 23,
2021
 Percent of
Available
Votes
 
Daniel P. Amos 4,642,443 .7 34,708,192 3.1 
W. Paul Bowers 38,403 * 206,911 * 
Toshihiko Fukuzawa 3,012,814 .4 30,012,814 2.6 
Thomas J. Kenny 30,107 * 163,905 * 
Georgette D. Kiser 7,077 * 7,077 * 
Karole F. Lloyd 33,646 * 145,984 * 
Nobuchika Mori 3,738 * 3,738 * 
Joseph L. Moskowitz 58,349 * 233,183 * 
Barbara K. Rimer, DrPH 125,731 * 730,558 .1 
Katherine T. Rohrer 12,990 * 12,990 * 
Melvin T. Stith 42,251 * 291,506 * 

*Percentage not listed if less than .1%.
(1)Includes 526,588 shares of restricted stock awarded under the Long-Term Incentive Plan for Daniel P. Amos that he has the right to vote. These shares will vest three years from the date of grant if the Company attains certain performance goals. Includes options to purchase shares, which are exercisable within 60 days for: Joseph L Moskowitz, 41,729 and Barbara K. Rimer, DrPH, 97,322. Also includes shares of restricted stock awarded under the Long-Term Incentive Plan for Toshihiko Fukuzawa, Georgette D. Kiser, Karole F. Lloyd, Barbara K. Rimer, DrPH, Katherine T. Rohrer, and Melvin T. Stith 4,430 each, W. Paul Bowers, 6,144, Nobuchika Mori, 3,738, and Joseph L. Moskowitz, 2,215, for which these individuals have the right to vote. These shares will vest one year from the date of grant.

nominee as of February 27, 2024:

Name
Shares of Common Stock
Beneficially Owned
(1)
Percent of
Outstanding Shares
Voting Rights(2)
Percent of
Available Votes
Daniel P. Amos3,076,179 .517,749,509 1.3 
W. Paul Bowers61,817 *335,616 
Arthur R. Collins5,592 *5,592 *
Miwako Hosoda5,014 *5,014 *
Thomas J. Kenny22,778 *136,546 
Georgette D. Kiser15,377 *15,377 
Karole F. Lloyd44,896 *44,896 
Nobuchika Mori11,106 *11,106 
Joseph L. Moskowitz60,164 *260,891 
Barbara K. Rimer, DrPH73,965 *502,194 *
Katherine T. Rohrer19,240 *19,240 
*    Percentage not listed if less than .1%.
(1)Includes 422,983 shares of restricted stock awarded under the Long-Term Incentive Plan for Daniel P. Amos that he has the right to vote. These shares will vest three years from the date of grant if the Company attains certain performance goals. Includes options to purchase shares, which are exercisable within 60 days for: Joseph L Moskowitz, 34,154, and Barbara K. Rimer, DrPH, 38,850. Also includes shares of restricted stock awarded under the following shares:

Daniel P. Amos: 5,017 shares owned by his spouse; 936,826 shares owned by a partnership of which he is a partner; 908,632 shares owned by trusts of which he is trustee; 444,708 shares owned by the Daniel P. Amos Family Foundation, Inc.; 1,173,439 owned by the Soma Foundation, Inc.
Toshihiko Fukuzawa: 3,000,000 shares owned by The Mizuho Trust & Banking Co., Ltd. Mr. Fukuzawa represents the power to vote these shares.

2021 Proxy Statement67
Long-Term Incentive Plan in 2023 for Arthur R. Collins, Thomas J. Kenny, Georgette D. Kiser, Karole F. Lloyd, Nobuchika Mori, Joseph L. Moskowitz, Barbara K. Rimer, DrPH, and Katherine T. Rohrer, 2,386 each; W. Paul Bowers, 5,640; and Miwako Hosoda, 5,014, for which these individuals have the right to vote. These shares will vest one year from the date of grant. For Daniel P. Amos, includes 5,051 shares owned by his spouse; 941,326 shares owned by a partnership of which he is a partner; and 908,632 shares owned by trusts of which he is trustee. No Director has any pledged shares.
(2)     Shares of Common Stock held in “street” or “nominee” name are presumed to be entitled to one vote per share. See the “Description of Voting Rights” section below for more information.


82AFLAC INCORPORATEDSTOCK OWNERSHIP

Table of Contents

Stock Ownership

Security Ownership of Management

The following table sets forth, as of February 23, 2021,27, 2024, the number of shares and percentage of outstanding shares of Common Stock beneficially owned by: (i) our named executive officers, comprising our CEO, CFO, and the three other most highly compensated executive officers as listed in the Executive Compensation section of this Proxy Statement whose information was not provided under the heading “Proposal 1: Election of Directors,” and (ii) all Directors, nominees and executive officers as a group.

COMMON STOCK BENEFICIALLY OWNED AND APPROXIMATE PERCENTAGE OF CLASS AS OF FEBRUARY 23, 2021

Name Shares(1) Percent of
Shares
 Votes Percent of
Votes
 
Max K. Brodén 81,108 * 81,108 * 
Frederick J. Crawford 399,834 .1 1,189,710 .1 
Eric M. Kirsch 296,568 * 640,638 .1 
Audrey Boone Tillman 353,907 .1 1,147,185 .1 
All Directors, nominees, and executive officers as a group (22 individuals) 10,164,500 1.5 73,191,622 6.5 

*Percentage not listed if less than .1%.
(1)Includes options that are exercisable within 60 days for Max K. Brodén, 4,668; Frederick J. Crawford, 87,764; Eric M. Kirsch, 38,230; Audrey Boone Tillman, 88,138; and for all Directors and executive officers as a group to purchase 594,063 shares. Includes the following shares of restricted stock awarded under the Long-Term Incentive Plan: in 2019, 2020 and 2021 for Max K. Brodén, 59,264; Frederick J. Crawford, 123,572; Eric M. Kirsch, 81,292; and Audrey Boone Tillman, 101,006. These shares will vest 3 years from the date of grant if the Company attains certain performance goals. Also includes shares of restricted stock awarded under the Long-Term Incentive Plan for all Directors and executive officers as a group of 1,292,905. The grantees have the right to vote their restricted stock, but they may not transfer the shares until they have vested. No Director nominee or executive officer has any pledged shares. For information on the Company’s pledging policy, please see “Stock Ownership Guidelines; Hedging and Pledging Restrictions” on page 48.

Name
Shares of Common Stock
Beneficially Owned
(1)
Percent of
Outstanding Shares
Voting Rights(2)
Percent of
Available Votes
Max K. Brodén171,017 *213,029 
Frederick J. Crawford189,645 *189,645 *
Bradley E. Dyslin39,761 *39,761 
Audrey Boone Tillman371,752 .1768,348 .1
All Directors, nominees, and executive officers as a group (22 individuals)
4,648,120 .821,087,701 1.5
*    Percentage not listed if less than .1%.
(1)Includes options that are exercisable within 60 days for Max K. Brodén, 4,668, and Audrey Boone Tillman, 44,058; and for all Directors and executive officers as a group to purchase 156,269 shares. Includes the following shares of restricted stock awarded under the Long-Term Incentive Plan: in 2022, 2023, and 2024 for Max K. Brodén, 85,611, and Audrey Boone Tillman, 87,170; in 2022 and 2023 for Frederick J. Crawford, 89,645; and in 2023 and 2024 for Bradley E. Dyslin, 33,544. These shares will vest 3 years from the date of grant if the Company attains certain performance goals. Also includes shares of restricted stock awarded under the Long-Term Incentive Plan for all Directors and executive officers as a group of 950,388. The grantees have the right to vote their restricted stock, but they may not transfer the shares until they have vested. No Director, nominee or executive officer has any pledged shares. For information on the Company’s pledging policy, please see “Stock Ownership Guidelines; Hedging and Pledging Restrictions” on page 58.
(2)     Shares of Common Stock held in “street” or “nominee” name are presumed to be entitled to one vote per share. See the “Description of Voting Rights” section below for more information.
Delinquent Section 16(a) Reports

Pursuant to Section 16 of the Securities Exchange Act of 1934, executive officers, Directors, and holders of more than 10% of the Common Stock are required to file reports of their trading in Company equity securities with the SEC. Based solely on a review of the copies of such reports received by the Company, or written representations from certain reporting persons, the Company believes that all filings required to be made by its reporting persons complied with all applicable Section 16 filing requirements during the last fiscal year with one exception: Dr. Barbara K. Rimer, a Director,Frederic Jean Guy Simard, an executive officer, did not timely report the saleon Form 4 a purchase of 1,005122 shares of stockthe Company’s Common Stock executed on December 11, 2020.November 9, 2023 in his 401(k) Plan. A Form 4 forreporting this transaction was filed on December 16, 2020.

68Aflac Incorporated
8, 2023.


2024 PROXY STATEMENT83

SOLICITATION AND REVOCATION
OF PROXY

Table of Contents

Solicitation and Revocation of Proxy

This Proxy Statement is furnished to shareholders in connection with the solicitation of proxies by the Company’s Board of Directors (the “Board”), on behalf of the Company, for use at the Annual Meeting of Shareholders to be held on Monday, May 3, 20216, 2024 for the purposes set forth in the accompanying Notice of Annual Meeting and described in detail herein, and any adjournment of that meeting. The Annual Meeting will be held at 10 a.m. Eastern Time. We continue to monitor developments regarding the coronavirus (COVID-19). In the interest of the health and well-being of our shareholders, the Annual Meeting will be heldTime solely by means of remote communication in a virtual meeting format. Details on how to participate are available at www.virtualshareholdermeeting.com/AFL2021AFL2024 and investors.aflac.com.

The mailing address of our principal executive offices is Aflac Incorporated, 1932 Wynnton Road, Columbus, Georgia 31999.

All properly executed proxies returned to the Company will be voted in accordance with the instructions contained thereon. If you return your signed proxy with no voting instructions indicated, the proxy will be voted FOR the election of all Director nominees named in this Proxy Statement and FOR approval of Proposals 2 and 3, and according to the discretion of the proxy holders on any other matters that may properly come before the Annual Meeting or any postponement or adjournment thereof. If you are a shareholder of record, you also may submit your proxy online or by telephone in accordance with the procedures set forth in the enclosed proxy. Shareholders can revoke a proxy at any time before it is exercised by giving written notice to that effect to the Corporate Secretary of the Company or by submitting a later-dated proxy or subsequent internet or telephonic proxy.

This Proxy Statement and the accompanying proxy are being first delivered to shareholders on or about March 18, 2021.

21, 2024.

Solicitation of Proxies

The Company will pay the cost of soliciting proxies. The Company will make arrangements with brokerage firms, custodians, and other fiduciaries to send proxy materials to their customers, and will reimburse these entities for the associated mailing and related expenses. In addition, certain officers and other employees of the Company may solicit proxies by telephone and by personal contacts, but those individuals will not receive additional compensation for these efforts. The Company has retained Georgeson LLC to assist in the solicitation of proxies for a fee of $10,000, plus reimbursement of reasonable out-of-pocket expenses.

Proxy Materials and Annual Report

As permitted by SEC rules, we are making these proxy materials available to our shareholders electronically. We believe providing online access to our critical documents will conserve natural resources and reduce the costs of printing and distributing our proxy materials. Accordingly, we have mailed to most of our shareholders a notice about the internet availability of this Proxy Statement and the Company’s Annual Report on Form 10-K for the year ended December 31, 20202023 (“Annual Report”) instead of paper copies of those documents. The notice contains instructions on how to access our reports online, how to vote at proxyvote.com, and how to request and receive a paper copy of our proxy materials, including this Proxy Statement and our Annual Report. If you select the online access option for the Proxy Statement, Annual Report, and other account mailings, you will receive an electronic notice of availability of your proxy materials. If you do not receive a notice and did not already elect online access, you will receive a paper copy of the proxy materials by mail.

For future documents, registered shareholders may select a method of delivery by visiting https://shareholder.broadridge.com/aflac. If you own shares indirectly through a broker, bank, or other nominee, please contact your financial institution for additional information regarding delivery options.

2021 Proxy Statement69


84AFLAC INCORPORATEDSOLICITATION AND REVOCATION OF PROXY

Table of Contents

Solicitation and Revocation of Proxy

Multiple Shareholders Sharing the Same Address

The Company is sending only one Annual Report and one Proxy Statement or notice of availability of these materials to shareholders who consented and who share a single address. This is known as “householding.” However, any registered shareholder who wishes to receive a separate Annual Report or Proxy Statement may contact Shareholder Services by phone at (706) 596-3581, by email at shareholder@aflac.com, or by mail at the address set forth above and we will promptly provide additional copies. If you receive multiple copies of the Annual Report or Proxy Statement or notice of availability of these materials, you may request householding by contacting Shareholder Services (if you are a registered shareholder) or by contacting the holder of record (if you own the Company’s shares through a bank, broker, or other holder of record).

Description of Voting Rights

The Company believes that long-term shareholders should have a greater say in our success. Accordingly, as approved by shareholders, the Company’s Articles of Incorporation provide that each share of the Company’s Common Stock is entitled to one vote (“short-term shares”) until it has been held by the same beneficial owner for a continuous period of longer than 48 months prior to the record date of the meeting, at which time each share becomes entitled to ten votes.votes (“long-term shares”). If a share is transferred by gift, devise, or bequest, or otherwise through the laws of inheritance, descent, or distribution from the estate of the transferor, or by distribution to a beneficiary of shares held in trust, the transferee is deemed to be the same beneficial owner as the transferor for purposes of determining the number of votes per share. Shares acquired as a direct result of a stock split, stock dividend, or other distribution with respect to existing shares are deemed to have been acquired and held continuously from the date on which the underlying shares were acquired. Shares of Common Stock acquired pursuant to the exercise of a stock option are deemed to have been acquired on the date the option was granted.

The Company’s time-phased voting rights differ significantly from dual-class share structures as neither the long-term shares nor the short-term shares (1) have a preference over the other with regard to dividends or upon liquidation, (2) carry any preemptive rights enabling a holder to subscribe for or receive shares, (3) are entitled to vote cumulatively for Directors, or (4) differ in any respect other than the additional voting rights.
The Company’s voting rights structure was approved by over 90% of our shareholders in 1985 and serves to amplify the voice of long-term shareholders by providing them, regardless of affiliation or views on management or the Board, with more say by virtue of their longer financial commitment to the Company.
Shares of Common Stock held in “street” or “nominee” name are presumed to have been heldbe short-term shares (held for less than 48 monthsmonths) and are entitled to one vote per share unless this presumption is rebutted by evidence to the contrary. If you wish to demonstrate that you have held your Common Stock in street name for longer than 48 months, please complete and execute the affidavit appearing on the reverse side of your proxy. The Board may require evidence to support the affidavit.

Quorum and Vote Requirements

Holders of record of Common Stock at the close of business on February 23, 2021,27, 2024, will be entitled to vote at the Annual Meeting. At that date, the number of outstanding shares of Common Stock entitled to vote was 687,600,156.575,408,110. According to the Company’s records, this represents the following voting rights:

Number of shares Votes per share Yields this many votes
640,276,788@1=640,276,788
47,323,368@10=473,233,680
687,600,156 Total 1,113,510,468

Number of sharesVotes per shareYields this many votes
484,220,652@1=484,220,652
91,187,460@10=911,874,600
575,408,110 Total1,396,095,252
If all of the outstanding shares were entitled to ten votes per share, the total number of possible votes would be 6,876,001,560.5,754,081,100. However, for purposes of this Proxy Statement, we assume that the total number of votes that may be cast at the Annual Meeting will be 1,113,510,468.

1,396,095,252.

The holders of shares representing a majority of the voting rights entitled to vote at the Annual Meeting, present in person or represented by proxy, will constitute a quorum for the transaction of any business that comes before the meeting. Abstentions are counted as “shares present” for purposes of determining whether a quorum exists. A broker non-vote occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner. Broker non-votes are counted as “shares present” at the Annual Meeting for purposes of determining whether a quorum exists.

70Aflac Incorporated


SOLICITATION AND REVOCATION OF PROXY2024 PROXY STATEMENT85

Table of Contents

Solicitation and Revocation of Proxy

The following table shows the voting requirements for each proposal we expect at the Annual Meeting.

ProposalVote required to PassEffect of abstentions and broker non-votes
Uncontested election of directorsVotes cast for a nominee exceed votes cast against that nomineeAbstentions and broker non-votes are not counted as votes cast and have no effect
Advisory say-on-payMajority of the votes castAbstentions and broker non-votes are not counted as votes cast and have no effect
Ratification of the Independent Registered Public Accounting FirmMajority of the votes castAbstentions are not counted as votes cast and have no effect. Brokers and other nominees may vote without instructions with respect to this proposal, so we do not expect broker non-votes.

If a nominee who is already serving as a Director is not re-elected at the Annual Meeting in an uncontested election, Georgia law provides that Director would continue to serve on our Board as a “holdover director.” However, our Director Resignation Policy, which is part of the Company’s Guidelines on Significant Corporate Governance Issues, provides that holdover directors must tender a resignation to our Chairman of the Board. The Corporate Governance Committee will consider such resignation and recommend to the Board whether to accept or reject it. In considering whether to accept or reject the tendered resignation, the Corporate Governance Committee will consider all factors its members deem relevant, including the stated reasons why shareholders voted against such Director, the qualifications of the Director, and whether the resignation would be in the best interests of the Company and its shareholders. The Board will formally act on the Corporate Governance Committee’s recommendation no later than ninety days following the date of the Annual Meeting at which the election occurred. The Company will, within four business days after such decision werewas made, publicly disclose that decision in a Form 8-K filed with the SEC, together with a full explanation of the process by which the decision was made and, if applicable, the reasons for rejecting the tendered resignation. If there were a nominee who was not already serving as a Director, and that individual was not elected at the Annual Meeting, that nominee would not become a Director or a holdover director.

In a contested election at an annual meeting of shareholders (meaning the number of nominees exceeds the number of Directors to be elected), the standard for election of Directors would be a plurality of the shares represented in person or by proxy at such meeting and entitled to vote on the election of Directors.

Effect of Not Casting a Vote

If you hold your shares in street name, it is critical that you provide voting instructions to the record owner. Your bank or broker is not permitted to vote shares you hold in street name without your instructions in the election of Directors (Proposal 1) or on the advisory vote on executive compensation (Proposal 2). Broker non-votes on these matters will have no effect on the outcome of the proposals. Your bank or broker may vote uninstructed shares on the ratification of the appointment of the Company’s independent registered public accounting firm (Proposal 3).

If you are a shareholder of record and you do not return your proxy card, no votes will be cast on your behalf on any item of business at the Annual Meeting.

2021 Proxy Statement71


86AFLAC INCORPORATED

OTHER MATTERS

Table of Contents

Other Matters

The Board is not aware of any matters that are expected to come before the 20212024 Annual Meeting other than those referred to in this Proxy Statement. If any other matter should come before the Annual Meeting, the people named in the accompanying proxy (or their substitutes) intend to vote the proxies in accordance with their best judgment.

Submission of Shareholder Proposals and Nominations for the 20222025 Annual Meeting

Proposals for Inclusion in our 20222025 Proxy Materials

SEC rules permit shareholders to submit proposals to be included in our materials if the shareholder and the proposal satisfy the requirements specified in Rule 14a-8 under the Securities Exchange Act of 1934. For a shareholder proposal to be considered for inclusion in our proxy materials for the 20222025 Annual Meeting of Shareholders, the proposal must be received at the address provided below byon or before November 18, 2021.

21, 2024.

Director Nominations for Inclusion in our 20222025 Proxy Materials Pursuant to our Proxy Access Bylaw

Our proxy access Bylaw permits a shareholder (or a group of up to twenty shareholders) who owns shares of our outstanding Common Stock representing at least 3% of the votes entitled to be cast on the election of Directors, and who has owned such shares continuously for at least three years, to nominate and include in our proxy materials Director candidates constituting up to 20% of the Board, if the nominating shareholder(s) and the nominee(s) satisfy the requirements specified in our Bylaws. For the 20222025 Annual Meeting of Shareholders, notice of a proxy access nomination must be received at the address provided below between October 19, 2021,22, 2024, and November 18, 2021.

21, 2024. The notice of a proxy access nomination must also comply with the additional notice requirements of SEC Rule 14a-19(b).

Other Proposals or Director Nominations to be Brought Before our 20222025 Annual Meeting

Our Bylaws set forth procedures for shareholders who wish to propose items of business or to nominate Director candidates that are not intended to be included in our proxy materials. For the 20222025 Annual Meeting of Shareholders, notice of such proposals or nominations must be received at the address provided below between January 3, 2022,6, 2025, and February 2, 2022.5, 2025. In the unlikely event the Company moves the 20222025 Annual Meeting of Shareholders to a date that is more than 25 days before or after the date that is the one-year anniversary of this year’s Annual Meeting date (i.e., May 3, 2021)6, 2024), the Company must receive such notice no later than the close of business on the 10th 10th day following the day on which notice of the meeting date is first mailed to shareholders or the Company makes a public announcement of the meeting date, whichever occurs first.

In addition to satisfying the foregoing requirements and other procedures set forth under the Company’s Bylaws, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Securities Exchange Act of 1934 no later than March 7, 2025.
Address for Submission of Notices and Additional Information

All shareholder nominations of individuals for election as Directors or proposals of other items of business to be considered by shareholders at the 20222025 Annual Meeting of Shareholders (whether or not intended for inclusion in our proxy materials) must be submitted in writing to our Corporate Secretary at Aflac Incorporated, 1932 Wynnton Road, Columbus, Georgia 31999.

Both the proxy access and the advance notice provisions of our Bylaws require a shareholder’s notice of a nomination or other item of business to include certain information. Director nominees also must meet certain eligibility requirements. If you wish to introduce a nomination or other item of business, please review our Bylaws.

72Aflac Incorporated


OTHER MATTERS2024 PROXY STATEMENT87

Cautionary Note Regarding Forward-Looking Statements

Table

The Private Securities Litigation Reform Act of Contents

Other Matters

1995 provides a safe harbor to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The Company desires to take advantage of these provisions. Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results, environmental, social, and governance matters, or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as the ones listed below or similar words, as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements.

expect
anticipate
believe
goal
objective
aims
may
should
estimate
intends
projects
plans to
will
assumes
potential
target
outlook
Our actual future results and trends may differ materially from those we anticipate depending on a variety of factors, including, but not limited to, the risks and uncertainties discussed in our Annual Report

on Form 10-K for the year ended December 31, 2023 and subsequent reports filed with the SEC. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or for any other reason.

Annual Report
The Company has delivered a copy of its 20202023 Annual Report on Form 10-K to each shareholder entitled to vote at the 20212024 Annual Meeting of Shareholders. It is also available via the Internet by going to https://investors.aflac.com and selecting “SEC Filings” under the “Financials” section as well as at the website of the United States Securities and Exchange Commission at www.sec.gov. For a printed copy, contact Shareholder Services by phone at (706) 596-3581, by email at shareholder@aflac.com, or by mail at:

Shareholder Services
Aflac Incorporated
Worldwide Headquarters
1932 Wynnton Road
Columbus, Georgia 31999

Exercise Your Right to Vote

The Company encourages you to vote. Please vote by internet or telephone, or sign, date, and return your proxy or voting instruction form in the prepaid envelope you received if you requested paper copies of our proxy materials. We encourage you to attend our virtual 20212024 Annual Meeting on May 3, 2021.6, 2024. For more information on voting and attending the virtual Annual Meeting, please see the “Notice of 20212024 Annual Meeting of Shareholders” and the “Attending the Virtual Annual Meeting” sections.

By order of the Board of Directors,

page01_sigmilk.jpg
J. Matthew Loudermilk

CorporateSecretary


March 18, 2021

2021 Proxy Statement73
21, 2024


88AFLAC INCORPORATED

Table of Contents

AppendixAPPENDIX ADefinition of Non-U.S.DEFINITION OF NON-U.S. GAAP Measures and Reconciliations to CorrespondingMEASURES AND RECONCILIATIONS TO CORRESPONDING U.S. GAAP Measures

The Proxy StatementMEASURES

This document includes references to the Company’s financial performance measures; adjusted earnings; adjusted earnings per diluted share, excluding current period foreign currency impact; adjusted revenues, excluding current period foreign currency impact; amortized hedge costs/income; and adjusted return on equity (“AROE”). (References in this Proxy Statement such as “currency-neutral” or “excluding the impact of foreign currency” are synonymous with “excluding foreign currency impact.”) These measures which are not calculated in accordance with “U.S. GAAP,” but this appendix provides reconciliations to each of the most comparable U.S. GAAP measures.

TheseUnited States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. The Company’s management uses adjusted earnings and adjusted earnings per diluted share, excluding foreign currency impact, to evaluate the financial performance of the Company’s insurance operations on a consolidated basis, and believes that a presentation of these measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business.

The Company defines adjusted earnings as the profits derived from operations. The most comparable U.S. GAAP measure is net earnings. Adjusted earnings are adjusted revenues less benefits and adjusted expenses. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding net investment gains and losses, except for amortized hedge costs/income related to foreign currency exposure management strategies and net interest cash flows from derivatives associated with certain investment strategies. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company’s underlying business performance.

Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company’s Japan segment or in the Corporate and Other segment. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight line basis over the term of the hedge. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income. The Company believes that amortized hedge costs/income, which are a component of adjusted earnings, measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income.

Adjusted return on equity (ROE) excluding foreign currency impact is calculated using adjusted earnings excluding current period foreign currency impact divided by average shareholders’ equity, excluding accumulated other comprehensive income. The most comparable U.S. GAAP financial measure is return on average equity as determined using net earnings and average total shareholders’ equity.

Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. The most comparable U.S. GAAP measure is net earnings.

Adjusted earnings per diluted share excluding current period foreign currency impact are adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The most comparable U.S. GAAP measure is net earnings per share.

74Aflac Incorporated

Table of Contents

Appendix – Definition of Non-U.S. GAAP Measures and Reconciliations to Corresponding U.S. GAAP Measures

Adjusted revenues, excluding current period foreign currency impact are adjusted revenues calculated using the average foreign currency exchange rate for the comparable prior year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. The most comparable U.S. GAAP measure is total revenues.

Due to the size of Aflac Japan, whosewhere the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on the Company’s reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company’s financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts on book value and the currency-neutral operating performance over time.

The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The Company defines the non-U.S. GAAP financial measures included in this document as follows:
Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company’s underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.
Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company’s business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.
Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the


APPENDIX A - DEFINITION OF NON-U.S. GAAP MEASURES AND RECONCILIATIONS TO CORRESPONDING U.S. GAAP MEASURES2024 PROXY STATEMENT89
impact of interest cash flows from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.
Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company’s Japan segment or in Corporate and other. These amortized hedge costs/ income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the term of the hedge. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.
Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.
Adjusted return on equity excluding foreign currency impact is adjusted earnings excluding the current period foreign currency impact divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). The Company considers adjusted return on equity excluding foreign currency impact important as it excludes changes in foreign currency and components of AOCI, which fluctuate due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency impact is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.
Adjusted revenues excluding current period foreign currency impact are adjusted revenues calculated using the average foreign currency exchange rate for the comparable prior year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes that are outside management’s control. The most comparable U.S. GAAP financial measure for adjusted revenues excluding current period foreign currency impact is total revenues.
Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. The Company considers adjusted book value important as it excludes AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measure for adjusted book value is total book value.
Aflac Japan net earned premium (as adjusted for MIP) is a measure that adjusts Aflac Japan's net earned premiums under U.S. GAAP for certain variables including the change in deferred profit liability (DPL) on limited payment contracts, any in-year reinsurance transactions that are not in Plan, and earned premiums from Aflac Pet Small amount-and-Short-term Insurance Co., Ltd. that are excluded from the Company’s MIP basis. The most comparable U.S. GAAP measure is net earned premiums.
Amounts reported in this Proxy Statement may not foot due to rounding.


90AFLAC INCORPORATEDAPPENDIX A - DEFINITION OF NON-U.S. GAAP MEASURES AND RECONCILIATIONS TO CORRESPONDING U.S. GAAP MEASURES
Reconciliations of Non-U.S. GAAP Measures

The tables on the following pages provide reconciliations of adjusted earnings and adjusted earnings per diluted share, each excluding foreign currency impact, adjusted net investment gains and losses, adjusted net investment income, adjusted return on equity excluding foreign currency, and adjusted revenues excluding current period foreign currency, impact, to the most directly comparable U.S. GAAP measures for the years ended December 31, 20202023 and 2019.

RECONCILIATION OF U.S. GAAP NET EARNINGS TO ADJUSTED EARNINGS2022.

RECONCILIATION OF U.S. GAAP NET EARNINGS TO ADJUSTED EARNINGS
(Excluding Foreign Currency)
In MillionsPer Diluted Share
Twelve Months Ended December 31,2023202220232022
Net earnings$4,659 $4,418 $7.78 $6.93 
Items impacting net earnings:
Adjusted net investment (gains) losses(1)
(914)(447)(1.53)(.70)
Other and non-recurring (income) loss(39)(1)(.07).00
Income tax (benefit) expense on items excluded from adjusted earnings(2)
26 (357).04(.56)
Adjusted earnings3,733 3,614 6.23 5.67
Current period foreign currency impact(3)
113 N/A.19N/A
Adjusted earnings excluding current period foreign currency impact$3,847 $3,614 $6.43 $5.67 
(1)

(EXCLUDING FOREIGN CURRENCY)

  In Millions  Per Diluted Share 
Twelve Months Ended December 31,                                        2020  2019  2020  2019
Net earnings $   4,778  $   3,304  $     6.67  $     4.43 
Items impacting net earnings:                
Net investment (gains) losses(2),(3),(4),(5)  229   15   .32   .02 
Other and non-recurring (income) loss  28   1   .04   .00 
Income tax (benefit) expense on items excluded from adjusted earnings  (72)  (3)  (.10)  .00 
Tax reform adjustment(6)  0   (4)  .00   (.01)
Tax valuation allowance release(7)  (1,411)  0   (1.97)  .00 
Adjusted earnings  3,552   3,314   4.96   4.44 
Current period foreign currency impact(8)  (31)  N/A   (.04)  N/A 
Adjusted earnings excluding current period foreign currency impact $3,521  $3,314  $4.92  $4.44 

(1)Amounts may not foot due to rounding.
(2)Amortized hedge costs of $206 in 2020 and $257 in 2019, related to certain foreign currency exposure management strategies have been reclassified from net investment gains (losses) and included in adjusted earnings as a decrease to net investment income.
(3)Amortized hedge income of $97 in 2020 and $89 in 2019, related to certain foreign currency exposure management strategies have been reclassified from realized investment gains (losses) and included in adjusted earnings as increase to net investment income.
(4)Net interest cash flows from derivatives associated with certain investment strategies of $12 in 2020 and $(17) in 2019 have been reclassified from net investment gains (losses) and included in adjusted earnings as a component of net investment income.
(5)A gain of $56 in 2020 and $66 in 2019, respectively, related to the interest rate component of the change in fair value of foreign currency swaps on notes payable have been reclassified from net investment gains (losses) and included in adjusted earnings as a component of interest expense.
(6)The impact of Tax Reform was adjusted in 2019 as a result of additional guidance released by the IRS.
(7)One-time tax benefit recognized in 2020 representing the release of valuation allowances on deferred foreign tax credits due to new tax regulations
(8)Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

2021 Proxy Statement75
See reconciliation of net investment (gains) losses to adjusted net investment (gains) losses below.
(2)Includes release of $452 million in deferred taxes in 2022.
(3)Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.
Prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.
RECONCILIATION OF U.S. GAAP NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES
In Millions
Twelve Months Ended December 31,20232022
Net investment (gains) losses$(590)$(363)
Items impacting net investment (gains) losses:
Amortized hedge costs(157)(112)
Amortized hedge income121 68 
Net interest cash flows from derivatives associated with certain investment strategies(328)(90)
Interest rate component of the change in fair value of foreign currency swaps on notes payable41 50 
Adjusted net investment (gains) losses$(914)$(447)
RECONCILIATION OF U.S. GAAP NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME
In Millions
Twelve Months Ended December 31,20232022
Net investment income$3,811 $3,656 
Items impacting net investment income:
Amortized hedge costs(157)(112)
Amortized hedge income121 68 
Net interest cash flows from derivatives associated with certain investment strategies(328)(90)
Adjusted net investment income$3,447 $3,522 


APPENDIX A - DEFINITION OF NON-U.S. GAAP MEASURES AND RECONCILIATIONS TO CORRESPONDING U.S. GAAP MEASURES2024 PROXY STATEMENT91

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE
(Excluding Impact of Foreign Currency)
Twelve Months Ended December 31,20232022
U.S. GAAP ROE - Net earnings(1)
22.1 %23.8 %
Impact of excluding unrealized foreign currency translation gains (losses)(3.1)%(2.5)%
Impact of excluding unrealized gains (losses) on securities and derivatives.2 %4.1 %
Impact of excluding effect of changes in discount rate assumptions(1.9)%(8.2)%
Impact of excluding pension liability adjustment— %(.1)%
Impact of excluding AOCI(4.9)%(6.8)%
U.S. GAAP ROE - less AOCI17.2 %17.0 %
Differences between adjusted earnings and net earnings(2)
(3.4)%(3.1)%
Adjusted ROE - reported13.8 %13.9 %
Less: Impact of foreign currency(3)
(.4)%N/A
Adjusted ROE, excluding impact of foreign currency14.2 %13.9 %

Table of Contents

Appendix – Definition of Non-U.S. GAAP Measures and Reconciliations to Corresponding

(1)U.S. GAAP Measures

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE is calculated by dividing net earnings (annualized) by average shareholders’ equity.

(2)See separate reconciliation of net income to adjusted earnings.
(3)Impact of foreign currency is calculated by restating all foreign currency components of the income statement to the weighted average foreign currency exchange rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure..
Prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.
RECONCILIATION OF U.S. GAAP TOTAL REVENUES TO ADJUSTED REVENUES
(Excluding Current Period Foreign Currency Impact)
In Millions
Twelve Months Ended December 31,20232022
Total Revenues - U.S. GAAP$18,701 $19,140 
Add: Total U.S. GAAP Realized Losses(590)(363)
Add: Realized capital gain/loss items included in Adjusted Revenue
Amortized hedge costs(157)(112)
Amortized hedge income121 68 
Interest cash flows on derivatives associated with investment strategies(328)(90)
Differences between adjusted revenues and total revenues
Adjusted revenues$17,747 $18,643 
Less: Impact of foreign currency(1)
(729)N/A
Adjusted revenues, excluding foreign currency impact$18,476 $18,643 
(1)

(EXCLUDING FOREIGN CURRENCY)

Twelve Months Ended December 31, 2020 2019
Net earnings - U.S. GAAP ROE(2)                                                     15.3%       12.6%
Impact of excluding unrealized foreign currency translation gains (losses)  (0.9)  (1.0)
Impact of excluding unrealized gains (losses) on securities and derivatives  6.2   3.6 
Impact of excluding pension liability adjustment  (0.2)  (0.1)
Impact of excluding AOCI  5.1   2.5 
U.S. GAAP ROE - less AOCI  20.3   15.1 
Differences between adjusted earnings and net earnings(3)  (5.2)   
Adjusted ROE - reported  15.1   15.2 
Less: Impact of foreign currency(4)  0.1   N/A 
Adjusted ROE, excluding impact of foreign currency  15.0   15.2 

(1)Amounts presented may not foot due to rounding.
(2)U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders’ equity.
(3)See separate reconciliation of net earnings to adjusted earnings.
(4)Impact of foreign currency is calculated by restating all yen components of the income statement to the weighted average yen rate for the comparable prior year period. The impact is the difference of the restated adjusted earnings compared to reported adjusted earnings. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.

RECONCILIATION OF U.S. GAAP TOTAL REVENUES TO ADJUSTED REVENUES(1)

(EXCLUDING CURRENT PERIOD FOREIGN CURRENCY IMPACT)

Twelve Months Ended December 31, 2020  2019
Total Revenue - U.S. GAAP                                               $   22,147  $   22,307 
Add: Total U.S. GAAP Net Investment Losses  270   135 
Add: Net investment gain/loss items included in Adjusted Revenue        
Amortized hedge (costs)/income  (109)  (168)
Interest cash flows on derivatives associated with investment strategies  12   (17)
Differences between adjusted revenues and total revenues        
Adjusted revenues $22,320  $22,256 
Less: Impact of foreign currency(2)  295   N/A 
Adjusted revenues, excluding foreign currency impact $22,025  $22,256 

(1)Amounts presented may not foot due to rounding.
(2)Impact of foreign currency is calculated by restating all yen components of the income statement to the weighted average yen rate for the comparable prior year period. The impact is the difference of the restated adjusted revenues compared to reported adjusted revenues. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.

76Aflac Incorporated
Impact of foreign currency is calculated by restating all yen components of the income statement to the weighted average yen rate for the comparable prior year period. The impact is the difference of the restated adjusted revenues compared to reported adjusted revenues. For comparative purposes, only current period income is restated using the weighted average prior period exchange rate, which eliminates the foreign currency impact for the current period. This allows for equal comparison of this financial measure.
Prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.
RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE
In Millions
December 31,20232022
U.S. GAAP book value$21,985 $20,140 
Less:
Unrealized foreign currency translation gains (losses)(4,069)(3,564)
Unrealized gains (losses) on securities and derivatives1,117 (729)
Effect of changes in discount rate assumptions(2,560)(2,100)
Pension liability adjustment(8)(36)
Total AOCI(5,520)(6,429)
Adjusted book value$27,505 $26,569 
Prior-year amounts have been adjusted for the adoption of accounting guidance on January 1, 2023 related to accounting for long-duration insurance contracts.


92AFLAC INCORPORATED

APPENDIX B – ATTENDING THE VIRTUAL ANNUAL MEETING

Table

The Board has made the decision that the Annual Meeting be held solely by means of Contents

Environmental, Social, and Governance

After publishing our first ESG Report in 2020, we have taken an additional step of further integrating our reporting by combining key elementsremote communication.

How to Join the Virtual Annual Meeting
Shareholders as of the Yearclose of business on February 27, 2024 (Record Date) are invited to attend the virtual Annual Meeting at www.virtualshareholdermeeting.com/AFL2024 by entering the 16-digit control number included on their proxy card or notice that they previously received. If you hold your shares in Review, which providedstreet name and did not receive a high-level view16-digit unique control number with your proxy materials, please contact your bank, broker, or other holder of operationsrecord as soon as possible to obtain a valid legal proxy and financials;for instructions on how to obtain a control number to be admitted to and to vote at the Corporate Social Responsibility Report andAnnual Meeting. Online access to the ESG Report, both of which featuredwebcast will open 15 minutes prior to the special way by which we balance profit and purposedesignated start time. Shareholders may submit questions in writing through the virtual meeting platform. Those who do not have a control number may attend as guests, but will not be able to make a difference. The result of our efforts are found in one place,vote shares or submit questions during the Aflac Incorporated’s 2020 Business and Sustainability Report, at esg.aflac.com to make it easier for our shareholders and stakeholders to find this information. These disclosures align withwebcast. While voting during the Global Reporting Initiative, United Nations Sustainable Development Goals, Task Force on Climate-Related Financial Disclosures, and the Sustainability Accounting Standards Board.

Atvirtual meeting will be permitted, Aflac Incorporated we strongly believe that ethics, corporate citizenship, and success go handencourages shareholders to vote in hand. All things being equal, we believe most people prefer doing business with a company that is also a good corporate citizen. Whether it is helping families facing childhood cancer, conducting business with ethics and grace, providing opportunity for our workforce, or being ever-mindfuladvance of our environment, serving the community while helping others is not onlymeeting.

Vote BEFORE the right thing to do, it makes good business sense. This philosophy is a partmeeting:
Vote by one of our daily operations, our culture, and our actions in the community.

Environment

More than 85% of the eligible buildings the Company owns and operates in the United States have earned Energy Star certification as measured by square footage. Energy Star certified buildings use less energy and contribute fewer greenhouse gas emissions to the environment.
Became the first insurance company in the United States to achieve both ISO 50001 Energy Management System and ISO 14001 Environmental Management Systems certifications, which help to implement technical and management strategies that significantly cut energy costs and greenhouse gas emissions – and sustain those savings over time.
Aflac Incorporated has reduced its combined Scope 1 and Scope 2 greenhouse gas emissions by more than 50% compared to its 2007 base line.

Social

Nearly 17,000 Aflac independent sales associates contribute more than $500,000 from their commission checks to the Aflac Cancer Center each month.
In 2020, our employees in the United States put in nearly 11,000 volunteer hours with community and charitable organizations.

Named to Fortune’s list of World’s Most Admired Companies for the 20th time.Included in Black Enterprise magazine’s list of the 50 Best Companies for Diversity for 13 years.
LATINA Style’s list of 50 Best Companies for Latinas to Work for in the United States for 21 years.For the second consecutive year, on the Bloomberg Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation, and transparency.

Governance

Named a World’s Most Ethical Company by the Ethisphere Institute for 15 consecutive years
Won IDG’s 2020 CSO50 Awards for security projects and initiatives demonstrating outstanding business value and thought leadership
Placed #1 by Security Magazine’s Security 500 rankings in the Insurance/Reinsurance sector in 2020


Table of Contents

Aflac and Sproutel introduced My Special Aflac Duck®, a “smart” robotic companion designed to help children who are undergoing cancer treatments. Aflac aims to put a My Special Aflac Duck in the hands of every child, above the age of 3, diagnosed with cancer in the U.S. and Japan – free of charge.2020 marked an important milestone for the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta: the 25th anniversary of its establishment. Since its doors first opened in 1995, Aflac employees, The Aflac Foundation, Inc. and independent sales agents have contributed more than $150 million to childhood cancer research and treatment.

1932 Wynnton Road, Columbus GA 31999
aflac.com

Visit AflacChildhoodCancer.org to learn more.


Table of Contents

AFLAC INCORPORATED
C/O BROADRIDGE CORPORATE ISSUER SOLUTIONS
P.O. BOX 1342
BRENTWOOD, NY 11717

(ONLY IF YOU AGREE WITH YOUR VOTING RIGHTS CAN YOU VOTE BY PHONE)
VOTE BY INTERNET
Before The Meeting - Go to www.proxyvote.com

Use the Internet to transmit your voting instructions and for electronic delivery of information. Votefollowing methods by 11:59 p.m. Eastern Time on May 2, 20215, 2024 for shares held directly and by 11:59 p.m. Eastern Time on April 28, 2021May 1, 2024 for shares held in a Plan. Have your proxy card in hand when you accessPlan:

page01_internet.jpg
page01_elephone.jpg
page01_mail.jpg
icon-qrcode.jpg
INTERNET
Visit www.proxyvote.com. You will need the 16-digit control number that appears on your proxy card or notice.
TELEPHONE
If your shares are held in the name of a broker, bank, or other nominee, follow the telephone voting instructions, if any, provided on your proxy card. If your shares are registered in your name, call 1-800-690-6903 and follow the telephone voting instructions. You will need the 16-digit control number that appears on your proxy card.
MAIL
If you received a full package by mail, complete and sign the proxy card and return it in the enclosed postage pre-paid envelope.
TABLET OR SMARTPHONE
Scan the QR code that appears on your proxy card or notice using your mobile device.
Vote DURING the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

During The Meeting - meeting:

Go to www.virtualshareholdermeeting.com/AFL2021

YouAFL2024.

Shareholders may attend the meeting via the Internet and vote during the meeting. Havevirtual Annual Meeting by following the information that is printedinstructions on the website above.
The meeting webcast will begin promptly at 10 a.m., Eastern Time, on Monday, May 6, 2024. We encourage you to access the meeting prior to the start time, as check-in will begin at 9:45 a.m. If you experience technical difficulties during the check-in process or during the meeting, please call the technical support number that will be posted on the virtual Annual Meeting log-in page for assistance.



05_424611-3_pic_myaflacduck.jpg
bc_backcoveroption3-2.jpg
In 2018, Aflac and Empath Labs introduced My Special Aflac Duck®, a “smart” robotic companion designed tohelp comfort children who are undergoing treatment for cancer and sickle cell disease. Aflac aims to put a My Special Aflac Duck in the box marked by the arrow availablehands of every child, age 3 and follow the instructions.

VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m. Eastern Time on May 2, 2021 for shares held directlyabove, diagnosed with cancer and by 11:59 p.m. Eastern Time on April 28, 2021 for shares held in a Plan. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL
Mark, sign and date your proxy card and return itsickle cell disease in the postage-paid envelope weU.S., Japan and Northern Ireland – free of charge.



In the U.S.: Since 1995, Aflac’s contributions to the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta have provided or returnexceeded the $173 million mark, helping to make it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.





TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
D35838-P48933KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
AFLAC INCORPORATED
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ALL DIRECTOR NOMINEES IN PROPOSAL 1 AND "FOR" PROPOSALS 2 AND 3.
The following proposals are being submitted to the Shareholders:
1.     to elect as Directors of the Company the eleven nominees
named in the accompanying Proxy Statement to serve until the
next Annual Meeting and until their successors are duly elected
and qualified;

Nominees:ForAgainstAbstain
1a.     Daniel P. Amos
1b.W. Paul Bowers
1c.Toshihiko Fukuzawa
1d.Thomas J. Kenny
1e.Georgette D. Kiser
1f.Karole F. Lloyd
1g.Nobuchika Mori
1h.Joseph L. Moskowitz
1i.Barbara K. Rimer, DrPH
ForAgainstAbstain
1j. Katherine T. Rohrer
1k. Melvin T. Stith
2.     to consider the following non-binding advisory proposal:
"Resolved, on an advisory basis, the shareholders of Aflac Incorporated approve the compensation of the named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and accompanying tables and narrative in the Notice of 2021 Annual Meeting of Shareholders and Proxy Statement"
3.to consider and act upon the ratification of the appointment of KPMG LLP as independent registered public accounting firm of the Company for the year ending December 31, 2021


Sign here as name(s) appear(s) on account. If acting as Attorney, Executor, Trustee or in other representative capacity, please sign name and title.

Signature [PLEASE SIGN WITHIN BOX]DateSignature (Joint Owners)Date


Table of Contents

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:

The Notice and Proxy Statement as well as the Annual Report on Form 10-K for the year ended
December 31, 2020 are available at www.proxyvote.com.

We have been advised that many states are strictly enforcing escheatment laws and requiring shares held in “inactive” accounts to be escheated to the state in which the shareholder was last known to reside. One way you can ensure your account is active is to vote your shares.

Therefore, it is very important that you vote. If you have moved, please provide your new address to Aflac Incorporated: Attn: Shareholder Services, 1932 Wynnton Road, Columbus, GA 31999; by phone 800.227.4756 or by email shareholder@aflac.com.

Please inform us if you have multiple accounts under more than one name.





D35839-P48933

AFLAC INCORPORATED
Worldwide Headquarters
1932 Wynnton Road, Columbus, Georgia 31999

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned hereby appoints Daniel P. Amos and Audrey Boone Tillman as Proxies or either of them, each with the power to appoint his or her substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side, all the shares of Common Stock of Aflac Incorporated held of record by the undersigned on February 23, 2021, at the Annual Meeting of the Shareholderstop pediatric cancer programs in the United States according to be held on Monday, May 3, 2021, at 10:00 a.m.U.S. News and World Report, or any adjournment thereof.

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN ACCORDANCE WITH THE INSTRUCTIONS OF THE UNDERSIGNED SHAREHOLDER. IN THE ABSENCE OF SPECIFIC INSTRUCTIONS, THIS PROXY WILL BE VOTED "FOR" ALL DIRECTOR NOMINEES IN PROPOSAL 1 AND "FOR" PROPOSALS 2 AND 3, AND ACCORDING TO THE DISCRETION OF THE PROXY HOLDERS ON ANY OTHER MATTERS THAT MAY PROPERLY COME BEFORE THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT THEREOF.

DESCRIPTION OF VOTING RIGHTS

positively impacting children with cancer and rare blood disorders, including sickle cell.

In accordance with the Company's Articles of Incorporation, shares of the Company's Common Stock, par value $.10 per share (the "Common Stock") are entitled toJapan: Since 2001, three Aflac Parents House locations (two in Tokyo and one vote per share until theyin Osaka) have been held by the same beneficial owner for a continuous period of greater than 48 months prior to the record date of the meeting, at which time they become entitled to 10 votes per share. Where a share is transferred to a transferee by gift, devise, or bequest, or otherwise through the laws of inheritance, descent, or distribution from the estate of the transferor, or by distribution to a beneficiary of shares held in trust for such beneficiary, the transferee is deemed to be the same beneficial owner as the transferor for purposes of determining the number of votes per share. Shares acquiredserved as a direct result of a stock split, stock dividend, or other distribution with respect to existing shares ("dividend shares") are deemed to have been acquiredhome-away-from-home for more than 150,000 pediatric patients and held continuously from the date on which the shares with regard to which the issued dividend shares were acquired. Shares of Common Stock acquired pursuant to the exercise of a stock option are deemed to have been acquired on the date the option was granted.

Shares of Common Stock held in "street" or "nominee" name are presumed to have been heldtheir family members while receiving treatment for less than 48 months and are entitled to one vote per share unless this presumption is rebutted by providing evidence to the contrary to the Board of Directors of the Company. Shareholders desiring to rebut this presumption should complete and execute the affidavit. The Board of Directors reserves the right to require evidence to support the affidavit.

Only if you do not agree with the voting rights shown on the front of this Proxy should you complete the following:

Affidavit
Under the penalties of perjury, I do solemnly swear that I am entitled to the number of votes set forth below because

I agree to provide evidence to support this statement at the request of the Company. Shares @1 Vote/Share= Votes
Sign hereX Shares @10 Votes/Share= Votes
XDate, 2021Total= Votes
serious illnesses, like cancer.



bc_backcoveroption3-4.jpg



proxycard1.jpg



proxycard2.jpg